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Abstract 
 
Streptomycetes represent a rich source of potentially useful therapeutics. However, in a 
laboratory environment, a large proportion of their secondary metabolite gene clusters 
remain silent, and thus their full metabolic potential is not realised. One way to unlock 
these so-called "cryptic" clusters may be to manipulate specific regulatory proteins. But, 
the vast majority of these regulators are uncharacterized, making it difficult to do this in a 
rational way. The MarR family of regulatory proteins (MFRs) represents an important 
group of transcriptional regulators. Named after the first to be characterized in 
Escherichia coli, the multiple antibiotic resistance repressor (MarR), the members of this 
family are involved in a number of biological processes which include antibiotic 
resistance, virulence, oxidative stress responses and pathogenesis and are therefore of 
significant clinical interest. There are 42 of these MFRs present in the genome of 
Streptomyces coelicolor, a prolific producer of secondary metabolites, the majority of 
which are uncharacterized. 
 
In this work, the crystal structures of three of these MFRs from Streptomyces coelicolor, 
Sco3914, Sco4122 and Sco5413, have been determined using anomalous dispersion 
methods. The structure of Sco5413 was determined to 1.25 Å resolution, the highest 
resolution for an MFR at this point. Genetic and biophysical analyses of these 
transcription factors have also been performed and the DNA footprints of Sco3914 and 
Sco4122 have been defined. Disruption mutants for each of the genes have been created 
and phenotypic analysis revealed a distinct phenotype for Sco5413. The structures do not 
reveal a ligand for any of the structures, but comparisons with other MFR structures 
provide some evidence towards a conserved ligand binding site amongst MFRs.  
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1.1   Introduction 
The widespread emergence of new forms of bacteria which are resistant to antibacterial 
compounds is a cause for concern and investigation. Bacteria have evolved strategies to 
enable them to evade destruction from previously very effective antibiotics such as the 
fluoroquinolones and vancomycin. Some of the proteins involved in this resistance have 
also been implicated in regulating virulence genes (MgrA, for example, which is a global 
regulator in Staphylococcus aureus), and so are of increasing clinical importance in the 
efforts to control pathogenic bacteria. Understanding the roles and mechanisms of these 
proteins will assist the development of new methods of fighting and controlling the 
diseases caused by these organisms. The existence of structural homologues in 
saprophitic bacteria which are also prolific producers of antibiotics, such as 
streptomycetes, offers a valuable platform for the study of the regulatory systems and 
signalling networks in operation. The fact that streptomycetes produce a vast number of 
natural products is also of interest as the biosynthetic gene clusters offer a huge resource 
which could be exploited. However, the regulation of the pathways involved in these 
gene clusters is complicated and the vast majority of the numerous regulatory proteins 
involved remain uncharacterized. This work details the genetic and biophysical analysis of 
selected transcription factors belonging to the MarR family from Streptomyces coelicolor.  
 
1.2   Streptomyces coelicolor  
Streptomyces coelicolor is the most studied of the actinomycetes and, as such, it is the 
ideal model system for the study of streptomycetes in general. Its complete genome was 
published in 2002 and its chromosome is over 8 Mb long with a G+C content of 72.1% and 
is predicted to contain 7825 protein encoding genes (Bentley et al., 2002). The 
streptomycetes produce a wide range of antibiotics and antifungal compounds as well as 
immunosuppressants and anti-tumour agents which are useful for cancer treatments. 
They produce over two thirds of the natural antibiotic agents currently in use and 
therefore present a wealthy natural resource. Streptomyces coelicolor itself produces four 
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distinct antibiotic compounds: the blue-pigmented actinorhodin; red-pigmented 
undecylprodigiosin; methylenomycin (Mmy) and calcium-dependent antibiotic (CDA). The 
pigmented antibiotics offer a useful tool for the study of phenotypical responses to 
environmental changes and mutations. 
 
The regulation of secondary metabolite biosynthesis in Streptomyces is the result of a 
complex interplay between a variety of signals and sensors. It is difficult to fully 
comprehend the method of regulation and indeed the precise roles of the secondary 
metabolites in a laboratory setting. Streptomycetes inhabit the soil and therefore exist in 
an environment where they frequently encounter and must respond to threats and 
stresses which are quite different to those encountered during a laboratory experiment.  
However, the interplay between the signals and response elements presents an 
interesting challenge to those who wish to understand and exploit the regulatory 
networks and cascades which make the streptomycetes such prolific producers of 
antibiotics.  
 
Figure 1.1  Colonies of Streptomyces coelicolor producing blue-pigmented actinorhodin 
 
In liquid medium, antibiotic production generally occurs during the stationary phase 
(Bibb, 2005) whereas on agar, antibiotic production can overlap with morphological 
differentiation (Takano et al., 1992). Streptomyces coelicolor contains several pleiotropic 
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genes which have a role in the regulation of antibiotic biosynthesis. Amongst these are 
afsR and absB. AfsR is a protein which exhibits pleiotropic regulatory activity upon 
antibiotic biosynthetic genes, but only when grown on certain media.  absB mutants were 
found to be deficient in antibiotic synthesis but were able to sporulate (Adamidis & 
Champness, 1992), indicating that this gene is involved in the specific regulation of 
antibiotic synthesis.  
 
Antibiotic production can be triggered by the presence of small, diffusible molecules such 
as γ-butyrolactone, a hormone involved in quorum sensing. These small molecules can 
also be produced in response to physiological and environmental stress factors. The 
phosphorylated guanine nucleotide, ppGpp, has been studied in relation to its influence 
upon antibiotic production and its role in regulatory networks (Bibb, 1996). 
 
1.3   Control of antibiotic biosynthesis 
Antibiotic biosynthesis occurs usually after the growth phase, particularly when there is a 
nutritional limitation in the immediate environment (Martin & Demain, 1980). Soil 
bacteria such as streptomycetes are particularly adept producers of antibiotics. Their 
environment would necessitate this as they often encounter other soil dwelling microbes 
and need to compete for resources. Prior to this stationary/linear growth phase, bacteria 
can be susceptible to their own antibiotic. Streptomyces antibioticus, for example, is 
inhibited 50% by 4 mg ml-1 of streptomycin during the growth phase, whereas it produces 
about 120 mg ml-1 during idiophase (Martin & Demain, 1980). Resistance occurs generally 
as the antibiotic is produced. This is further supported by the findings of a study upon the 
transcription of mmy and mmr during the biosynthesis of methylenomycin (Hobbs et al., 
1992). This study also observed the inhibition of actinorhodin synthesis by phosphate and 
gave methylenomycin as the sole antibiotic produced. The inhibition of actinorhodin 
production was purported to be at the level of transcription as no actIII transcripts were 
found in the culture containing 11 mM phosphate whereas both actIII and mmy 
transcripts were found in media containing 1 mM phosphate.  
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The Abs‾ phenotype revealed that mutations in the absA and abaB loci blocked antibiotic 
synthesis but not sporulation (Adamidis et al., 1990). This work determined that there are 
genes which are specifically involved in synthesis of antibiotics and, unlike the bld 
mutants, do not also affect morphological differentiation. This phenotype is not 
conditional upon the media used and as such, it provides a stepping stone to 
understanding how the antibiotic synthesis genes are regulated independent of genes 
associated with sporulation. Interestingly, it was also found that the absA mutants were 
as resistant to methylenomycin as the wild type strain, despite not producing antibiotic 
itself. Antibiotic resistance usually occurs following antibiotic synthesis and it is generally 
induced by the antibiotic or precursor molecules.  
 
Another locus, absB, also gives rise to the Abs‾  phenotype upon mutation  (Adamidis & 
Champness, 1992). Production of all four antibiotics was also blocked in this mutant. A 
mutation in this locus gave a mutant which was able to sporulate like the WT but was 
deficient in antibiotic synthesis. By cloning multiple copies of the actII-ORF4 gene into 
these mutants, production of actinorhodin was restored, suggesting that this gene is 
somehow regulated by absB. absA encodes a two-component signal transduction system 
(Brian et al., 1996) which is linked to the transcription of  actII-ORF4 and redD which code 
for actII-ORF4 and RedD: pathway specific transcriptional activators in the actinorhodin 
and undecylprodigiosin biosynthetic pathways respectively (Gramajo et al., 1993, Takano 
et al., 1992). They are OmpR-like DNA-binding proteins whose expression is regulated in a 
growth-phase dependent mechanism. AbsA1 is a sensor kinase whilst AbsA2 is a response 
regulator. absB encodes RNase III, a homologue of RNaseII from E. coli  (Price et al., 1999), 
which is a double-stranded RNA specific endoribonuclease. This enzyme is required for 
the regulation of antibiotic biosynthesis and for the formation of sporulation septa  (Sello 
& Buttner, 2008). Its specific mode of regulation has not been determined, but it has been 
suggested that it could degrade mRNA which encodes a repressor or activate other 
transcripts of genes involved in regulation (Aceti & Champness, 1998). It has recently 
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been shown that it regulates its own expression by cleaving its own transcript (Xu et al., 
2008) and participates in a post-transcriptional autoregulatory feedback loop with AdpA 
(Xu et al., 2010).  
 
Mutations of other loci involved in antibiotic synthesis, such as afsR and abaA, also 
revealed regulation systems which act independently of sporulation. afsR encodes a 
transcriptional activator with ATPase activity which is phosphorylated by a kinase, such as 
AfsK. AfsR is a pleiotropic regulator of genes involved in Act, Red and CDA production and, 
as it is phosphorylated by several kinases, it is capable of integrating a variety of signals 
(Bibb, 2005, Horinouchi, 2003). The abaA  mutation abolishes actinorhodin production 
and reduces the production of CDA and undecylprodigiosin, but synthesis of 
methylenomycin is unaffected (Fernandez-Moreno et al., 1992). 
 
The phosphorylated guanine nucleotide, ppGpp, is a secondary metabolite which is also 
known as a stringent factor. Synthesis of ppGpp occurs under conditions of amino acid 
starvation by the ribosome associated ppGpp synthetase, RelA. The synthesis of ppGpp 
was induced under conditions of sufficient nutrition by modification of the N-terminal of 
the ppGpp synthetase gene, relA (controlled by a thiostrepton-inducible promoter) 
(Hesketh et al., 2001). These induced concentrations of ppGpp were linked to the 
induction of transcription of actII-ORF4. There was no link found to the production of 
undecylprodigioisin. A ∆relA mutant strain of S. coelicolor, M570, was found to be unable 
to produce the pigmented actinorhodin and undecylprodigiosin. It was concluded that 
this RelA protein is involved in activating regulatory proteins in the antibiotic synthesis 
pathways.  A later study showed that Sco4336 was induced by the production of ppGpp 
(Hesketh et al., 2007). It is possible that this is related to the increase in transcription of 
actII-ORF4 and cdaR regulatory genes. There is some evidence to suggest that sco4336 
transposon mutants have a reduced ability to synthesize Act but only on certain media. 
This implies a global role for ppGpp synthesis in morphological differentiation and 
antibiotic production in S. coelicolor (2). 
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1.4   MarR Family of transcriptional Regulators (MFRs) 
The MarR family of proteins (MFRs) constitute a group of transcriptional regulators which 
regulate a diverse range of genes and consequent cellular processes. To date, there are 
over 13000 MFR sequences which have been annotated in genome databases 
(http://pfam.sanger.ac.uk/).  The structures of several members of the MarR family (MFR) 
have been solved by X-ray diffraction and they all contain the characteristic winged helix-
turn-helix (wHTH) DNA binding motif as well as being triangular in shape. They exist as 
homodimers in solution and typically bind anionic lipophilic effector molecules, such as 
salicylate, which modify the dimer's affinity for DNA (Wilkinson & Grove, 2006). Salicylate 
has been found to induce the expression of the mar operon  of Escherichia coli (Cohen et 
al., 1993b) and MarR was the first structure to have been solved with this ligand bound. 
Many subsequent studies of MFRs have focused on this ligand and several other 
structures have since been determined in complex with salicylate. The members of this 
family are transcriptional regulators which are involved in a variety of processes including 
antibiotic resistance, pathogenesis and aromatic catabolic pathways. Mutations in the 
mar locus were first implicated in the amplifiable resistance to multiple, unrelated 
antibiotics in E. coli (George & Levy, 1983) and clinical isolates of these drug-resistant 
mutants revealed multiple mutations in the marR gene (Maneewannakul & Levy, 1996). 
Thus, the role of MarR in regulating this operon is clearly of clinical interest. Over half of 
the MFRs which have been characterized are known to be autoregulatory (Wilkinson & 
Grove, 2006). Typically, they bind to pseudopalindromic sequences at sites which can 
overlap the -35 and/or -10 promoter regions of their target genes (Martin & Rosner, 
1995, Martin & Rosner, 2004, Wilkinson & Grove, 2006). This mode of binding would 
make it a steric inhibitor of RNA polymerase binding and thus a repressor of transcription. 
The majority of MFRs are repressors, but some have been shown to activate genes, for 
example, OhrR in Streptomcyes coelicolor (see section 1.4.2).  
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The mar locus has been well characterized, genetically and functionally (Cohen et al., 
1993a). Introduction of a mutant marR gave a slight increase in resistance to tetracycline, 
chloramphenicol and norfloxacin, strongly suggesting that MarR is a repressor of the 
marRAB operon (Cohen et al., 1993a). Further evidence that MarR is the repressor of 
marO was provided by incorporating multiple copies of the operator sequence in the 
genome which led to the reduced repression of the marRAB operon. MarA was found to 
have significant sequence identity to transcriptional activators (or positive regulators) 
found in E. coli such as AraC and RhaR (involved in carbohydrate metabolism) and SoxS, 
which is involved in oxidative stress response. The similarities between SoxS and MarA 
were more marked as they were both relatively short proteins whilst the carboxy-
terminal ends of these proteins have a higher homology to the other proteins of this 
family. The C-terminal domains are thought to be the DNA-binding domains and they 
have the characteristic helix-turn-helix motifs.  This work follows on from an earlier study 
which concluded that Mar mutants had a reduced expression of the outer membrane 
porin, OmpF (Cohen et al., 1989). The study went on to investigate the role of marA upon 
this phenotype: by inserting a Tn5 transposon into marA, it was found that OmpF 
expression was restored. marA affects the expression of micF, an antisense RNA which in 
turn decreases the amount of ompF mRNA available for translation (Mizuno et al., 1984). 
By fusing lacZ to ompF, it was determined that marA affects ompF post-transcriptionally. 
However, insertion of Tn5 into marA of Mar mutants only partially restored OmpF 
expression whilst it restored antibiotic susceptibility to that of the wild type strain. Clearly 
there are other factors involved in antibiotic resistance in Mar strains.  
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Figure 1.2  Diagramatic representation of the mar operon in E. coli. 
 
Several efflux pumps have been shown to contribute to the Mar phenotype: a study of 
the AcrAB efflux pump showed that the marR1 mutants did not exhibit the increased 
resistance of the Mar phenotype in the absence of this system, thereby asserting that it is 
necessary for antibiotic resistance in the Mar mutants (Okusu et al., 1996). In the marR1 
mutant, binding of this repressor to the marRAB operon was prevented resulting in the 
transcription of the operon. In the ∆acrAB strain, this MarR mutation was not seen to 
increase antibiotic resistance. In fact, it had the same level of resistance to five different 
antibiotics (with the exception of tetracycline) as did the ∆acrAB strain with wild type 
MarR.   
 
 
1.4.1 Structure of MarR 
The structure of MarR, shown in Figure 1.4, has been solved to 2.3 Å resolution (Alekshun 
et al., 2001) and it was the first reported structure of a MarR protein. MarR was shown to 
crystallize as a dimer and each subunit is an αβ-protein which can be divided into two 
domains. An α-helical interface composed of the N- and C- terminal helices which 
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intertwine and connect the two subunits. The DNA-binding domain was recognized by the 
characteristic arrangement of secondary elements: H1-S1-H2-H3-S2-W1-S3 (Figure 1.3) 
(Gajiwala & Burley, 2000) and the electropositive surface residues of this region.  
 
Figure 1.3  Topology of the winged helix motif as presented by Gajiwala and Burley, 2000. 
 
In E. coli MarR, α4 was proposed to be the DNA recognition helix (equivalent of H3 in the 
model depicted in Figure 1.3) and W1 is also implicated in DNA-interactions, based on 
mutations of residues in these regions which resulted in the abolition of DNA binding 
(Alekshun et al., 2000). R94C was found to abolish DNA-binding. This residue, along with 
D92, has been found to be highly conserved amongst the MarR family and the OhrR 
structure bound to DNA reveals the equivalent R94 interacts with the phosphate 
backbone of the minor groove. However, without a crystal structure of the protein bound 
to DNA, the precise interactions between residues and nucleotides in this protein is 
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unknown. MarR also has a pair of salt-bridges formed between R73 and D67' (and the 
reciprocal pair) which stabilize the interaction between these two subunits.   
 
Figure 1.4    A ribbon diagram of MarR as presented by Alekshun and Levy, 2001. The secondary structures 
of one monomer are labelled and coloured.  
 
Salicylate bound to MarR was determined clearly in this structure: two molecules can be 
observed per monomer. This contrasts with the study of MTH313 (Saridakis et al., 2008) 
which found only one salicylate bound per monomer. This binding site was found to be 
between the recognition helix and the dimer helical interface on each subunit of MTH313. 
In other words, they are not equivalent and the study reports that the first binding site 
induces a large conformational change, but not the second. Both salicylate binding sites 
of MarR are positioned either side of the DNA-recognition helix so that they could affect 
DNA binding. Indeed, salicylate has been shown to activate the mar operon (Cohen et al., 
1993b) and, specifically, it has been shown to  inhibit MarR (Alekshun & Levy, 1999). This 
salicylate-bound MarR structure cannot be modelled onto B-DNA (Wilkinson & Grove, 
2006) or superimposed onto the OhrR-ohrR complex, strongly suggesting that it is in a 
conformation which does not allow DNA binding. In the MTH313 models, the large, 
asymmetrical structural change which occurred on binding salicylate causes the DNA-
binding lobes to move apart by about 7 Å. The authors suggest that this open structure is 
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the inactive form which is incapable of DNA-binding. Comparing this structure to 
salicylate-bound MarR, they go on to argue that perhaps the MarR structure is actually in 
the active conformation as the separation of its lobes is similar to the apo (active) form of 
MTH313. This has since been disputed by Wilke et al. (2008): superimposing salicylate-
bound MTH313 onto DNA-bound Bacillus subtilis OhrR reveals that is is in fact well 
configured for DNA binding. Whichever conclusion is correct, it is evidently clear that the 
MarR proteins have significant structural flexibility which affects their DNA-binding 
abilities.  
 
1.4.2   MarR proteins have structural flexibility – HucR 
HucR is a MarR homologue from Deinococcus radiodurans, an extremely resilient 
bacterium whose genome encodes orthologues of nearly every known stress response 
protein. HucR binds to a pseudopalindromic sequence: 8 bp half-sites separated by 2 bp. 
This binding site is located in a shared promoter region between hucR and a putative 
uricase which could mean that there is a mechanism of simultaneous corepression 
between these two genes (as the substrate for uricase is uric acid which is an efficient 
antagonist of DNA binding by HucR) (Wilkinson & Grove, 2004). Uric acid is also a 
scavenger of reactive oxygen species, suggesting that HucR plays a role in resistance of D. 
radiodurans to oxidative stress. The structure of this MarR family member reveals that it 
has an extra N-terminal α-helix which participates in dimerization (Bordelon et al., 2006). 
The presence of two stacked histidines (His51 and His51') at the dimer interface suggests 
that these may participate in the pH-dependent DNA-binding mechanism. Circular 
dichroism spectra show that there is modification of the secondary structure of DNA upon 
binding of HucR (Wilkinson & Grove, 2005). Although there is no structure of HucR with 
ligand bound, the authors of this study concluded that there must be significant structural 
change upon binding of uric acid as the crystals cracked when transferred to mother 
liquor solution containing uric acid. Using site-directed mutagenesis and molecular-
modeling, the urate-binding site of HucR has been defined and Trp20 (located in the extra 
helix) and Arg80 (in the DNA-recognition helix) shown to be the critical residues for ligand 
interaction (Perera et al., 2009). The hypothesis is that HucR has the potential for 
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conformational flexibility observed in other MarR proteins and that this structural 
rearrangement is initiated by the binding of the ligand, urate, which propagates to the 
DNA recognition helices. Following the determination of the required residues for urate-
binding and communication of the presence of this ligand to the DNA-recognition helices, 
a new subfamily of MarR homologues has been proposed. This is based on the predicted 
conservation of function denoted by a urate-binding signature: the urate responsive 
transcriptional regulator (UrtR), and the family includes HucR, PecS from Agrobacterium 
tumefaciens (Perera & Grove, 2010b) and MftR from Burkholderia thailandensis (Grove, 
2010). Bioinformatic analysis of this subfamily found that the vast majority of the genes 
divergently transcribed to UrtRs annotated in sequence databases are membrane 
transporters. This proves interesting relating to the MFRs in S. coelicolor: Sco3133 is 
predicted to be a member of the UrtR subfamily and it is transcribed divergently to a 
putative trans-aconitate methyltransferase. The designation of such subfamilies indicates 
the growing wealth of information about MFRs and this should prove useful in exploiting 
their regulatory functions for clinical purposes. 
 
In this work, a structural homology model based on HucR was used in the structural 
solution of two MFRs. Particular attention is paid to the presence of the extra helix of 
HucR and how this relates to two of the models presented here.  
 
1.4.3 Organic hydroperoxide resistance in bacteria – thiol switches 
Some of the MFRs which have been characterized are known to participate in the 
regulation of multi-drug efflux pumps. MgrA is a MarR homologue which is a key global 
regulator of virulence and resistance genes in the human pathogen, Staphylococcus 
aureus. It is a pleiotropic regulator which regulates a vast number of genes (~350) in this 
organism (Luong et al., 2006). The transcription of multiple multidrug efflux pumps, 
including NorA and NorB (Truong-Bolduc et al., 2005), is regulated by MgrA and it is 
therefore responsible for mediating resistance to fluoroquinolones and vancomycin. It is 
located 7 kb from norA and 700 kb from norB (Truong-Bolduc et al., 2003). Microarray 
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analysis has shown  that MgrA can both negatively and positively regulate the same genes 
at different time points (Luong et al., 2006). The suggestion is that there are other 
regulators involved in other pathways during different stages of the organism’s growth 
and that some genes are indirectly regulated by this protein. Indeed, it has also been 
observed that MgrA can act as a repressor of genes where other proteins act as activators 
and vice versa. MgrA represses norB directly and activates abcA directly, whereas NorG (a 
GntR-like transcriptional regulator) behaves as a direct activator for norB and a direct 
repressor for abcA. Thus the complexity of the systems at work increases, but unravelling 
them offers much potential.  
 
The crystal structure of MgrA gave valuable clues as to its mechanism, suggesting that it 
operates by sensing reactive oxygen species via the oxidation of a cysteine located in the 
dimer interface on each monomer. Cys12 is the only cysteine residue found in the MgrA 
sequence and is located in helix α1. It can hydrogen bond with Ser113 and Tyr38 of the 
other monomer and therefore bears a similarity to the lone cysteine (Cys15) found in the 
oxygen sensing repressor, OhrR from Bacillus subtilis (Fuangthong & Helmann, 2002). The 
hydrogen bonds between Cys12 and the other two residues could be broken by oxidation, 
which could cause a conformational change resulting in DNA dissociation. This was found 
to be the case in this study which revealed that the MgrA-DNA complex in vitro did 
dissociate upon addition of a variety of oxidants, whilst the complex reformed upon 
addition of a dithiothreitol (DTT) (Chen et al., 2006). An MgrA C12S mutant remained in 
complex with the DNA under oxidizing conditions, confirming the oxidation of this specific 
residue in the wild type protein. This represents a strategy of regulating multiple 
pathways involved in defence and resistance with one protein which can sense the threat. 
It also offers a potential target for future drug development.   
 
The OhrR repressor in Bacillus subtilis participates in sensing organic hydroperoxides 
through conserved cysteine residues (Fuangthong & Helmann, 2002). It binds to the ohrA 
operator and represses this gene which encodes a protein involved in organic 
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hydroperoxide resistance (Fuangthong et al., 2001). Reactive oxygen species (ROS) such 
as organic hydroperoxides can cause irreversible damage to cells and DNA and so a 
mechanism of sensing the presence of these molecules and rendering them harmless has 
emerged in bacteria. Its mechanism varies between species and has been found to be 
dependent upon the number of cysteine residues.  These become oxidized which give rise 
to changes in conformation and thus affect binding to DNA. Such a mechanism can 
involve the formation of a reversible disulphide bridge, as is the case with OxyR in E. coli 
and MexR in Pseudomonas aeruginosa. In the case of BsOhrR (Bacillus subtilis), however, 
the mechanism involves a single cysteine residue (Cys15) which becomes oxidized to form 
cysteine-sulfenic acid. Conversely, OhrR from Xanthomonas campestris (XcOhrR) has 
three conserved cysteines, two of which can form intersubunit disulphide bonds upon 
oxidation: Cys22 and Cys127’ (Panmanee et al., 2006), which gives rise to a substantial 
conformational change and significant reorientation of the α4 helices rendering the 
protein incapable of binding to DNA.  
 
 OhrR also exists in S. coelicolor and falls into the same category as BsOhrR in that it has a 
single oxidizable cysteine, Cys28 (Oh et al., 2007). In this organism, OhrR works as a 
repressor of its own transcription and that of the divergently transcribed gene, ohrA, and 
ohrR when reduced by binding cooperatively to the operator region between the two 
genes and sterically blocking transcription by RNA polymerase (RNAP). Upon oxidation, it 
induces ohrA by derepression whilst ohrR is activated by the oxidized OhrR. In the 
oxidized state, it has a reduced affinity for DNA but a dimer may still remain bound and 
acts as an activator by promoting the recruitment of RNAP. This dual role is different to 
the role of OhrR in Bacillus subtilis which, as far is known, only represses the ohrA gene 
under reducing conditions. The ability of Cys28 to sense organic peroxides and the 
regulatory response of OhrR were established through the creation of a C28S mutant. The 
affinity of this mutant for the DNA probe was unaffected following treatment with an 
oxidant, indicating the role of this residue in the redox regulation of the protein. 
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The actual mechanisms involved in some of these reactive cysteine proteins have been 
described in several studies which have found that there is a sulfenic acid intermediate 
involved in the reaction, and this applies to both single and multiple cysteine sensors. The 
difference is the subsequent reaction whereby the disulphide bond is formed between 
the single cysteine and a low molecular weight (LMW) thiol, or the two cysteines present 
in the protein molecule react with each other to form a disulphide bond.  
 
SarZ, another single cysteine MFR which is redox active, undergoes a cysteine oxidation 
reaction when exposed to organic hydroperoxides (OHPs) which disrupts DNA binding 
(Poor et al., 2009). Cys13 forms a sulfenic acid intermediate which was shown to be 
insufficient for derepression. It undergoes a further reaction with LMW thiols present in 
the cell to form a mixed disulphide (S-cysteinylation). This inactivates the protein and thus 
derepresses the gene. The crystal structures of the reduced (SarZ-SH), sulfenic acid (SarZ-
SOH) and disulphide-modified (SarZ-BT) forms of SarZ demonstrate how the disruption of 
a hydrogen-bonding network surrounding the Cys13 caused by disulphide formation and 
the subsequent movement of Phe117’ culminates in the conformational change which 
results in the dissociation of the protein from DNA. This allosteric mechanism defines the 
complete picture for the single cysteine regulatory proteins.  
 
Figure 1.5  Superimposed crystal structures of SarZ in the reduced (dark red), mixed disulphide (blue) and 
sulfenic acid (yellow) forms.  
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Most recently, a study on the MarR type regulator, HypR, has provided further insights 
into the mechanisms of the dual cysteine class of repressors. The crystal structures of 
both the reduced and oxidized forms of this protein have been determined and revealed 
structural changes in the protein which result in the movement of the α4 helices towards 
each other by 4 Å (Palm et al., 2012). HypR is activated by sodium hypochlorite (NaOCl) 
stress which induces the formation a Cys14-Cys49’ intersubunit disulphide bond. This 
results in the transcription of hypO which encodes a putative nitroreductase. Cys14 is well 
conserved in other N-terminal cysteine containing MarR homologues. This work also 
determined the pKa values of the cysteines and found Cys14 has a lower value of 6.36 
which would mean that it is probably deprotonated at physiological pH, making it 
particularly reactive and therefore useful to an oxidative stress response.  
 
1.4.4 Protein-DNA interactions 
The MFRs characterized to date control gene expression by interacting with 
pseudopalindromic DNA sequences (Wilkinson & Grove, 2006). Genetic analysis of the 
ohrA operon reveals an inverted repeat which is reported to be the binding site of OhrR 
(Fuangthong et al., 2001). It was also found that OhrR will tolerate imperfect inverted 
repeats in the binding region (up to three mismatches). This is another feature of the 
MarR homologues: they generally bind to pseudopalindromic sequences and also, many 
of them, to their own promoters (Perera & Grove, 2010a).  
 
 
Figure 1.6  A model for the binding of two MarR dimers on DNA between two divergently transcribed 
genes.  The red arrows represent the (pseudo)palindromic sequences which the proteins recognize. 
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MepR is a MarR homologue in Staphylococcus aureus which has been shown to bind to its 
own promoter. It represses its own transcription as well as that of the multidrug efflux 
pump, MepA (Kaatz et al., 2006). Gel mobility shift assays revealed that MepR binds 
upstream of its gene. There is also evidence that it binds the mepA gene as a dimer of 
dimers whilst it binds its own operator sequence as a single dimer (Kumaraswami et al., 
2009). It is induced by binding to most, but not all, MepA substrates and this interaction 
alleviates repression of mepA (Kaatz et al., 2006). The interaction of protein with 
substrate at the mepR operator is different and remains to be clarified. What is 
interesting is that many of the substrates are cationic and it has a region which 
corresponds to the ArmR hydrophobic binding pocket of MexR. However, there is as yet 
no structure of this protein with a ligand bound. The structural data for this protein reveal 
that it is in a particularly open conformation which the authors deem unsuitable for DNA-
binding. This was further exemplified by superimposing the structure onto DNA-bound 
BsOhrR.   
 
MexR, however, has been shown to undergo a significant conformational change upon 
the binding of its repressor, the peptide, ArmR. Binding of this molecule results in the 
rearrangement of the dimerization region which consequently affects the DNA-binding 
regions, displacing the DNA recognition helices by 13 Å (from 29 Å to 16 Å in the apo 
structure with an RMSD value for the dimers of 2.8 Å) (Chen et al., 2010). This apo-MexR 
conformation is reportedly capable of binding DNA. Strikingly, the superimposition of the 
oxidized form of MexR with the reduced MexR gives a relatively small RMSD value of 1.6 
Å2 with only small movement of the DNA recognition helices, instead inducing a localized 
shift in the HTH region which prevents DNA binding due to steric clashes. The main 
conclusion from this study is that there are two distinct cellular regulatory pathways 
present in P. aeruginosa to regulate multidrug resistance.  
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SlyA, an important transcription and virulence factor in Salmonella typhimurium, has been 
shown to recognize a partially palindromic site within its own promoter region (Stapleton 
et al., 2002) and at least five SlyA dimers bind in this region. The structure of SlyA in 
complex with a 22 base pair (bp) DNA duplex (Dolan et al., 2011) derived from its 
promoter region sequence which contains the 12 bp pseudopalindrome, TTAGCAAGCTAA, 
its high affinity binding site (Stapleton et al., 2002). The structure was solved to 2.96 Å 
resolution and is visually very different to the structure of the apo SlyA (refined to 2.4 Å 
resolution). The separation between the α4 recognition helices in the apo structure is 15 
Å and these are held in place by intermolecular salt bridges between E59 and R65’.  The 
binding of the α4 recognition helices results in a widening of the major groove at the 
centre of the duplex by up to 2.3 Å. In this structure, R65 has been shown to provide the 
sole direct contact between the DNA and the recognition helix (via bidentate H-bonds 
with guanine 14), whilst the α2 helix also participates in an electrostatic interaction with 
the N-terminal positive dipole and the DNA backbone (Figure 1.7). Van der Waals contacts 
are also made by P61 and S62. Further contacts can be seen between the β-wing and α3 
helix with the minor groove and these display some differences between each subunit, 
relecting the asymmetry of the sequences flanking the 12 bp pseudopalindrome.  
Specifically, R86 (equivalent to OhrR R94) which interacts with a pair of sugar rings of two 
specifically positioned nucleotides.  The proposal is that this residue has an important role 
in the indirect readout of the DNA by “measuring” the width of the minor groove via its 
interactions with these sugar moieties, allowing SlyA to recognize DNA shape rather than 
sequence. The number of contacts with the DNA backbone outnumber the contacts with 
bases of the operator, again pointing towards a mechanism of indirect readout of the 
high-affinity site.  
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Figure 1.7  SlyA-DNA contacts from crystal structure (PDB code 3Q5F). (a) Stereo view of hydrogen bond 
contacts made by Arg65 to guanine 14; (b) stereo view of contacts made by Arg86 with minor groove.  
(Dolan et al., 2011).  
This study also addressed the binding of small molecule ligands and their effects on DNA-
binding, following up the work on the unpublished salicylate bound SlyA structure, PDB 
code 3DEU. The crystal structures of both the DNA and salicylate bound SlyA dimers were 
superimposed at the monomer level with an RMSD value of 1.6 Å. This does not suggest a 
marked conformational change, but one of the salicylates from the 3DEU model was seen 
to occupy a position otherwise occupied by guanine 14 in the 3Q5F DNA complex 
structure. The superimposition also revealed that each α4 DNA recognition helix 
undergoes a rotation of ~35° around its axis which would disrupt protein-DNA contacts in 
this region via steric clashes. This supports the EMSA data which found that salicylate 
binding occludes DNA-binding (Stapleton et al., 2002), but at high concentrations (25 
mM). One of the main conclusions from this 2011 study is that the recognition of DNA 
shape as opposed to direct sequence reading will be a significant feature of MFR-DNA 
interactions. This is how MFRs can act as global regulators: their structural flexibility 
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contributes to their ability to recognize and interact with specific DNA sequences with 
some degree of degeneracy.  
 
SarA is an MFR found in Staphylococcus aureus (Cheung et al., 2008). It possesses the 
characteristic HTH and β-hairpin winged motifs which are involved in DNA interactions 
based on the model of its structural homologue, SarR (Liu et al., 2001). Mutations of 
conserved basic residues in the winged region revealed that R84 and R90 are required for 
interactions with DNA (Liu et al., 2006) whereas conserved basic residues (K63 and K69) in 
the HTH region were found not to be essential. This is consistent with the findings for 
several other MarR-like proteins. The acidic residues, D8 and E11, have a role in the 
activation of SarA. It has been suggested that they coordinate divalent cations such that 
two dimers are connected via a divalent cation bridge. Gel retardation assays confirmed 
the existence of these multimeric protein-DNA complexes. The significance of these 
multimers in the regulation of transcription was probed by complementation of a D8A-
E11A mutant with the sarA mutant phenotype. It failed to complement this mutant and 
so it has been proposed these residues are necessary for activation of SarA. In the 
absence of divalent cations, the acidic residues could repel each other and so prevent the 
complexation of several homodimers on the DNA. This could affect the topology of the 
DNA for correct binding of RNA polymerase on the promoter. 
 
AbsC, a pleiotropic regulator of antibiotic production in Streptomyces coelicolor, binds to 
its own promoter (work carried out in Mervyn Bibb's group, JIC) which is also the case 
with MarR. R91 was found to be vital to DNA-binding as the R91W mutant does not 
retard the 198 bp fragment containing the absC promoter in a gel-shift assay. This residue 
is highly conserved in MarR homologues and in the OhrR-DNA complex (Figure 1.8), R94 
can be seen to interact with the O2 and O4’ of thymine 7 located in the minor groove 
(Hong et al., 2005b). This residue mirrors that of R86 in SlyA, which also enters the minor 
groove of DNA.  In OhrR, D92 is also located in the wing domain of the protein and 
interacts with C5’ of adenine 25 and the phosphate backbone of thymine 26, as well as 
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making an electrostatic interaction with R94 (again, the equivalent D84 in SlyA also 
interacts with R86). It has been suggested that D92 is also conserved amongst the MarR 
family and this can be seen in some of the homologues selected for this research project 
and this provides a useful model for the DNA-binding mechanism of the MarR family. 
Oxidation of this complex by organic hydroperoxides results in the induction of OhrR 
which in turn leads to ohrA transcription.  
 
 
Figure 1.8  (a) OhrR-ohrA operator complex (taken from Hong et al., 2005b). (b) Schematic of the 
protein:DNA interactions (Hong et al., 2005b). Base specific contacts are indicated by the red arrows; blue 
and purple arrows indicate DNA backbone contacts; green arrows, Van der Waals contacts.  
 
The current data for MFRs in complex with a ligand and/or with DNA point towards a 
mechanism which links ligand binding with attenuation of DNA-binding. The binding of a 
ligand is communicated to the DNA-binding domain resulting in a movement of the α4 
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recognition helices such that DNA-binding is no longer favourable. Thus, MFRs must have 
considerable conformational flexibility in order to bind DNA sequence with specificity. 
Such conformational flexibility may also be extended to the DNA helix, as the circular 
dichroism spectroscopy data for the alteration of DNA secondary structure by HucR has 
demonstrated (Wilkinson & Grove, 2005).  
 
1.4.5 MarR family proteins involved in the regulation of virulence factors 
RovA is a member of the MarR/SlyA family which is involved in the regulation of the 
virulence factors in the human pathogens, Yersinia pseudotuberculosis and Yersinia 
enterocolitica (Cathelyn et al., 2006). It has been shown to regulate the invasion factor 
invasion (inv) and appears to have a more global role in the virulence of Y. Pestis, 
causative agent of the bubonic plague, which lacks the inv gene. This pathogen requires a 
very complex regulatory system to coordinate integration of environmental signals with 
regulation of gene expression, given that it infects very different hosts: fleas and humans. 
Its success depends on tight regulation and this study concluded that RovA is an 
important global regulator of genes associated with virulence in Y. Pestis. 
 
MfbR is involved in regulating virulence factors in the necrosis-inducing plant pathogen, 
Dickeya dadantii (Reverchon et al., 2010).  This protein represses its own transcription 
and acts as an activator of genes involved in virulence, specifically plant-cell wall 
degrading enzymes. MfbR is pH responsive and is unable to activate these virulence genes 
under acidic conditions during the early stages of infection. At an advanced stage of 
infection, the apoplast is more alkaline and this activates MfbR and in turn, upregulates 
the transcription of the virulence genes.  
 
1.4.6 Effector molecules of MarR proteins 
There appears to be some diversity in the types of effectors which members of the MarR 
family bind. Identifying effector molecules is perhaps the most challenging aspect of 
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studying MFRs; to date, very few of these ligands have been conclusively identified. MarR 
itself was crystallized in complex with salicylate and two binding sites were determined 
for this interaction. Whilst the Mar phenotype is induced by the binding of salicylate 
(Alekshun & Levy, 1999, Martin & Rosner, 1995), the protein was crystallized with a high 
concentration of salicylate (250 mM) and thus the physiological relevance of these sites 
has been questioned. Nevertheless, subsequent studies of MFRs have tended to focus on 
salicylate as a potential ligand and a few have been found to complex with this molecule.  
 
The structure of MTH313 from Methanobacterium thermoautotrophicum has been solved 
both in its apo form and complexed with salicylate (Saridakis et al., 2008). This structure 
revealed two asymmetrical binding sites for salicylate (Figure 1.9), but only one of these, 
site 1 (SAL1), was considered to be biologically relevant as it affects the position of the 
DNA recognition helix in that monomer, resulting in an asymmetrical conformational 
change. The position of this site is at the dimer interface between helices α1’,α3 and α7 
and is composed of predominantly hydrophobic residues with a small number of 
charged/polar residues. Salicylate has been shown to disrupt DNA-binding of MTH313 and 
the suggestion in this work was that this is due to a large, asymmetrical conformational 
change.  
 
Figure 1.9  The crystal structure of MTH313 (a) apo form and (b) in complex with salicylate; image shows 
the two, asymmetrical binding sites. Image taken from Saridakis et al., 2008. 
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ST1710, from Sulfolubus tokodaii (Kumarevel et al., 2009), and SlyA, from Salmonella 
enterica (PDB ref. 3DEU; Le Trong et al., 2008, unpublished), are two other MFRs which 
have both been crystallized in complex with salicylate. Three salicylate molecules per 
monomer were determined for SlyA and interestingly, one of these sites corresponded to 
the SAL1 site in MTH313 (Perera & Grove, 2010a) whilst ST1710 has one salicylate 
molecule bound per monomer in symmetrically opposed sites, again in a comparable 
location.  
 
The evidence is accumulating for a conserved ligand binding site amongst MFRs. TcaR is a 
multifunctional repressor from Staphylococcus epidermis and has been implicated in 
resistance to antibiotics such as methicillin and teicoplanin (Brandenberger et al., 2000). 
It appears to have a dual regulatory function; activating another global regulator, SarS 
and repressing the transcription of a probable adhesin, SasF (McCallum et al., 2004) and 
has a direct effect on the production of the protective biofilm which is necessary for the 
survival of this pathogen. A comprehensive structural study of TcaR in complex with 
several antibiotic molecules provides further information regarding a conserved ligand 
binding site and the allosteric mechanisms of MFR regulation (Chang et al., 2010). TcaR 
was crystallized with salicylate, penicillin G (PnG), ampicillin, methicillin and kanamycin 
whilst the inhibition of TcaR by these compounds, in addition to gentamycin, 
streptomycin and chloramphenicol, was tested using electrophoretic mobility shift assay 
(EMSA). The study presented eight distinct (non-equivalent) binding sites on the dimer for 
salicylate and these were reported to drive an asymmetrical conformational change 
which would likely disfavour DNA-binding. Two sites were determined for PnG, but only 
one of these was considered to be biologically relevant and this one is located between 
the helical dimerization and DNA-binding domains and induces an asymmetrical 
conformational change similar to that observed in the salicylate structure. Each of the 
other antibiotics in the crystal complexes were found to have two binding sites, the first 
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of which was suggested to be the most biologically important as it could regulate TcaR 
activity. These findings are consistent with a conserved binding pocket for MFRs. 
 
Figure 1.10  Comparison of the salicylate binding sites on four MFR structures: TcaR – blue; E. coli MarR – 
orange; MTH313 – magenta and ST1710 – teal. The putative conserved SAL1 binding site is circled.  
 
Whereas the DNA binding affinity of MarR and TcaR is significantly reduced by salicylate, 
MexR suffers no such inhibition in its DNA binding upon the addition of salicylate (Lim et 
al., 2002). MexR is a member of the MarR family of proteins and it negatively regulates 
the expression of a multidrug efflux system, such as MexAB-OprM. Pseudomonas 
aeruginosa is a gram-negative human pathogen which can prove fatal to patients with 
compromised immune systems. It evades antibiotic treatment through its outer 
membrane which has a low permeability, and through the expression of efflux pumps 
(which are hyperexpressed in the mexR mutants). The presence of two redox-active 
cysteines in this protein is the subject of a study which concludes that it senses oxidative 
stress through these cysteines (Cys30 and Cys62) (Chen et al., 2008, Chen et al., 2006). 
These form intermonomer disulphide bonds upon oxidation which result in a 
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conformational change, causing the protein to dissociate from the promoter DNA. The 
mexAB-oprM operon is thus activated and the drug efflux system switched on. MexR is 
also inactivated by an antirepressor peptide, ArmR, which associates with the protein 
allosterically (Wilke et al., 2008). The crystal structure of the MexR dimer in complex with 
a fragment of ArmR reveals that this peptide binds in a hydrophobic cavity in the centre 
of the protein and induces a conformational change which renders MexR incapable of 
binding DNA. Superimposition of the MexRll-ArmRc complex with the DNA-binding 
domain of apo-MexR dimer CD shows that the α4 recognition helix is displaced by 13 Å 
whilst the wing is displaced by 18 Å from its expected position in the minor groove. 
Further evidence that the binding of ArmR prevents DNA-binding is provided by the 
presence of E50 of ArmR which projects between the two MexR DNA-binding domains. 
This negatively charged residue would result in electrostatic repulsion and so weaken the 
interaction between MexR and the DNA. The pseudo-symmetrical binding site overlaps 
with the small effector molecule binding sites found in other MarR homologues (Figure 
1.10), but the interactions of the peptide with the protein surface are multiple and 
therefore stabilize this conformation. Interesting comparisons with other MarR 
homologues were made in this study (Wilke et al., 2008). Whilst there are obvious 
similarities such as the overall structure and the importance of wing residues R83 and R91 
to DNA-binding, there are significant differences which bring into question the current 
theories on effector binding and mechanisms. Not least is the criticism of the salicylate-
bound MTH313 structure which is proposed by Saridakis et al. (2008) to be in the inactive 
form. Wilke et al. (2008) state that this structure is better configured for DNA-binding 
when superimposed onto the OhrR-ohra operator complex than is the apo-form of the 
protein. The structure of MTH313 has been presented in both its apo form and also 
complexed with salicylate (Saridakis et al., 2008). The two structures were compared and 
it was found that the DNA binding lobe undergoes a large, asymmetrical conformational 
change which, according to Wilke et al. (2008), prevents it binding its promoter region. 
However, electrophoretic mobility shift assays would indicate that salicylate does act as 
an inactivator of MTH313 (Saridakis et al., 2008).  
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The variety of ligands which can associate with different MFRs is becoming apparent. 
MexR, mentioned previously, can bind a peptide effector and LVIS553 has been shown to 
specifically recognize novobiocin as an effector (Pagliai et al., 2010).  The Streptococcus 
pneumoniae adhesion competence regulator, AdcR, is the first metal-dependent member 
of the MarR family to be structurally characterized. Its structure was solved to 2 Å 
resolution and reveals two zinc ions bound per monomer (Guerra et al., 2011). This 
structure presents an interesting new insight into allosteric mechanisms in MarR-DNA 
interactions. The superimposition of the helix-turn-helix motifs of DNA-bound SlyA with 
Zn(II)-bound AdcR has a root mean square deviation value of only 0.5 Å, suggesting that 
this protein is in a conformation for DNA binding. Thus, binding of an effector in this case 
induces high affinity DNA binding.  
 
The MarR proteins bind DNA as dimers and display the same characteristic fold despite 
typically having less than 20% amino acid sequence identity (Nichols et al., 2009). This 
consists of a winged helix-turn-helix DNA binding motif with a dimerization domain which 
is mostly helical. It is this helical dimerization domain which is affected by ligand binding 
(or oxidation of key residues), resulting in movement of the two DNA binding regions such 
that the protein dissociates from the DNA. The arms of the interface and the wHTH 
domains were shown to reorientate upon ligand binding in MTH313 (Saridakis et al., 
2008). As more structures of protein-ligand complexes become available, so the 
knowledge database required for interpretation of the mechanisms at work grows, 
increasing the opportunities to develop novel therapeutics to target these repressors.  
 
1.5   MarR homologues in Streptomyces coelicolor 
There are 42 MarR homologues in Streptomyces coelicolor (Figure 1.11) and taking its 
very complex life cycle into consideration, this is perhaps not overly surprising. However, 
this presents an interesting challenge to characterize these proteins to uncover their 
physiological roles as well as attempting to use this information to make some more 
global assumptions about MarR mechanisms and gene regulation. Much of the work that 
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has been done so far has focused on OhrR (discussed above) and AbsC, which has been 
linked to the gene cluster controlling the expression of coelibactin (Hesketh et al., 2009) 
and specifically the zinc-responsive Zur repressor (Kallifidas et al., 2010). A mutation in 
AbsC results in the zinc-dependent pleiotropic defect in the production of both 
actinorhodin and undecylprodigiosin and AbsC and Zur have been shown to tightly 
regulate coelibactin production by direct interactions with the coelibactin cluster. What is 
still not known is the identity of the ligand for AbsC. Work is ongoing to determine the 
identity of this ligand through structural analyses (Stevenson et al., 2007). Sco6704 is the 
most recent of the 42 MFRs in S. coelicolor to be characterized and it has been linked to 
the β-ketoadipate pathway and is responsive to protocatechuate and p-hydroxybenzoate 
(Davis & Sello, 2010).  
 
Figure 1.11  Phylogenetic tree showing the 42 MarR homologues in Streptomyces coelicolor. The five which 
were selected for this study are boxed. The three which feature in this thesis are in green. 
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It is, of course, possible that each of the MarR proteins could potentially bind a variety of 
ligands, each of which could elicit a very different response across homologues from a 
multitude of species. Evidently, there is much scope for research to uncover the common 
and also the specific mechanisms in operation of each protein. The clinical importance of 
MarR proteins due to their functions in multidrug resistance is obvious and the continued 
discovery of the diversity of their functions and mechanisms is increasingly relevant in 
developing an effective armoury against pathogenic bacteria.  
 
1.6   Aims of the project 
Despite the growing body of biological information for the MarR family of transcriptional 
repressors, their mode of action and specific inhibitors remains elusive.  This project aims 
to perform biophysical analyses of several of the MFRs present in Streptomyces coelicolor 
in an effort to understand their biological function as well as gaining further structural 
information about MarR family proteins in general. The specific aims of the project 
included: 1) the generation of deletion mutants with phenotypic analyses of these in an 
effort to determine biological functions; 2) cloning of the MFR genes into an expression 
vector and the overexpression of the protein for downstream analyses; 3) crystallization 
and structural determination of the MFRs and subsequent analyses leading to 4) 
generation of site-directed mutants for further biophysical and structural analyses; 5) 
identification of the regulons of each of the MFRs using a variety of methods, including 
SPR. The information obtained from these objectives will contribute to the understanding 
of the MarR family of proteins as well as transcription factors in general.  
Five of the 42 MFR homologues in S. coelicolor were initially selected for the purpose of 
this study and three of these have featured in this thesis.  
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2.1 Molecular Biology Methods 
2.1.1 Bacterial Strains and Plasmids 
Table 2.1  E. coli strains used in this work 
Strain Genotype Antibiotic resistance Reference 
DH5α recA1 endA1 gyrA96 thi-1 
hsdR17 supE44 relA1 lac 
None (Sambrook et al., 
2001) 
OmniMAX™ 2 F´ proAB lacIq lacZΔM15 
Tn10(TetR ) Δ(ccdAB) mcrA 
Δ(mrr hsdRMS-mcrBC) Φ 
80(lacZ)ΔM15 Δ(lacZYA-
argF)U169 endA1 recA1 
supE44 thi-1 gyrA96 relA1 
tonA panD 
None  
ET12567/pUZ8002 dam13::Tn9 dcm6  hsdM  
hsdR recF143  zjj201::Tn10  
galK  galT22 ara14  lacY1  
xyl5  leuB6 
 thil  tonA31  rpL136  hisG4  
tsx78 mtli glnV44  F- 
Cm, Tet (MacNeil et al., 1992) 
(Datsenko and 
Wanner, 2000) 
 
 
 
 
BL21(DE3)pLysS F–, ompT, hsdSB (rB–, mB–), 
dcm, gal, λ(DE3) [lacI 
lacUV5-T7 gene 1 ind1 
sam7 nin5]), pLysS [Cmr] 
 
Cm (Studier & Moffatt, 
1986) 
 
Table 2.2 Streptomyces coelicolor A3 (2) strains used in this work 
Strain Genotype Source/ Reference 
M145 Wild type (Kieser et al., 2000) 
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M145 
Δsco3914::apr 
M145 Δsco3914::apr This work 
M145 
Δsco4122::apr 
M145 Δsco4122::apr This work 
M145 
Δsco4961::apr 
M145 Δsco4961::apr This work 
M145 
Δsco5413::apr 
M145 Δsco54134::apr This work 
 
Table 2.3  Plasmids and cosmids used and constructed in this study 
Plasmid Vector Insert Genotype/Use Antibiotic 
resistance 
Reference/So
urce 
 
Supercos 1 Supercos 1 None Neo, bla Carb, Kan 
 
Stratagene 
pUZ8002 RK2 None RK2 derivative with 
defective oriT 
Kan (Paget et al., 
1999) 
pOPINF pTriEx2  Overexpression vector 
for N-terminally His-
tagged protein 
(3CProtease cleavable 
tag) 
Carb (Berrow et 
al., 2007) 
pIJ773 pBluescript aac(3)IV(Apr
aR) + oriT 
Apramycin resistance 
gene flanked by FLP 
recognition sites 
Apr, Carb 
 
(Gust et al., 
2003) 
pGem pGem None Cloning vector Carb 
 
Promega 
pLysS pLysS None Expression of T7 
lysozyme 
Cm 
 
(Moffatt & 
Studier, 
1987) 
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pIJ10257 pMS81 330-bp 
ermEp* 
(KpnI-PstI) 
with 
ribosome 
binding site 
and 
multicloning 
site 
from pIJ8723  
Integrative 
Streptomyces  
expression vector 
Hyg 
 
(Hong et al., 
2005b) 
 
2.1.2 Buffer and solutions 
Solution/buffer Compostion  
1 x SDS-PAGE running buffer Tris base 
Glycine 
SDS 
25 mM 
200 mM 
0.1 % 
Cosmid isolation solution I Glucose 
Tris-HCl (pH 8) 
EDTA 
 
50 mM 
25 mM 
10 mM 
Cosmid isolation solution II NaOH 
SDS 
0.2 M 
1 % (w/v) 
 
Cosmid isolation solution III Sodium acetate (pH 4.8) 
Acetic acid 
 
3 M 
E. coli cell lysis buffer Tris-HCl (pH 8) 
NaCl 
Imidazole 
0.2 % Tween-20 
DNAse 
Complete protease inhibitor tablets 
(Roche)  
 
25 mM 
0.5 M 
40 mM 
2 ml 
0.1 mg ml-1  
According to the 
manufacturer’s 
recommendations 
S. coelicolor cell lysis buffer Tris-HCl (pH 8) 
NaCl 
Lysozyme 
Protease inhibitor  
10 mM 
50 mM 
10 mg ml-1 
1 tablet 
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Immunoprecipitation (IP) 
buffer 
Tris-HCl (pH 8) 
NaCl 
Triton X-100 
SDS 
Protease inhibitor  
100 mM 
250 mM 
0.5 % (w/v) 
0.1 % (w/v) 
1 tablet 
IP elution buffer Tris-HCl pH 7.6 
EDTA 
SDS 
50 mM 
10 mM 
1 % (w/v) 
Buffer A 
 
Tris-HCl (pH 8) 
NaCl 
Imidazole 
25 mM 
0.5 M 
40 mM 
Buffer B Tris-HCl (pH 8) 
NaCl 
Imidazole 
25 mM 
0.5 M 
500 mM 
Gel filtration buffer HEPES pH 7.5  
NaCl 
50 mM 
250 mM 
Tag cleavage buffer Tris-HCl (pH 8) 
NaCl 
Β-mercaptoethanol 
25 mM 
0.5 M 
2 mM 
Lysozyme solution (genomic 
DNA extractions) 
Sucrose 
Tris-HCl (pH 8) 
EDTA (pH 8) 
Lysozyme (Sigma) 
0.3 M 
25 mM 
25 mM 
2 mg ml-1  
SDS stock solution 
 
10% (w/v) in H2O, filtered through a 0.45m membrane. 
TAE buffer Tris 
Acetic acid 
EDTA 
40 mM 
1.142 % 
1 mM 
 
TBS/Tween (TBST) Tris-HCl (pH7.6) 
NaCl 
Tween 
20 mM 
137 mM 
0.1 % (w/v) 
 
TES buffer Tris-HCl (pH 8) 
EDTA 
NaCl 
10 mM 
1 mM 
1 M 
Western blot blocking solution TBS/Tween with the addition of 10 % skimmed milk powder 
Western blot transfer buffer 
(pH 9.9) 
NaHCO3 
Na2CO3 
Methanol 
10 mM 
3 mM 
20 % (w/v) 
 
Running buffer for wet 
transfer 
Tris 
Glycine 
Distilled water 
25 mM 
192 mM 
Up to 1000 ml 
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2.1.3 Solid media 
Medium Composition  Instructions for preparation 
L-Agar  
 
Agar 
Difco Bacto tryptone 
NaCl 
Glucose 
Distilled water 
10 g 
10 g 
5 g 
1 g 
Up to 1000 ml 
The ingredients, except agar, 
were dissolved, in the distilled 
water and 200 ml aliquots were 
dispensed into 250 ml 
Erlenmeyer flasks containing 2 g 
agar. The flasks were closed and 
autoclaved. 
Difco nutrient agar 
(DNA) 
 
Difco Nutrient Agar 
Distilled water 
4.6 g 
200 ml 
Difco Nutrient Agar was placed 
in each 250 ml Erlenmeyer flask 
and distilled water was added. 
The flasks were closed and 
autoclaved. 
Tryptone Soya 
Agar (TSA) 
 
Oxoid Tryptone Soya 
Broth powder       
Distilled water   
Lab M  agar                                         
 
30 g 
Up to 1000 ml 
10 g
The Tryptone Soya Broth 
powder was dissolved in the 
distilled water and 200 ml 
aliquots were dispensed into 
250 ml Erlenmeyer flasks each 
containing 2.0 g Lab M agar. The 
flasks were closed and 
autoclaved. 
Mannitol soya 
flour medium 
(SFM) 
 
Agar   
Mannitol  
Soya Flour  
Tap water 
   
20 g 
20 g 
20 g 
Up to 1000 ml 
The mannitol was dissolved in 
the water and 200 ml aliquots 
poured into 250 ml Erlenmeyer 
flasks each containing 2 g agar 
and 2 g soya flour. The flasks 
were closed and autoclaved 
twice (115 C/15min), with 
gentle shaking between the two 
runs.  
Minimal medium 
for Streptomyces 
(MM)  
 
L-asparagine   0.5 g 
K2HPO4    0.5 g 
MgSO4.7H2O    0.2 g 
FeSO4.7H2O    0.01 g 
Lab M Agar     10 g 
De-ionised water   1000 ml 
10 % Mannitol 
0.5 g 
0.5 g 
0.2 g 
0.01 g
10 g 
Up to 1000 ml 
20 ml 
The ingredients except agar 
were dissolved and the pH 
adjusted to 7.0 -7.2. 200 ml 
aliquots were dispensed into 
250 ml Erlenmeyer flasks 
containing 2 g Lab M agar. The 
flasks were closed and 
autoclaved. Before use the 
medium was re-melted and 20 
ml 10 % mannitol (or another 
carbon source) added. 
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Medium Composition  Instructions for preparation 
R2 Sucrose 
K2SO4  
MgCl2.6H2O  
Glucose 
DifcoCasamino acids  0.1 g 
Difco Bacto agar 
Distilled water 
At the time of  
Use, add:- 
KH2PO4 (0.5 %) 
CaCl2.2H2O (3.68 %) 
L-proline (20 %) 
TES buffer (5.73 %, 
adjusted to pH 7.2) 
Trace elements 
solution I 
NaOH (1 N)   
103 g 
0.25 g 
10.12 g 
10 g 
0.1 g 
22 g 
Up to 800 ml 
 
 
1 ml 
8 ml 
1.5 ml 
 
10 ml 
 
0.2 ml 
0.5 ml 
The ingredients were dissolved, 
in the distilled water and 80 ml 
aliquots were dispensed into 
250 ml Erlenmeyer flasks 
containing 2.2 g Difco Bacto 
agar. The flasks were closed and 
autoclaved. At the time of use, 
the medium was re-melted and 
the remaining autoclaved 
solutions were added to each 
flask in order listed: 
R2YE   R2YE was made in the same way 
as R2 with 5 ml 10 % Difco yeast 
extract solution added once the 
medium had been re-melted. 
R5 Sucrose  
K2SO4  
MgCl2.6H2O  
Glucose  
Difco Casamino  
acids  
Trace elements 
solution I 
Difco yeast extract  
TES buffer 
Difco Bacto agar 
Distilled water  
At time of use, add:- 
KH2PO4 (0.5 %)  
CaCl2.2H2O (5 M) 
L-proline (20 %)  
NaOH (1 N)   
103 g 
0.25 g 
10.12 g 
10 g 
 
0.1 g 
 
2 ml 
5 g 
5.73 g 
22 g 
Up to 1000 ml 
 
1 ml 
0.4 ml 
1.5 ml 
0.7 ml 
The ingredients were dissolved, 
in the distilled water and 100 ml 
aliquots were dispensed into 
250 ml Erlenmeyer flasks each 
containing 2.2 g Difco Bacto 
agar. The flasks were closed and 
autoclaved. At the time of use, 
the medium was re-melted and 
the remaining autoclaved 
solutions were added to each 
flask in the order listed: 
Chapter 2 – Materials and Methods 
 
38 
 
Medium Composition  Instructions for preparation 
Trace elements 
solution I (for 
R2/R2YE/R5) 
ZnCl2  
FeCl3.6H2O 
CuCl2.2H2O 
MnCl2.4H2O  
Na2B4O7.10H2O  
(NH4)6Mo7O24.4H2O. 
Distilled water 
40 mg 
200 mg 
10 mg 
10 mg 
10 mg 
10 mg 
Up to 1000 ml 
Trace elements solution was 
filter-sterilised and stored at 
277 K. 
 
 
2.1.4 Liquid media 
Medium Composition  Instructions for preparation 
 
L (Lennox) broth 
(LB) 
Difco Bacto tryptone 
Difco yeast extract 
NaCl 
Glucose 
Distilled water 
10 g 
5 g 
5 g 
1 g 
Up to 1000 ml 
The ingredients were dissolved, 
in the distilled water and 
autoclaved. 
2 X YT medium Difco Bacto tryptone 
Difco yeast extract 
NaCl 
Distilled water 
16 g 
10 g 
5 g 
Up to 1000 ml 
The ingredients were dissolved, 
in the distilled water and 10 ml 
aliquots were dispensed into 
universals and autoclaved. 
SOB medium Tryptone 
Yeast extract 
NaCl 
Distilled water 
20 g 
5 g 
0.5 g 
Up to 1000 ml 
After dissolving the solutes in 
water, 10 ml 250 mM KCl was 
added and the pH was adjusted 
to pH 7 with 5 N NaOH. The 
volume was then made up to 
1000 ml with deionised water 
and autoclaved. 
SOC medium   SOC medium is identical to SOB 
medium except that after 
autoclaving, 20 ml of sterile 1 M 
solution of glucose and 5 ml of 
sterile 2 M MgCl2 were added. 
M9 Minimal media Na2HPO4,  
KH2PO4,  
NaCl 
NH4Cl 
6 g 
3 g 
0.5 g 
1 g 
The ingredients were dissolved, 
in the distilled water and 
autoclaved. 
TSB (Tryptone 
soya broth) 
Oxoid Tryptone Soya 
Broth powder 
30 g 
 
The ingredients were dissolved, 
in the distilled water and 
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Distilled water 
 
Up to 1000 ml 
autoclaved. 
NMMP (Minimal 
liquid medium) 
(NH4)2SO4 
Difco Casaminoacids 
MgSO4.7H2O 
PEG 6000 
Minor elements 
solution 
Distilled water 
 
At time of use, add:- 
NaH2PO4/K2HPO4 
buffer (0.1M, pH6.8) 
Carbon source (20%) 
 
2 g 
5 g 
0.6 g 
50 g 
 
1 ml 
800 ml 
 
 
 
15 ml 
2.5 ml 
80 ml aliquots were dispensed 
and autoclaved. 
YEME (Yeast 
extract-malt 
extract medium) 
Difco Bacto-peptone 
Difco yeast extract 
Oxoid malt extract 
Glucose 
Sucrose 
Distilled water 
 
At time of use, add:- 
MgCl2.6H2O (2.5 M) 
3 g 
5 g 
5 g 
10 g 
340 g 
To 1000 ml 
 
 
2 ml 
The ingredients were dissolved, 
in the distilled water and 
autoclaved. 
 
 
2.1.5 Antibiotics 
Antibiotic Solvent Concentration in media (μg/ml) 
Carbenicillin (Carb) 
Kanamycin (Kan) 
Chloramphenicol (Cm) 
Apramycin (Apr) 
Nalidixic acid (Nal) 
Water 
Water 
Ethanol (100%) 
Water 
Water 
100 
50 
25 
50 
20 
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2.1.6 Preparation of electro-competent cells and transformation of DNA 
A single colony was used to inoculate 10 ml LB and grown overnight with shaking at 310 
K.  100 l of this preculture was inoculated into 10 ml SOB and grown at 310 K (303 K for 
BW25113/pIJ790) for 3-4 h with shaking at 200 rpm until an OD600 of ~0.6 was attained. 
The cells were recovered by centrifugation at 3000 x g for 5 min at 277 K in a Sorvall GS3 
rotor. After decanting the medium the pellet was resuspended by gentle mixing in 10 ml 
ice-cold 10% glycerol.  The cells were centrifuged as before and washed in 10% glycerol a 
further two times. After decanting the supernatant, cells were resuspended in the 
remaining ~ 100 l of 10% (v/v) glycerol. 
 
For each transformation, 50 µl electro-competent cell suspension was mixed with ~ 100 
ng DNA. Electroporation was carried out in a 0.2 cm ice-cold electroporation cuvette 
using a GenePulser II (Bio-Rad) set to: 200 , 25 F and 2.5 kV. The expected time 
constant is 4.5 – 4.9 ms. After electroporation, 1 ml ice cold LB was added immediately to 
the shocked cells and incubated with shaking (200 rpm) for 1 h at 310 K (303 K for 
BW25113/pIJ790 transformed with cosmid). Transformants were selected by spreading 
onto LB agar containing the appropriate antibiotic. 
 
2.1.7 Preparation of chemically competent cells and transformation of DNA 
Strains of E. coli were made competent for the uptake of plasmid DNA using a modified 
version of the calcium chloride method (Mandel & Higa, 1970).  A single bacterial colony 
was grown in 10 ml of LB at 310 K to early log phase (OD 600 nm approximately 0.6) and 
then incubated on ice for 20 min.  The cells were centrifuged for 10 min at 3,000 x g and 
the supernatant discarded.  The cells were then re-suspended in 5 ml of ice cold 100 mM 
CaCl2 and left on ice for a further 15 min.  The cells were centrifuged again and re-
suspended in 1 ml of 100 mM CaCl2, 15% glycerol and left on ice for 15 min. Cells were 
stored in 200 l aliquots at 193 K. 
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For transformation, 1 μl of the appropriate DNA miniprep plasmid solution, typically 
containing 10-20 μg of DNA, was added to a 200 l aliquot of the competent cells and left 
on ice for 30 min.  The cells were heat shocked for 90 seconds at 315 K and placed back 
on ice for a few minutes prior to incubating with 1 ml of LB at 310 K for approximately 1 h 
before plating approximately 200 μl, onto solid LB agar petri plates containing the 
appropriate antibiotic selection.  (For the pOPINF transformants following each InFusion 
reaction, cells were pelleted by centrifugation at 13000 rpm and the entire pellet 
resuspended in 150 μl LB as there was a very low rate of successful transformants). The 
plates were then incubated at 310 K overnight.  
 
2.1.8 Plasmid isolation from E. coli  
Qiagen miniprep kits were used according to the manufacturer’s instructions (and the 
buffer components are also described in the instructions). A 10 ml overnight LB culture 
grown from a single colony harbouring the plasmid of interest was harvested by 
centrifugation at 13000 rpm for 10 min. The cell pellet was resuspended in buffer P1 and 
underwent alkaline lysis (buffer P2). The lysate was then neutralised and adjusted to a 
high salt condition by the addition of buffer N3. The tube was centrifuged in a 
microcentrifuge at 13000 rpm to remove cell debris and precipitated protein. The 
supernatant was then applied to a silica membrane mounted in a microcentrifuge tube 
where it was washed under high salt and ethanolic buffer conditions. The DNA was eluted 
from the column in ultrapure water or elution buffer. Plasmid DNA was stored at 253 K. 
 
2.1.9 DNA electrophoresis on agarose 
DNA samples were separated using 1% agarose gels which were prepared by dissolving 1 
g agarose in 100 ml TAE (40 mM Tris-acetate, 2 mM EDTA) buffer by heating for 2 minutes 
in a microwave.  The agarose was allowed to cool until hand warm and then 1 μg ml-1 of 
ethidium bromide was added.  The gel was poured into a horizontal gel running 
apparatus, containing a comb for well formation and allowed to set.  The DNA sample was 
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mixed with loading dye prior to loading into a well.  A commercially available 1 kb DNA 
ladder was also loaded into a well as a reference.  The gel was run in TAE buffer at 100 V 
and the DNA was visualised by UV radiation. 
 
2.1.10 Restriction digestion of DNA 
Restriction enzyme digestion of cosmids, plasmids or genomic DNA was carried out 
according to the enzyme manufacturer’s instructions. In the case of double digests, an 
appropriate buffer was selected after consulting the manufacturer’s literature (Roche or 
Invitrogen). The reaction volume was usually 20 µl for analytical digests and 50 µl for 
preparative digests. Unless otherwise instructed, digests were typically carried out for 1 h 
at 310 K and contained the following reaction components:- 
Total volume – 20 µL 
dH2O    12 µL 
Buffer     2 µL 
DNA     5 µL 
Enzyme    1 µL 
 
2.1.11 DNA extraction from agarose gels 
DNA fragments separated in agarose gels were excised from the gel using a clean scalpel 
and purified using the Qiaquick™ gel extraction kit, following the manufacturer’s 
instructions. Briefly, the agarose gel slice containing the DNA fragment of interest was 
dissolved in a neutral pH, high salt buffer provided with the kit and applied to a silica gel 
membrane mounted in a microcentrifuge tube. The column was washed and the DNA 
fragment was eluted in water or elution buffer. 
 
2.1.12 Ligation of DNA 
Fragments to be ligated were purified from solution using a Qiagen PCR purification kit or 
from an agarose gel using a Qiagen gel extraction kit. The purifications were carried out 
according to the manufacturer’s instructions and the DNA was eluted in water. A ligation 
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reaction volume of 10 µl was carried out with an insert: vector molar ratio of 3:1. 
Ligations were carried out overnight at 289 K using high concentration T4 DNA ligase 
(Promega). 
 
2.1.13 DNA Sequencing  
DNA was sequenced by The Genome Analysis Centre (TGAC) in Norwich. Plasmid samples 
were submitted to TGAC in water at a concentration of ~200 ng μl-1 and the sequencing 
was performed using a T7 forward promoter primer (supplied by TGAC) or gene specific 
primers (supplied with sample). Results were analysed using Vector NTI® (Invitrogen) or 
Chromas Lite (Technelysium). 
 
2.1.14 Growth and storage of E. coli 
 E. coli was grown at 310 K overnight on L-agar or shaking in LB broth (303 K for 
BW25113/pIJ790).  For selection of plasmid-containing cells, the appropriate antibiotics 
were added at the appropriate concentrations. For long-term storage, overnight LB 
cultures of E. coli strains were mixed with an equal volume of 40% (v/v) glycerol and 
stored at 193 K. 
 
2.1.15 General PCR protocol  
PCR from Streptomyces coelicolor M145 genomic DNA was typically carried out using 10 
ng DNA as template (genomic DNA prepared according to section 2.2.4). PCR from 
plasmid DNA was typically carried out using 0.5 µl of a standard plasmid preparation as 
template. 
PCR mix for 50 μl volume:- 
5% (v/v) DMSO   2.5 μl 
10x PCR reaction buffer  5 μl 
5 mM dNTP mix   2 μl 
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For primer (100 pmol μl-1)  1 μl 
Rev primer (100 pmol μl-1)  1 μl  
Template (50 – 200 ng μl-1)  1 μl (use 2 to 3 x this for genomic DNA) 
Taq polymerase   1 μl 
Water     33 μl 
 
 
General purpose PCR programme:- 
1. 95°C for 4 min 
2. 95 °C for 45 sec 
3. 55°C for 45 sec 
4. 72°C for 1 min 30 sec 
5. Go to step 2 26 more times 
6. 72°C for 7 min 
7. END 
 
Times were adjusted according to product lengths and the annealing temperature in step 
3 was optimized for the specific set of primers. 
 
2.1.16 Colony PCR 
Colony PCR was used for the rapid screening of recombinant plasmids from E. coli 
colonies during cloning. The PCR was carried out as described for general PCR, except that 
template DNA was substituted with E. coli cells and the initial denaturation cycle was 
extended for an additional 1 minute. 
 
2.1.17 Site-directed mutagenesis methods 
Initially, the site-directed mutagenesis by PCR methods was attempted. This approach 
utilized the QuikChange Lightning Kit (Stratagene). The appropriate oligos were designed 
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and ordered (Invitrogen) and were diluted with water to produce a 125 ng μl-1 solution. 
PCR reactions were set up, one for each mutation, as follows:- 
  
1 µl   Pfu turbo 2.5 U µl-1  (Stratagene) 
5 µl   10 x Pfu turbo buffer 
1 µl   (2 mM) dNTP mix 
1.25 µl  Forward primer (125 ng) 
1.25 µl  Reverse primer (125 ng) 
1 µl  Template DNA   
 
The template DNA was pOPINFsco3914 at 90 ng µl-1.    The PCR reactions were run using 
the PCR program below:- 
 
1. 95°C for 2 min 
2. 95°C for 30 sec 
3. 60°C for 30 sec 
4. 68°C for 10 min  
5. Go to step 2 18 more times 
6. 68°C for 10 min 
7. END 
 
Many variations of this PCR program and of the reaction components were used during 
the multiple attempts to obtain a mutated plasmid product. Unfortunately, this method 
did not work and so the mutants were synthesized by GenScript and subcloned into the 
pOPINF expression vector. 
 
2.1.18 Electrophoretic mobility shift assay (EMSA) 
The EMSA DNA probes spanning the entire sco4961-4962 and sco5413-5414 intergenic 
regions were amplified by PCR using primers and then 5’-end labelled using [γ32-P] ATP 
and T4 polynucleotide kinase (New England Biolabs). Binding of Sco5413 to DNA was 
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carried out in 20 μl EMSA Buffer [20 mM Tris, pH 8.0, 1 μg poly(dI-dC), 1 mM EDTA, 100 
mM NaCl, 0.5 mM DTT, 8% (v/v) glycerol] containing 0.1 nM radiolabelled DNA 
(approximately 8000 cpm) and varying amounts of Sco5413. After incubation at 303 K for 
5 min, the binding reaction mixtures were loaded on 5% (w/v) native polyacrylamide gels 
and run in TBE buffer at 120 V for 45 min. EMSA data were collected and analysed on a 
PhosphoImager (FujiFilm) using Multi Gauge image analysis software (FujiFilm).  
 
Non-denaturing 5 % polyacrylamide gel:- 
1.5 ml 40% acrylamide (37.5:1)   
1.2 ml 10xTBE 
9.3 ml dH2O     
15 l TEMED 
150 l 10% (w/v) APS  
 
2.1.19 Chromatin Immunoprecipitation on Chip (ChIP on Chip) 
Wild type M145 and M145Δsco5413 spores were pregerminated as described in section 
2.2.1 and used to inoculate 4 x 50 ml (one for each timepoint) 50:50 TSB/YEME. After 16 
hours, formaldehyde was added to a final concentration of 1% (v/v) and the culture 
incubated for a further 30 minutes. The addition of formaldehyde induces cross-linking of 
any proteins that are attached to the genomic DNA. Glycine was added to a final 
concentration of 125 mM to stop the reaction and incubation continued for a further 5 
minutes at room temperature. The cells were then harvested by centrifugation at 7000 
rpm for 5 minutes at 277 K and then washed twice with 25 ml of ice-cold PBS buffer. This 
was repeated for the samples taken after 90 hours of growth.  
 
For the immunoprecipitation of the protein, the cells were resuspended in 750 μl of lysis 
buffer and incubated for 25 minutes at 298 K in a water bath. The samples were then 
placed on ice and 750 μl of IP buffer was added and incubated for a further 2 minutes. 
The slurry was transferred to a 2 ml tube and sonicated 8 times for 15 seconds at 50% 
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power. The tubes were incubated on ice between each sonication cycle. This step was 
performed to shear the genomic DNA into ~ 500 bp fragments. These fragments were 
treated twice with phenol/chloroform before checking on agarose gel. The samples were 
then centrifuged at 14000 rpm for 10 minutes at 277 K to remove debris and the 
supernatant transferred to a new tube and the centrifugation repeated. 725 μl and 25 μl 
of the lysate were transferred to a new tube for the ‘IP’ and ‘total DNA’ samples, 
respectively. 
 
The extract was pre-cleared using ~1/10th vol (75 l) of an equilibrated 50% protein A-
Sepharose slurry. This was incubated for 1 hr at 277 K on a rotating wheel and then 
centrifuged for 15 min at full speed at 277 K and 700 l of supernatant was transferred to 
a new tube. 1/10th-volume of the antibody stock (50-75 l) was added and incubated 
overnight at 277 K on a rotating wheel. 1/10th vol (75l) of an equilibrated 50% protein A-
Sepharose slurry was added to recover antibody-protein-DNA complexes. This was 
incubated for 4 hr at 277 K on a rotating wheel and then centrifuged for 5 min at 3500 
rpm and washed twice for 15 minutes with gentle agitation with 1 ml 0.5 x IP buffer, and 
then twice with 1 x IP buffer. 2 x 500 l was transferred to a fresh tube after the first 
wash to remove DNA/protein absorbed to the side of the tube.  
 
To elute the protein, 150 l of IP elution buffer was added to the beads and to 10 l of 
the “total DNA” sample set aside before IP. This was mixed and incubated at 338 K 
overnight. The following morning, the tubes were inverted several times. The beads were 
removed by spinning at maximum speed for 5 minutes. The supernatant was removed 
and the remainder of the DNA “re-extracted” with ~ 50 l TE and incubation at  338 K for 
5 minutes. 2 μl of proteinase K 10 mg ml-1 was added and incubated for 1.5 hrs at 328 K. 
The DNA was extracted using phenol/chloroform, extracting the organic phase with TE 
buffer, and purified using the QiaQuick kit (following the manufacturer’s instructions). 
The concentration of the DNA was determined using the using the ND-1000 
spectrophotometer (NanoDrop®). The DNA labelling and hybridization to the DNA 
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microarrays were performed by Oxford Gene Technology (OGT). The data were analyzed 
using the OGT ChIP Browser. 
 
2.2 Streptomyces coelicolor cultivation methods and genetic manipulation 
2.2.1 Growth and storage of S. coelicolor 
For the generation of spore stocks, S. coelicolor spores were streaked out onto mannitol 
soya flour solid medium (SFM). The plates were incubated at 303 K for up to 7 days and 
spores were harvested according to the protocol described in (Kieser, 2000). Spore stocks 
were stored in 20 % (w/v) glycerol at 253 K or 193 K.  
 
For liquid culturing of S. coelicolor, 100 μl (~108) spores were heat shocked at 323 K for 10 
min in 5 ml TES buffer. An equal volume of 2 x YT medium was added and this was 
incubated at 310 K for 5-6 h. The small, emerging germ tubes were microscopically visible 
at this stage. The germinated spores were harvested by centrifugation at 3000 x g on a 
benchtop centrifuge and then resuspended in 500 µl of TES buffer and vortexed to 
disperse the aggregating germlings. TSB liquid medium was inoculated to OD450 of 0.03-
0.05.  Cultures were grown with shaking at 303 K until late stationary phase. Mycelia were 
harvested by centrifugation at 3000 x g in a benchtop centrifuge. 
  
2.2.2 Cosmid isolation from E. coli  
A 10 ml overnight culture of E. coli containing the cosmid of interest was harvested by 
centrifugation and the pellet resuspended by vortexing in 100 µl solution I (50 mM Tris-
HCl, pH 8; 10 mM EDTA). Cosmid isolation from E. coli was carried out by alkaline lysis as 
described by Sambrook & Russell, (2001).  The cell pellet from 1.5 ml of culture was 
resuspended by vortexing in 100 µl solution I (50 mM Tris-HCl, pH 8; 10 mM EDTA).  200 
µl solution II (200 mM NaOH; 1 % SDS) was added immediately and the tube inverted ten 
times. 150 µl solution III (3 M potassium acetate, pH 5.5) was then added and mixed by 
inverting the tube five times. The tube was then centrifuged at 16000 x g in a 
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microcentrifuge for 5 minutes at room temperature. The supernatant was mixed with 400 
µl phenol/chloroform, vortexed briefly to mix and then centrifuged at 16000 x g in a 
microcentrifuge for 5 minutes. The upper phase was then transferred to a 1.5 ml tube, 
600 µl of ice cold isopropanol was added and DNA precipitation was achieved by placing 
the tube on ice for 10 minutes followed by centrifuging at 16000 x g in a micro centrifuge 
for 5 minutes. The pellet was washed with 200 µl 70% ethanol and centrifuged at 16000 x 
g in a microcentrifuge for 5 minutes. The tube was left open for 5 minutes at room 
temperature to allow the pellet to dry prior to resuspending in 50 l 10 mM Tris-HCl (pH 
8). 
 
2.2.3 Genomic DNA extractions from S. coelicolor 
2 µl of S. coelicolor spore stock was used to inoculate 10 ml SOC and grown overnight 
with shaking at 303 K. The mycelia were recovered by centrifugation at 3000 x g for 5 min 
at 277 K in a Sorvall GS3 rotor. The mycelium was resuspended in 500 µl of lysozyme 
solution and then incubated at 310 K for 60 min. 50 μl of 10 % (w/v) SDS was then added 
and incubation was continued at 310 K for a further 15 minutes. The sample was then 
vortexed until the viscosity of the solution had decreased. 300 µl 
phenol/chloroform/isoamyl alcohol was added and vortexed briefly until completely 
mixed. The sample was centrifuged in a microcentrifuge on 16000 x g for 8 minutes. 
Following centrifugation, the aqueous phase was removed to a fresh Eppendorf tube. To 
decrease viscosity, 200 µl water was added to the supernatant. The supernatant was 
extracted twice with phenol/chloroform/isoamyl alcohol. Precipitation of the DNA was 
achieved by the addition of 0.1 volumes of 3 M sodium acetate and 1 volume of ice-cold 
isopropanol and incubating on ice for 10 minutes. The precipitated DNA was then 
recovered by centrifugation in a microcentrifuge at 16000 x g for 5 minutes. The DNA 
pellet was then washed with 70% (v/v) ethanol before dissolving in 500 μl elution buffer 
at room temperature for 2 hours.  DNAse free RNAse was then added to a final 
concentration of 40 μg ml-1 and the sample was incubated at 310 K for 30 minutes. The 
DNA sample then underwent two phenol/chloroform/isoamyl alcohol extractions.  The 
DNA was precipitated and washed as before and was then dissolved in 100 μl elution 
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buffer. The DNA concentration was determined by spectrophotometry using the 
Nanodrop. 
 
2.2.4 Growth curves 
For the generation of growth curves, wild type M145 and M145Δsco5413 spores were 
pregerminated and used to inoculate 3 x 50 ml flasks of minimal media supplemented 
with 10 mM N-acetyl glucosamine. These were incubated at 303 K with shaking at 200 
rpm. 1 ml samples (triplicates) were collected at 6 hour intervals for 72 hours. The 
samples were stored at 253 K and processed at the same time.  
 
To assess the cell density, the cells were defrosted and the optical density at 450 nm was 
measured and plotted. To assess the total protein content of the cells, the pellets were 
resuspended in 200 μl 1M NaOH and boiled at 373 K for 5 minutes. They were vortexed 
and boiled again for a further 5 minutes before centrifuging at 13000 rpm for 6 minutes 
to remove cell debris. A standard curve was generated to calculate the protein 
concentrations in the experimental samples using bovine serum albumin (BSA) standards 
of 0.1, 0.2, 0.4, 0.6, 0.8, 1.0, 1.2 and 1.4 ng/ml which were prepared in cuvettes in 0.5 ml 
volumes.  The DC protein assay (Bio-Rad) was used according to the manufacturer’s 
instructions, with an equivalent amount of protein buffer in each BSA standard, sample 
and blank.  
 
2.3 REDIRECT™ technology – PCR targeting to generate deletion mutants 
2.3.1 Amplification of disruption cassette by PCR 
The pIJ773 template was amplified using gene specific primers for each deletion mutant. 
These were designed in accordance with the criteria specified by (Gust et al., 2003) and 
are shown in Table 2.4. The cassette is flanked by the gene-specific 39 nt homology 
extensions and the inclusion of oriT (RK2) allows conjugal transfer of the PCR targeted 
cosmid DNA into S. coelicolor (Figure 2.1).  
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Figure 2.1  Designing long PCR primers to amplify the pIJ773 disruption cassette to make a gene deletion 
(Gust et al., 2003). 
 
All PCR amplifications were performed using the Expand high fidelity PCR system 
according to the manufacturer’s instructions (Roche). Reaction components:- 
 
Primers (100 pmoles μl-1)  0.5 µl each 50 pmoles each 
Template DNA (100 ng μl-1)  0.5 µl   50 ng ~ 0.06 pmoles 
Buffer (10x)    5 µl  1 x 
dNTPs (10 mM)   1 µl each 50 µM each 
DMSO  (100%)   2.5 µl  5% 
DNA polymerase (2.5 U μl-1)  1 µl  2.5 Units  
Water     36 µl 
Total volume    50 µl 
 
 
PCR program:- 
 
1. Denaturation:  94°C, 2 min  
2. Denaturation:  94°C, 45 s 
3. Primer annealing:  50°C, 45 s   10 cycles 
4. Extension:  72°C, 90 s 
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5. Denaturation:  94°C, 45 s 
6. Primer annealing:  55°C, 45 s   15 cycles 
7. Extension:  72°C, 90 s 
8. Final extension: 72°C, 5 min 
 
5 µl of the PCR product was used for analysis by agarose gel electrophoresis. To remove 
enzymes and unincorporated primers and dNTPs, the remaining 45 µl of the PCR product 
was purified using the Qiagen PCR purification kit according to the manufacturer’s 
instructions. The PCR product was eluted from the column with 20 µl of water to give a 
DNA concentration of approximately 100 ng μl-1.  
 
Table 2.4  Primers used to amplify the pIJ773 disruption cassette. The sequence which is complementary to 
the disruption cassette is shown in red. 
Oligo name Sequence 
Sco3914 For ACCCTGGTCTCAGCCACTCCTGGACGGAGGATCCACATGATTCCGGGGATCCGTCGACC 
Sco3914 Rev TAGAACGGGCCGACGCCAGGTTGCCCGGACAGGCTCTATGTAGGCTGGAGCTG CTTC 
Sco4122 Forward CTTCAAAGCAAAGGAGTTGCGTGCCATACTGCGGCCATGATTCCGGGGATCCGTCGACC 
Sco4122 Reverse CCCGCAGAGGGCTGTCAAGCGTCGCTGTCAAGATCTTTATGTAGGCTGGAGCTGCTTC 
Sco4336 Forward GGTATTTCGCCAGACTAATGAGTTACGCTAAGGAACATGATTCCGGGGATCCGTCGACC 
Sco4336 Reverse CGTACTCAAAAGGGTTCGCCTCCTTGCGAGAACTGCTTATGTAGGCTGGAGCTGCTTC 
Sco4961 Forward GAGCCCCCGGCCATGCCCACAACACCTGAAATGTCGATGATTCCGGGGATCCGTCGACC 
Sco4961 Reverse AGCCCGGGAAGGCTCCGGAAATGCGGGAAGGGTCGTTCATGTAGGCTGGAGCTGCTTC 
Sco5413 Forward TGACCGGCATGTGACCGGCCGGTAAGGTCTCTTGCCGTGATTCCGGGGATCCGTCGACC  
Sco5413 Reverse GTCGGGCGACTCGCCGGGCCCGCCCGGCCCGCGCGCTCATGTAGGCTGGAGCTGCTTC 
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Table 2.5  Primers used to verify positive transformants using PCR (Checking primers). 
3914 Forward CGTTCCGATCCCGAAGGCCC 172 bp upstream of gene 
3914 Reverse ACCCTGAGGCGTTCGAAGGC    170 bp downstream of gene 
4122 Forward CCCACGTGGATCCGGCGCA 177 bp upstream of gene 
4122 Reverse GTTACGGTCCCGTGGCAA 73 bp downstream of gene 
4336 Forward CGGGTGAACTGCGGGTTT 93 bp upstream of gene 
4336 Reverse CGTTCTGCGAGGGGCGGCGG 129 bp downstream of gene 
4961 Forward CGCCGTGCGCCGTTGTGAC 144 bp upstream of gene 
4961 Reverse TGCGAACCCCGTTCCGGAAA 105 bp downstream of gene 
5413 Forward GTGTGACGGACGGTCTCACG 135 bp upstream of gene 
5413 Reverse GGTGACGTACGCCATGACCC 126 bp downstream of gene 
 
Table 2.6  Primers used to amplify disruption cassette (for verifying) 
pIJ773_P1 ATTCCGGGGATCCGTCGACC  Disruption cassette For 
pIJ773_P2 TGTAGGCTGGAGCTGCTTC  Disruption cassette Rev 
 
2.3.2 Introduction of S. coelicolor cosmids into E. coli BW25113/pIJ790 by 
electroporation 
 E. coli BW25113 is a -RED recombination-proficient host strain and contains pIJ790, 
which carries the antibiotic resistance marker cat (chloramphenicol resistance) and a 
temperature sensitive origin of replication (replicates at 303 K, not at 310 K). 
BW25113/pIJ790 was grown overnight at 303 K in 10 ml LB containing chloramphenicol 
(25 g ml-1). 100 l of the overnight culture were inoculated into 10 ml SOB containing 
chloramphenicol (25 g ml-1) and grown for 3-4 h at 303 K with shaking at 200 rpm to an 
OD600 of ~0.6. Electrocompetent cells were generated from this culture and transformed 
with 100 ng cosmid DNA by electroporation. Transformants were selected by spreading 
onto L-agar containing carbenicillin (100 g ml-1), kanamycin (50 g ml-1) and 
chloramphenicol (25 µg ml-1) and incubating overnight at 303 K.  
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2.3.3 PCR targeting of the S. coelicolor cosmid 
10 ml SOB (without MgSO4) containing carbenicillin (100 μg ml
-1), kanamycin (50 μg ml-1) 
and chloramphenicol (25 µg ml-1) were inoculated at a concentration of 1% with an 
overnight culture of E. coli BW25113/pIJ790 containing the cosmid of interest. 100 µl 1 M 
L-arabinose was added to a final concentration of 10 mM to induce the λ RED 
recombination system. The culture was grown for 3-4 h at 303 K shaking at 200 rpm to an 
OD600 of ~0.6 and electrocompetent cells were prepared.  50 µl cell suspension was then 
mixed with ~100 ng (1-2 µl) of PCR product and electroporated. Selection for gene 
disruption in the cosmid of interest was carried out on LB agar containing carbenicillin 
(100 μg ml-1), kanamycin (50 μg ml-1) and apramycin (50 µg ml-1) overnight at 310 K. 
Table 2.7  Cosmids used for the generation of the deletion mutants by PCR targeting 
Target gene S. coelicolor cosmid 
sco3914 StQ11 
Sco4122 StD72A 
Sco4336 StD19 
Sco4961 StK13 
Sco5413 St8F4 
 
2.3.4 Confirmation of gene disruption by restriction digest and PCR 
The gene disruption was confirmed by restriction analysis. The reaction volume was 
usually 20 µl for analytical digests. Cosmid DNA of pIJ773 transformants was isolated from 
10 ml 310 K overnight LB cultures, containing carbenicillin (100 μg ml-1), kanamycin (50 μg 
ml-1) and apramycin (50 μg ml-1). Alkaline lysis followed by phenol/chloroform extraction 
produced DNA suitable for restriction analysis. Restriction digests were analysed by 
agarose gel electrophoresis. 
 
The positive transformants were also verified by PCR using the checking primers (Table 
2.5) which anneal 100-200 bp upstream and downstream of the recombination region. 
These PCR products were analysed by agarose gel electrophoresis.  
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2.3.5 Transfer of mutant cosmids into S. coelicolor 
 As S. coelicolor carries a methyl-specific restriction system it was necessary to passage 
the targeted cosmids containing an apramycin resistance-oriT cassette through a non-
methylating E. coli host. To achieve this, the cosmids were introduced by transformation 
into the non-methylating E. coli ET12567 containing the RP4 derivative pUZ8002. The 
cosmid was then transferred to M145 by conjugation. 10 μl of an M145 spore stock was 
added to 500 μl of 2xYT broth and heat-shocked at 323 K for 10 minutes. These were then 
mixed with 500 μl of the E. coli ET12567 cell suspension and centrifuged briefly. Most of 
the supernatant was removed and the cells resuspended in the remaining ~50 μl. A 
dilution series (10-1 -  10-4) was prepared from this in 100 μl water and plated on SFM agar 
supplemented with 10 mM MgCl2 and no antibiotics. These were incubated at 303 K for 
16-20 hours after which time each plate overlaid with 1 ml of water containing 0.5 mg 
nalidixic acid and 1.25 mg apramycin. Incubation was continued for a further 24 hours. 
Exconjugants were subsequently selected using the appropriate antibiotic. Replica-plating 
of each SFM agar plate with single colonies onto DNA plates containing nalidixic acid (25 
µg ml-1) and apramycin (50 µg ml-1) with and without kanamycin (50 µg ml-1) allowed 
double crossover exconjugants (kanamycinS and apramycinR) to be identified. KanamycinS 
clones were picked from the DNA plates and streaked for single colonies on SFM agar 
containing nalidixic acid (25 µg ml-1) and apramycin (50 µg ml-1). The kanamycin sensitivity 
was confirmed by replica plating onto DNA plates containing nalidixic acid (25 µg ml-1) 
with and without kanamycin (50 µg ml-1). Purified kanamycin sensitive strains were then 
verified by PCR. 
 
2.3.6 Phenotypic analysis of deletion mutants 
All of the deletion mutants generated in this work were phenotypically characterized on 
solid media. Particular attention was paid to the production of pigmented antibiotic 
(actinorhodin and/or undecylprodigiosin), sporulation and the relative sizes of the 
colonies. Spore stocks were streaked for single colonies on to the following media: SFM, 
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R5, DNA, minimal media (MM) and L agar, all of which were supplemented with different 
carbon sources (1% glucose/1% glycerol/1% mannitol/10 mM N-acetyl glucosamine). 
Plates were incubated for seven days and the growing bacteria were monitored daily (by 
visual inspection) for phenotypic differences between the deletion mutant strains and the 
wild type strain M145. The results of this analysis are summarised in the relevant 
chapters. 
 
2.4 Protein preparation methods 
2.4.1 Protein overexpression 
The five selected MarR homologue genes were amplified from Streptomyces coelicolor 
M145 genomic DNA using the primers shown in Table 2.8 and the PCR program detailed 
in section 2.1.15. These fragments were checked and purified from 1% agarose and then 
cloned into the pOPINF vector (with an N-terminal 3C Precision protease cleavable 
hexahistidine tag) which had been digested with HindIII and KpnI using the In-Fusion™ 
PCR Cloning Kit (Berrow et al., 2007).  This method, which uses PCR fragments with 5’ 
ends which are complementary to the vector sequence, is outlined in Figure 2.2.  The In-
Fusion Dry-Down mix was incubated for 30 minutes at 315 K and then immediately 
diluted with 20 μl TE buffer (10 mM Tris-HCl pH 8 and 1 mM EDTA pH 8). The reaction can 
then be frozen or used to transform immediately. 
Table 2.8  Oligos used to amplify sequences from Streptomyces coelicolor genomic DNA. The sequences 
which are homologous to the pOPINF vector are in red; the gene specific sequences are in black. 
Oligo name Sequence 
Sco3914 Forward AAGTTCTGTTTCAGGGCCCGACAGCGACGGACCCCGCG 
Sco3914 Reverse ATGGTCTAGAAAGCTTTAGGCGGGCACCGGTGCC 
Sco4122 Forward AAGTTCTGTTTCAGGGCCCGGGCGACACCTCCGGCGCC   
Sco4122 Reverse ATGGTCTAGAAAGCTTTAATCGAGGTCGCTGAGCCGGCC 
Sco4336 Forward AAGTTCTGTTTCAGGGCCCGCCGGACCTCAAGCATGGCGACG 
Sco4336 Reverse ATGGTCTAGAAAGCTTTACTTGTGTGCGAGCTTCTCCAGCACGG 
Sco4961 Forward AAGTTCTGTTTCAGGGCCCGGACATGACGACCGCCGGTGACACC 
Sco4961 Reverse ATGGTCTAGAAAGCTTTAGGAGCCCGAGGGGGCG 
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Sco5413 Forward AAGTTCTGTTTCAGGGCCCGCCGAAGCCCCTCAGTCTCTCCTTCG 
Sco5413 Reverse ATGGTCTAGAAAGCTTTAGTCCTCGTCGAAGTCGCCCGC 
 
 
Figure 2.2  Ligation-independent cloning using the the In-Fusion™ PCR Cloning Kit (Clontech). 
 
DH5α and OmnimaxII (Invitrogen) cells were transformed with this construct and plated 
on LB agar containing 0.02% X-gal; 1 mM IPTG and 100 μg ml-1 carbenicillin. The resultant 
white colonies were checked by PCR using the gene-specific primers and those containing 
a band of the correct size were sequenced. These pOPINF constructs were purified from 
the E. coli subcloning strain then introduced into chemically competent E. coli expression 
strain BL21(DE3)(pLysS) cells by transformation (see section 2.1.7). The proteins were 
overexpressed in Luria Bertani media (10 g l-1 NaCl, 10 g l-1 tryptone and 5 g l-1 yeast 
extract) (Miller, 1972). Protein expression was then induced by the addition of 1 mM 
isopropyl-β-D-thiogalactopyranoside (IPTG) and the cells were left shaking at 310 K, (or at 
a reduced temperature to improve protein solubility) for between 6-18 h.  The cells were 
harvested by centrifugation in a Sorvall Evolution centrifuge (7 min, 5500 rev min-1, 277 K, 
SLC-4000 rotor) and stored at 254 K.     
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2.4.2 Cell lysis 
The cell pellet was resuspended in lysis buffer (50 mM Tris pH 8, 0.5 M NaCl, 40 mM 
imidazole and 1% Tween-20) containing a Complete EDTA-free protease-inhibitor cocktail 
(Roche) and Deoxyribonuclease I was added to a concentration of approximately 20 µg 
ml-1 resuspended cells. The lysis of each preparation was performed either using a 
sonicator or a cell disruptor and the cell debris removed by centrifugation in a Sorvall 
Evolution centrifuge (25 min, 16000 rev min-1, 277 K, SS34 rotor).  
 
2.4.3 Purification by immobilized metal ion affinity chromatography (IMAC) 
The supernatant was subsequently filtered (0.22 μm filter) to remove any remaining cell 
debris and then applied to a 1 ml Ni2+ charged  His-Trap Chelating HP column (GE 
Healthcare) which had been pre-equilibrated with buffer A (50 mM Tris pH 8, 0.5 M NaCl, 
40 mM imidazole). All protein purifications were performed at 277 K. The column was 
washed with 20 ml of buffer A, to elute loosely bound proteins, before eluting the protein 
of interest by a linear gradient to 0.5 M imidazole in buffer A. The fractions containing the 
protein were analyzed using SDS-PAGE and then pooled and concentrated using an 
Amicon-Ultra 10 kDa cutoff concentrator (Millipore).  
 
2.4.4 Size exclusion gel filtration chromatography 
Further purification of the proteins was performed by applying the concentrated samples 
to a Superdex-75 HiLoad HP gel filtration column (GE Healthcare) which had been pre-
equilibrated with 25 mM HEPES pH 7.5, 0.2 M NaCl. This method separates the proteins 
on the basis of size. The protein sample was loaded onto the column at 1 ml min-1 and an 
isocratic elution was then applied for 1 column volume. The fractions containing the 
protein were again analyzed using SDS-PAGE and concentrated (concentrations of each 
protein are specified in the relevant sections.) Size exclusion chromatography was also 
used to estimate the oligomeric state of the protein by comparing the elution volume 
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against a standard curve of proteins of known molecular weight.  The Superdex 75 HiLoad 
HP gel filtration column (GE Healthcare) was calibrated using the low molecular weight 
protein standards kit (GE Healthcare) according to the manufacturer’s instructions.  A 
calibration curve was then used to estimate the size of the protein of interest. 
 
2.4.5 Analysis of protein samples by SDS-PAGE 
SDS-PAGE was used to analyse protein samples by monitoring the migration of the 
proteins through a polyacrylamide gel based on their molecular size.  Gels were poured 
and run using the BioRad Mini Protean apparatus. These gels consisted of a stacking gel, 
resolving gel and running buffer, which were prepared by the Laemmli method (Laemmli, 
1970). The stacking gel had a polyacrylamide concentration of 3.0% and the 
polyacrylamide concentration of the resolving gel was 15%.  A 15% resolving gel was 
prepared by mixing 3.2 ml Milli-Q (MQ) water (Millipore), 2.5 ml resolving buffer (1.5 M 
Tris-HCl pH 8.8, 0.4% (w/v) SDS) and 5.0 ml of a 30% acrylamide / bisacrylamide solution.  
50 μl of a 10% ammonium persulphate (APS) solution and 8 μl TEMED were added to start 
the polymerization and the mixture was then poured between the glass plates separated 
by two 1 mm spacers.  A layer of water was poured on top of the gel to obtain a flat 
surface and the gel was allowed to polymerise for approximately 30 minutes.  The 
stacking gel was then prepared by mixing 3.2 ml MQ water, 1.3 ml stacking gel buffer (0.5 
M Tris-HCl pH 6.8, 0.4% SDS) and 0.5 ml of a 30% acrylamide / bisacrylamide solution.  25 
μl of a 10% ammonium persulphate (APS) solution and 8 μl TEMED were added to start 
the polymerization and the mixture was then poured on top of the resolving gel.  A comb 
was added for well formation and the gel was left to polymerise for approximately 30 
min.  Gels were stored for up to one week at 277 K.  The protein samples were prepared 
by the addition of sample buffer (400 mM Tris-HCl, 6.4 % SDS, 160 mM EDTA, 32% 
glycerol, 16% β-mercaptoethanol and 4% bromophenol blue) and heating to 373 K for 
approximately 5 minutes prior to loading in the wells.  A low range molecular mass ladder 
was also loaded.  The gels were run using BioRad Mini Protean apparatus with a running 
buffer of 2.5 mM Tris-HCl, 192 mM glycine and 0.1% SDS at a constant voltage of 250 V. 
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The gels were stained with instant blue stain (Novexin) according to the manufacturer’s 
instructions, prior to destaining in MQ water.   
 
2.4.6 Protein concentration 
The concentration of protein was estimated using Bradford reagent in a method based on 
the Bradford assay (Bradford, 1976).  Duplicate samples diluted in water were added to 1 
ml of the Bradford reagent and the absorbance was then measured at 595 nm using a 
spectrophotometer.  Protein concentrations were then estimated using a standard curve 
prepared using Bovine Serum Albumin.  
 
2.4.7 Cleavage of the histidine tag 
The histidine tag was removed by proteolytic cleavage by human rhinovirus His-tagged 3C 
protease (Novagen), which cleaves after glutamine at its cleavage site (LEVLFQ↓GP). The 
protease itself contains a 6x histidine tag which allows its own purification by IMAC and 
also aids separation of the cleaved protein of interest from the reaction solution. To 
remove the tag, the protein was first diluted to a concentration of 1-2 mg ml-1 in tag 
cleavage buffer (buffer A with 2 mM β-mercaptoethanol – see section 2.1.2) and 12 μg of 
3C protease were added per mg of protein. This was incubated at 277 K for ~ 16 hours 
and the sample applied straight onto a nickel affinity column which had been pre-
equilibrated with tag cleavage buffer. The flow-through was collected and then the 
column was washed with 100% buffer B (0.5 M imidazole) to elute any uncleaved sample 
and the protease. Elution samples were analysed by SDS-PAGE.   
 
2.4.8 Dynamic Light Scattering (DLS) 
The quality of protein purified was assessed prior to crystallization using a Dynapro Titan 
Molecular Sizing instrument with temperature-controlled microsampler (Wyatt).  DLS 
measures the intensity of light scattered by the sample molecules as a function of time 
and from this, if the temperature and the solvent are known, the average size of the 
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molecules can be estimated.  It can also establish if the sample molecules are aggregating 
in solution and the polydispersity of the solution. Proteins that exist as monodisperse 
solutions have been shown to be more likely to crystallise than proteins that aggregate 
randomly (D'Arcy, 1994).  All protein samples that were tested using DLS were filtered 
through a 0.1 μm centrifugal filter (Millipore) prior to analysis of 13 μl of the protein 
sample in a quartz cuvette.  DLS was carried out according to the manufacturer’s 
instructions.   
 
2.4.9 Selenomethionine incorporation using metabolic inhibition 
 This method was adapted from (Doublie, 1997). A 50 ml culture of E. coli strain BL21 
(DE3) pLysS, containing the plasmid of interest, was grown overnight at 310 K in LB media 
with appropriate antibiotic selection.  The culture was then centrifuged and the cell pellet 
re-suspended in MQ water. This was repeated a further two times to remove any trace of 
LB media.  The cells were then re-suspended in water and used to inoculate 2 litres of 
minimal (M9) media supplemented with 0.2% (w/v) glucose, 2 mM MgSO4, 0.1 mM CaCl2, 
0.001% (w/v) thiamine and 20 ml of an amino acid stock.  The amino acid stock (20 ml) 
contained 40 mg of valine, phenylalanine, isoleucine, leucine, aspartic acid, glutamic acid, 
lysine, arginine, serine, threonine, tyrosine, histidine, glutamine and tryptophan.  The 
cells were left to grow with shaking at 310 K until an absorbance at 600 nm of 
approximately 0.4 was reached.  At this point a further 100 mg of threonine, lysine and 
phenylalanine, 50 mg of leucine, isoleucine and valine and 60 mg of selenomethionine 
were added.  The flasks were then shaken at 310 K for a further 45 min prior to the 
addition of 1 mM IPTG.  The cells were then left shaking overnight at 310 K and 
subsequently centrifuged, lysed and the protein purified in an identical manner as for the 
wild type protein. 
 
2.4.10 Western blot 
50 μl spore suspension were aliquoted into sterile eppendorfs and centrifuged for 1 
minute at 13000 rpm. The glycerol was removed and the pellet was resuspended in 1 ml 
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TES buffer. The spores were then heat shocked at 323 K for 10 minutes and cooled in cold 
water. The spores were then added to 10 ml 2xYT in universals containing baffles and 
incubated at 303 K with shaking at 250 rpm for up to 7 hours. The spores were checked 
using microscopy to observe the emerging germ tubes. The germlings were centrifuged 
for 8 minutes at 3000 rpm and resuspended in 1 ml TES buffer and vortexed to separate 
aggregated germlings. The OD450 of each sample was checked (using 1:100 and 1:1000 
dilutions) in order to determine the volume required to inoculate with and OD450 of 0.03-
0.05. 50 ml of TSB:YEME was inoculated with the suspension and incubated at 303 K with 
shaking at 250 rpm. 3 ml of this inoculum were collected every 6 hours for 48 hours. The 
spores were centrifuged at 3000 rpm for 1 minute and frozen at 253 K. These pellets were 
resuspended in 0.4 ml of sonication buffer (20 mM Tris-HCl pH 8; 5 mM EDTA and 
protease inhibitor) and sonicated for 5 cycles of 15 seconds each. The supernatant was 
collected by centrifuging at 13000 rpm at 277 K for 15 minutes and the protein 
concentration determined by Bradford assay. 10 μl of protein sample (with 4x sample 
buffer) was loaded per well (a stock protein solution of 150 μg ml-1 was prepared) and the 
proteins were separated on 15 % SDS-polyacrylamide gel electrophoresis gels at 90 V in 
the stacking gel and 140 V in the resolving gel.  
Wet transfer 
Once removed, both the gel and the Hybond C membrane (Amersham Pharmacia 
Biotech) were soaked in 1x running buffer for 20 minutes before blotting. The proteins 
were then blotted onto the membrane by wet transfer at 100 V for 1 hour at 277 K in 1x 
running buffer. The membranes were then removed and placed face up in 25 ml of 
blocking solution and incubated overnight at 277 K. 
Washing and antibody incubation 
The membranes were washed in TBST buffer for 15 minutes. Several dilutions of antibody 
were prepared in blocking solution: 1:500; 1:400; 1:300 and 1:200. The membranes were 
transferred to each of these solutions and incubated for 1 hour at room temperature. 
They were then washed twice in TBST for 15 minutes and incubated in 10 ml fresh 
blocking solution and secondary antibody (ECL Rabbit IgG – 1:10000 dilution) for 1 hour at 
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room temperature and then washed three times in TBST (10 minutes each wash). The 
blot was developed using ECL enhanced chemiluminescence system (GE Healthcare Life 
Sciences) and were exposed to X-ray film between 15 seconds to 5 minutes. 
 
2.4.11 Protein identification using mass spectrometry 
This was performed by the proteomics facility at the John Innes Centre. Samples were 
made up in 50/50 water/methanol + 0.1% (v/v) formic acid, loaded into coated 
borosilicate glass capillaries (Micromass, Manchester, UK) and sprayed into the nano-
electrospray ion-source of a Q-ToF 2 mass spectrometer (Micromass, Manchester, UK) in 
positive ion mode. Charge-states from the resulting spectra were deconvoluted using the 
MaxEnt algorithm (Micromass, Manchester, UK) to enable determination of exact 
molecular weights. 
 
2.5 Protein Crystallography Methods 
2.5.1 Crystallization 
All crystallization trials were set up using the vapour diffusion method.  A drop containing 
the protein solution is mixed with a precipitant solution and then is equilibrated against a 
reservoir containing the precipitant solution at a higher concentration than in the drop.  
Equilibration between the drop and the reservoir proceeds so that the precipitant 
concentration increases in the drop.  In an ideal case, this will lead to a level of saturation 
that will result in nucleation and the production of protein crystals. Crystallizations were 
performed at a constant temperature of 291 K. The initial screening was carried out with 
an OryxNano robot (Douglas Instruments Ltd) in 96-well sitting-drop MRC plates 
(Molecular Dimensions) using a variety of commercial screens (Molecular Dimensions and 
Qiagen). The drops consisted of 0.3 μl protein solution mixed with 0.3 μl precipitant 
solution with a total reservoir volume of 50 μl.  
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2.5.2 Crystallization optimization 
Any promising crystallization conditions observed in the screens were optimised.  All 
optimisations were carried out using hanging drop vapour diffusion using 24 well plates 
(Molecular Dimensions).  The drops typically contained 1 μl protein and 1 μl precipitant 
placed on a plastic coverslip which was then suspended and sealed with vacuum grease 
over a well containing 1 ml of precipitant.  Many crystallization optimisations were set up 
to obtain the best crystals for data collection. These also included additive screens 
(Hampton Research) as well as co-crystallization with halide compounds in an attempt to 
obtain derivative crystals for anomalous diffraction experiments.  
 
2.5.3 Crystal soaks  
Crystals were soaked with a variety of heavy atom compounds (potassium dicyanoaurate; 
thimerosal; potassium hexachloroplatinate) and halide solutions (Dauter et al., 2000).  
Typically the heavy atom was dissolved in an artificial crystallization solution at a 
concentration of 1-10 mM, but potassium iodide was used at a concentration of 1 M.  
Soaks were performed for varying lengths of time from 30 min (or 10 seconds for the 
iodide solution) to several hours at 291 K and the heavy atom solutions were kept in the 
dark to prevent any photochemical reactions (Ducruix & Giege, 1992). 
 
2.5.4 Cryoprotection of crystals for data collection 
A cryoprotectant is necessary so that the crystals can be cooled to cryogenic 
temperatures without the formation of ice.  Typically for cryoprotection, approximately 
10-15% of the volume of water in the crystallization solution was replaced with ethylene 
glycol or glycerol.  This was either done in the crystallization well conditions, or post-
crysallization, in which the crystals were transferred to the cryoprotectant using 
litholoops (Molecular Dimensions) for an optimised length of time, and were then cooled 
by plunging into liquid nitrogen and stored the mounted litholoops (Molecular 
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Dimensions) for transport to the synchrotron.  In some cases, further optimisation of the 
cryoprotectant was required.  
 
2.5.5 Data collection 
X-ray data were either collected ‘in house’ using a Mar 345-image plate detector (X-ray 
Research) mounted on a Rigaku RU-H3RHB rotating anode X-ray generator (operated at 
50 kV and 100 mA) fitted with osmic confocal optics and a copper rotating anode (Cu Kα;  
= 1.542 Å), or at the Diamond Light Source (DLS) Synchrotron facility in Oxfordshire. Data 
were collected both onsite and remotely at DLS. Several stations were used: i04-1 (fixed 
wavelength monochromatic beamline); the microfocus beamline, i24, and the tunable 
beamlines, i02, i03 and i04.  The diffracted X-rays were recorded on a MAR 345 image 
plate in house and on either charge coupled device (CCD) or photon counting pixel 
detectors at the synchrotron. 
 
2.5.6 Data processing 
Data were integrated with iMOSFLM (Leslie et al., 2007) or XDS (Kabsch) and scaled and 
merged using either SCALA (Evans, 2006) or, again, with XDS/Xia2 (Winter, 2010). The 
downstream processing was carried out using the CCP4 suite (Winn et al., 2011) or 
PHENIX (Adams et al., 2010). In all datasets, a subset of the data comprising 5% of the 
reflections was set aside for calculation of the free R factor (Kleywegt & Brunger, 1996, 
Brunger, 1993) during model refinement. 
 
2.5.7 Single isomorphous replacement with anomalous scattering (SIRAS) and Single 
wavelength anomalous diffraction (SAD) 
For this technique, crystals are derivatised by the introduction of a heavy atom.  This may 
be done by soaking the crystal in a crystallization solution containing the heavy atom.  In 
an ideal case only a few heavy atoms are incorporated into the crystal and the crystal 
lattice is unperturbed (isomorphous) by the soaking.  The heavy atom atom structure can 
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then be determined using a Patterson analysis. The structures of Sco3914 and Sco5413 
were determined using this method as the native and derivative crystals belonged to the 
same space groups with virtually identical cell dimensions.  
 
The SAD technique relies upon all of the measurements being taken from the same 
derivative crystal. This has been used to solve the structure of selenomethionine-labelled 
Sco4122. A fluorescence scan is performed on the crystal at the synchrotron to determine 
the f’ (dispersive component) and f’’ (absorptive) component as a function of the energy, 
in addition to ascertaining the wavelength of the absorption edge.  The X-ray wavelength 
is then chosen for data collection.  Commonly, a peak wavelength is chosen to maximise 
the f’’ value. It is important to collect high quality, complete data to solve the structure.  
The programs SOLVE (Terwilliger & Berendzen, 1999a, Terwilliger & Berendzen, 1999b) 
and PHENIX (Adams et al.) can all be used to locate the heavy atoms and obtain the 
required phase information. All of the phases determined in this work were obtained 
using PHENIX.  
 
2.5.8 Molecular replacement 
Molecular replacement is a technique that exploits the use of known similar structures to 
determine an initial estimate of the phase.   It is commonly used to solve different crystal 
forms of the same molecule or to solve structures that have high structural similarity.  If 
the search model and the new protein are isomorphous, as could be the case for soaking 
a small ligand into the protein crystal, the phases from the search model can be used 
directly to compute the electron density (ρ) for each point (x,y,z) in the unit cell from the 
native intensities of the new protein. If the phasing model is not isomorphous with the 
desired structure, as would be the case with a structurally similar protein, the problem is 
more difficult.  It is necessary to find the position and orientation of the phasing model in 
the new unit cell that would give phases that were most like those of the new protein.  
The program PHASER (McCoy, 2007) was used from the CCP4 suite of programs to try to 
solve the structures using molecular replacement.  PHASER was used to run rotation and 
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translation functions, combined with maximum likelihood.   None of the initial structures 
in this thesis could be solved by molecular replacement (Sco3914C16S was solved by this 
method using the Sco3914 model as a template), so experimental phasing methods were 
required. 
 
2.5.9 Phase improvement, model-building and refinement 
The protein model is improved and completed by alternating cycles of electron density 
modification, (re)building and refinement.  In some cases, automatic model building was 
carried out using the program BUCCANEER (Cowtan, 2006) or PHENIX Autobuild 
(Terwilliger et al., 2008).  The electron density maps and protein model were visualised 
using the program COOT (Emsley & Cowtan, 2004).  Manual model building of the protein 
model was carried out by manually altering it to fit the electron density.  Where 
appropriate, atoms were modelled into positive density and removed from negative 
density. Rigid body and restrained refinement of the protein structure was performed 
using REFMAC5 (Murshudov et al., 1997) and fitting and refinement of the water 
molecules was done using ARP/wARP (Perrakis et al., 1999).  Cycles of manual model 
building and refinement were continued until the model adequately accounted for the 
observed electron density, had acceptable stereochemical properties and no further 
improvements were observed in Rwork and Rfree values.   
 
2.5.10 Structure validation 
Automatic validation of the structure was carried out using the online program 
Molprobity (Chen et al., Davis et al., 2007).  One of the outputs of Molprobity is the 
Ramachandran plot (Ramachandran et al., 1963) and this monitors whether the main 
chain torsion angles are in a favourable conformation.  The presence of amino acids in the 
disallowed regions often highlights problems in the local area of the structure.  However, 
residues in the disallowed region can be genuine and may be residues of functional or 
structural significance. 
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Further analysis of the structures were performed by a visual inspection and also using a 
variety of online tools such as PDBSum (Laskowski, 2001) and the PISA server (Krissinel, 
2007). 
 
2.6 Surface Plasmon Resonance (SPR) 
SPR is a valuable technique for detecting and measuring intermolecular interactions. In 
this experiment, it was used to qualify and quantify the interactions between the proteins 
and their cognate DNA sequences by immobilizing the DNA. The method used here 
involves a streptavidin coated chip which can bind a biotin-labelled DNA molecule. The 
protein of interest is then flowed across the immobilized DNA (the association phase) and 
the response is measured for this and the subsequent dissociation phase.  
 
2.6.1 DNA Sequences and Bioinformatics 
All of the intergenic sequences used in the SPR experiments were obtained from StrepDB. 
The in silico analysis of these sequences to locate putative binding sites was performed 
using the MEME Suite (Motif based sequence analysis tools) (Bailey et al., 2009) and 
these searches were carried out by Govind Chandra. The search results for each of the 
proteins will be discussed in the relevant chapters.  
 
2.6.2 Testing the whole intergenic region 
The initial step involved amplifying the whole of the intergenic sequence by PCR in order 
to establish if there is any binding to this region. This was achieved by covalently 
attaching a biotinylated single-stranded DNA (ssDNA) linker to the streptavidin chip 
surface which could be used to capture double-stranded DNA (dsDNA) molecules which 
contain a single-stranded sequence at the 5’ end (which is complementary to the linker). 
This method (Reusable DNA Capture Technology - ReDCaT) was developed by Clare 
Stevenson, David Lawson and Sandra Greive and was used to test all of the sequences 
used in this study.  
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Biotinylated ssDNA linker sequence (1):- 
 5’ CGCATACGCAAACGCTAA – bio 3’ 
The intergenic sequences required the generation of a 20 bp 5’ overhanging ssDNA 
complementary in sequence to the 20 bp 3’ biotinylated oligo, which is immobilized on 
the streptavidin chip surface. This single-stranded overhanging sequence was achieved by 
the inclusion of an abasic site (1’,2’-Didoxyribose or dSpacer from Integrated DNA 
Technologies, Inc) in the forward PCR oligo which blocks transcription by DNA 
polymerase. The amplification was carried out in 3 steps as detailed in Figure 2.3. Taq 
polymerase was used as there is no exonuclease activity which would otherwise remove 
the single-stranded overhanging bases. The sequence specific oligos used are detailed in 
the relevant chapters.  
 
 
 
Figure 2.3  Autosticky PCR – generation of a 5’ overhang on the intergenic sequence of interest. The 5’ 
overhang is complementary to the 3’ biotinylated oligo which has been immobilized on a streptavidin chip 
surface.  
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PCR Step 1  The first PCR step involved the amplification of a larger template which 
incorporates the intergenic region of interest. This was necessary to avoid amplification of 
non-specific DNA and a BLAST search of the genome was performed to find the optimal 
primers to minimize the possibility of non-specific PCR product.  
Reaction mix 
 DMSO     2.5 μl 
10x PCR reaction buffer  5 μl 
10 mM dNTP mix   1 μl  
For primer (100 pmol μl-1)  1 μl 
Rev primer (100 pmol μl-1)  1 μl 
Template (50 – 200 ng μl-1)  1 μl (use 2 to 3 x this for genomic DNA) 
Taq polymerase   1 μl 
Water     37.5 μl 
 
PCR programme: 
1. 95°C for 4 min 
2. 95°C for 45 sec 
3. 55°C for 45 sec 
4. 72°C for 1 min 30 sec 
5. Go to step 2 26 more times 
6. 72°C for 7 min 
7. END 
 
Times can be shortened for short product lengths 
Annealing temperature in 3 may need optimising depending on the primer sequence.  
 
PCR Step 2 The intergenic region was then amplified from this template fragment to 
include a “nested” sequence which is complementary to the 3’ end of the forward oligo 
used in the final stage.  
PCR Step 3  The nested intergenic region was amplified again using the reverse oligo used 
in stage 2 and a forward oligo with an abasic site for the generation of the single stranded 
sequence. For this PCR reaction, the annealing temperature was set to 45°C.  
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For PCR steps 1 and 2, the PCR product was purified from 1% agarose gels using the 
Qiagen gel purification kit according to the manufacturer’s instructions. 
 
Loading the DNA  
The biotinylated ssDNA oligo was immobilized on the chip surface by using the wizard for 
immobilization on the Biacore T100 machine. The chip was washed three times with 50 
mM NaOH and 1 M NaCl in order to clear the chip surface prior to loading a 10 nM 
biotinylated oligo solution. All of the flow cells were subsequently blocked with three 60 
second injections of biotin polyethyleneoxide iodoacetamide (Sigma). A 1 μM solution of 
the autosticky PCR product was captured by injecting across the experimental flow cell 4 
(fc4), aiming for a capture level of 50-100 RU. As the generation of ssDNA overhangs is 
inefficient using the dspacers, it is necessary to use a slow rate of injection (10 μl min-1) 
over a longer period of time (~240 seconds). A 239 bp control sequence, kindly donated 
by Sandra Greive, was used in order to account for any non-specific binding and this was 
captured on the control flow cell 2:- 
Control sequence 
5’   TTATCAAAAAGAGTATTGACTTAAAGTCTAACCTATAGGATACTTACAGCCATCAGCAGGACG 
CACTCGCTCTTAAAAATTAGCCCTGAAGAAGGGCAGCATTCAAAGCAGAAGGCTTTGGGGTGTGT
GATACGAAACGAAGCATTGGCGGAATTCCAATCCCGAAACAGTTCGCAGGTAATAGTTAGAGCC
TGCATAACGGTTTCGGGATTTTTTATATCTGCACAACAGTTTTTTAT 3’ 
 
The reference cells (fc1 and fc3) contained no linker and were blocked with biotin. The 
experimental set up is shown in Figure 2.4.  
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Figure 2.4  Four flow cell chip experiment to test protein interaction with whole intergenic region 
 
2.6.3 Oligos used for the testing of the whole intergenic regions in SPR 
Biotinylated oligo (this is immobilized on the streptavadin chip) 
5’ CGC ATA CGC AAA CGC TAA – biotin 3’ 
 
Forward oligo with abasic site (idSp) 
5’TTA GCG TTT GCG TAT GCG /idSp/ TTA TCA AAA AGA GTA TTG AC 3’ 
 
Forward oligo with nested sequence 
5’ TTA TCA AAA AGA GTA TTG AC (~ 20 bases of target sequence) 3’ 
 
The PCR product from the final reaction was purified by the ethanol extraction method. 
The sample was pooled and precipitated with 1/10 volume of sodium acetate and 2 
volumes of 100% ethanol and incubated overnight at 277 K. The reaction was then 
centrifuged at 13000 rpm at room temperature for 30 minutes and the supernatant was 
removed immediately afterwards. The pellet was rinsed with 70% ethanol and allowed to 
dry for approximately 5 minutes. The DNA was dissolved gently in 30 μl water.  
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2.6.4 DNA footprinting  
This technique again utilized the reusable streptavidin chip to screen a number of DNA 
sequences to identify the cognate sequence. This time, however, the control sequence  
used above was omitted and, instead, the reference cell was loaded with the biotinylated 
linker sequence. All of the following experiments were carried out at 293 K using a 
Biacore T100/T200. The oligos were ordered from Sigma at a concentration of 100 μM. 
Stage 1 
In order to define the cognate binding sequence, it was necessary to fragment the 
intergenic region into overlapping sequences. The intergenic regions between sco5413-
5414; sco3914-3915 and sco4121-4122, were fragmented into shorter length sequences 
which incorporated ~22 base pair overlaps between each sequence (specific lengths are 
detailed in the relevant chapters). This was achieved using the Perl Overlapping Oligo 
Program (POOP) which was developed by Tung Le (unpublished work). The maximum 
length of 30 base pairs was chosen as DNA synthesis becomes expensive and less 
accurate above 50 bases (accounting for the extra 20 base pairs included on the reverse 
strand for annealing to the linker).  
 
The streptavidin chip was prepared by loading the biotinylated single-stranded linker onto 
the chip surface (fc1 and fc2). Typically, a capture level of 500 response units (RU) was set 
for the footprinting assay. For the affinity assay, this was adjusted to 100 RU (although 
the actual attained was 166 RU) as a lower response value improves the accuracy of such 
measurements (Stockley & Persson, 2009). The ssDNA linker was captured on both the 
control and experimental flow cells (in order to account for any non-specific binding to 
the linker sequence). The single stranded linker sequence is shown below:- 
5’ bio- GCAGGAGGACGTAGGGTAGG 3’ 
This sequence is a “random” sequence, distinct from the linker used for testing the whole 
intergenic region, which was designed by Clare Stevenson to minimize secondary 
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structure and self-dimer formation. The reverse complement of this sequence was then 
attached to the 3’ end of each of the reverse oligos (sequence specific oligos are detailed 
in the relevant chapters) during the oligo synthesis (Sigma).  
 
In this experiment, the complementary ssDNA sequences were annealed by mixing 60 μl 
of the forward oligo with 50 μl of the reverse oligo to give a 45 μM stock solution. This 
mixture was heated to 95°C for 10 minutes and then allowed to cool to room 
temperature. A larger volume of the forward oligo was used in order to maximize the 
potential for all of the linker strands (reverse) to form dsDNA and to reduce the 
opportunities for ssDNA to anneal to the chip. This was diluted to the working 
concentration of 1 μM with HBS-EP+ buffer. Each dsDNA sequence was then captured on 
the chip by running it across the analytical flow cell (fc2) containing the ssDNA linker at a 
flow rate of 10 μl min-1. The DNA captured was then washed with 0.5 M NaCl in order to 
remove any unbound DNA from the chip’s surface. The protein was then run across both 
the control and analytical flow cells (60 seconds at 30 μl min-1) and the results displayed 
as a percentage of the theoretical Rmax for each cycle. The theoretical Rmax was calculated 
as follows:- 
  
 Rmax =   MW protein/ MW DNA x DNA captured (RU) x stoichiometry (1) x 0.78 
 
An adjustment value for DNA of 0.78 was used to calculate the theoretical Rmax value as 
nucleic acids give a slightly higher RU than does protein (Buckle et al., 1996, Crouch et al., 
1999).  
 
Following the protein injection, the protein was allowed to dissociate for 300 seconds 
before a second salt wash (0.5 M for 60 seconds at 30 μl min-1) and a final wash with 1 M 
NaCl and 50 mM NaOH (60 seconds at 10 μl min-1) to remove both the protein and the 
DNA and regenerate the chip for the next cycle. Two replicates of each protein 
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concentration were run against each sequence. The outcome of this stage determined the 
sequences for stage 2. 
Stage 2 
This stage involved taking the sequence(s) which elicited the highest response in stage 1 
and eliminating 2 base pairs from each end in turn to narrow down the binding site 
(Figure 2.5). In order to account for any effects from the linker sequence, such as 
stabilization of binding due to the extra bases, the linker was subsequently attached to 
the reverse complement of the sequence to test the left hand boundary. The right hand 
and left hand boundaries were tested separately: two base pairs at a time were removed 
from the right hand side of the entire sequence, followed by two base pairs at a time 
from the left (the entire sequence). The specific sequences are detailed in the relevant 
chapters. The oligos were synthesized by Sigma and annealed using the protocol 
described previously. Again, three concentrations of the protein were run (in duplicate) 
and the interactions plotted as a percentage of the calculated Rmax. This information was 
analysed to determine the right and left hand boundaries of the sequence. The resultant 
sequence, with which the protein has the most significant interaction, was used in stage 3 
to investigate the strength of this interaction. 
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Figure 2.5  DNA footprinting, stages 1 and 2. 
 
Stage 3  
The affinity of the protein for the cognate sequence, which was determined in stage 2, 
was investigated. The “footprint” was determined by eliminating the defined number of 
base pairs from each end of the sequence and this new sequence was synthesized by 
Sigma. On flow cell 3 (the reference cell), a ssDNA sequence which was complementary to 
the ssDNA linker sequence was captured in order account for any non-specific 
interactions with the linker. The sequence being tested was captured on flow cell 4 and 
the chip was regenerated after each cycle. This time the protein was injected across the 
DNA at a flow rate of 100 μl min-1 for a period of 210 seconds to allow saturation of the 
DNA to occur. A dilution series was set up to include protein concentrations from 200 mM 
to 0.4 mM and each concentration was tested in triplicate. The responses were plotted 
against concentration and the affinity calculation was carried out using the Biacore T200 
data evaluation software.  
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2.7 Determination of pKa values of cysteine residues in Sco3914 
Sco3914 has two cysteines: Cys16 and Cys95. Cys16 is located in what would appear to be 
a putative ligand binding pocket, whereas Cys95 is located on the loop which could 
potentially make contacts with DNA. This experiment sought to determine the pKa of each 
of the cysteines in Sco3914 in an attempt to understand their relative reactivities. This 
information could also suggest the relevance of these cysteines to ligand detection and 
DNA-binding.  
 
2.7.1 DTNB assay to determine pKa of C16 and C95 
Ellman's reagent, or 5,5'-dithiobis(2-nitrobenzoate) (DTNB), undergoes a thiol-disulfide 
interchange in the presence of free thiols to generate the mixed disulfide and 2-nitro-5-
thiobenzoate (TNB2-). The stoichiometry of protein thiol to TNB formed is 1:1 and TNB has 
an intense absorption at 412 nm so it is possible to calculate the pKa by measuring the 
change in absorbance over time over a range of pH values. This was adapted from a 
similar experiment carried out on the MarR homologue, HypR  (Palm et al., 2012). 
 
Figure 2.6  The reaction between DTNB and the cysteine residue (RS
-
) in its thiolate form.  
In this experiment, the purified Sco3914C16S and Sco3914C95S mutants were used to 
determine the pKa of the Cys95 and Cys16 residues respectively by reaction with DTNB. 5 
μM of each protein were reacted with 20 μM DTNB in phosphate/citrate buffer (50 mM 
phosphate, 50 mM citrate, 100 mM NaCl) across the pH range  5.0-11.0  (5.0 ; 6.0; 6.5; 
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7.0; 7.5; 8.0; 8.5; 9.5; 10.0; 10.5; 11.0). The pH dependent rates of reaction of each 
cysteine with the DTNB were measured as a change in absorbance at 412 nm at room 
temperature on a Lambda 21 spectrophotometer (Perkin Elmer) over a period of 200 
seconds. The first order kinetic constants were calculated by a first fit of time-dependent 
absorbance change by non-linear regression (using SigmaPlot). A second fit of the initial 
rate of each reaction against the pH was used to calculate the pKa using the following 
equation in KaleidaGraph (Synergy Software):- 
Kobs = kmax*k a/ Ka + [H
+] 
The data were plotted in KaleidaGraph (Synergy Software) and the pKas of each cysteine 
with their associated error values calculated.  
 
2.8 Selecting the MarR proteins in Streptomyces coelicolor 
The initial part of the project involved selecting the proteins to be characterized. This was 
done using a variety of bioinformatics tools to choose 5 MFRs from the total of 42 in the 
S. coelicolor genome. The first method was using the microarray time course data for the 
Streptomyces coelicolor strains M570 (relA null mutant which is deficient in the 
production of act and red (Sun et al., 2001) and M600 (which is similar to M145 but 
differs in that it produces antibiotics at different time points) to analyse the expression 
profiles of each of the 42 genes. The data were viewed using GeneSpring (Agilent 
Technologies) software, with the assistance of Andy Hesketh and Maureen Bibb, and the 
main criteria were whether a protein was highly expressed or displayed a fluctuation in its 
expression level at a particular time point (e.g. 36 hours when sporulation occurs). The 
object was to select a protein which, when deleted from the genome, would yield a 
phenotype which differed to the wild type. The expression profiles for all 42 homologues 
were analysed, looking for any fluctuations over time, and the raw data were also used as 
this reveals the level of expression (on a log scale). The values of 0-50 were considered to 
be indicative of low expression. Also analysed were the microarray data for the 
orthologues in Streptomyces venezuelae to check that these also had a similar expression 
profile.  
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Figure 2.7  Microarray data from GeneSpring showing the expression profile of sco4122 over the course of a 
5 day experiment. 
The proteins were selected for their expression under the conditions measured in the 
microarray experiments and also their sequence identities to other species of 
streptomycete. The latter were obtained from the Streptomyces orthologues table 
(compiled by Govind Chandra, John Innes Centre), searching specifically for MFRs which 
had good conservation of identity across several species of streptomycete (S. griseus; 
S.coelicolor; S. scabies; S. avermitilis and S. venezuelae). Finally, the Streptomyces 
Annotation Server, StrepDB (http://strepdb.streptomyces.org.uk/), was also used to look 
for regions of synteny across the annotated genomes. 
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3.1 Introduction 
Sco3914 is one of the 42 putative transcriptional regulators of the MarR family of 
regulators  (MFRs) in Streptomyces coelicolor. Bioinformatic analysis predicts it to be a 
mainly helical protein of 154 amino acids, with the winged helix-turn-helix motif which is 
characteristic of some regulatory DNA-binding proteins. Sco3914 has been cloned, 
expressed, purified and crystallized and the structure solved to 1.5 Å resolution. A 
deletion mutant was generated in the host organism but no visible phenotype observed 
under the conditions tested. The DNA footprint of Sco3914 has been determined in this 
work by using Surface Plasmon Resonance (SPR) and the kinetics of this interaction also 
quantified. There is potential for this protein to be crystallized with its cognate DNA 
sequence in order to identify the precise protein-DNA interactions.  
 
 
Figure 3.1  A representation of the genomic context of sco3914 in the Streptomyces coelicolor genome. The 
divergently transcribed gene, sco3915, is a probable transmembrane efflux protein. Sco3914 binds to the 
intergenic region between these two genes. 
 
The sco3914 gene is 465 bp in length and has a GC content of 69%. It is an extremely well 
conserved gene amongst streptomycetes and has 68 orthologues amongst 112 
actinobacterial genomes and E. coli and Bacillus subtilis (bioinformatics analysis done by 
Govind Chandra, John Innes Centre). Its close homology to orthologues in other published 
sequences of streptomycetes can be seen in Table  below.  
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Table 3.1  The sequence identities shared between the orthologues from other Streptomycetes and 
Streptomyces coelicolor Sco3914. Sav – Streptomyces avermitilis; Ssc – Streptomyces scabius; Sgr – 
Streptomyces griseus: Sven – Streptomyces venezuelae. 
 
As MFRs are often autoregulatory (Rosenfeld et al., 2002), the intergenic region upstream 
of sco3914 was a logical starting place to look for Sco3914 operator sites. Moreover, since 
the adjacent gene, sco3915, is divergently transcribed from sco3914, Sco3914 could 
potentially regulate this gene as well. Sco3915 is annotated in the StrepDB server as a 
probable transmembrane efflux protein. Further bioinformatic analysis reveals that it 
shares a high sequence identity (>50%) with transmembrane efflux proteins or major 
facilitator superfamily protein members from a variety of streptomycetes and other 
actinobacteria including Nocardia and proteobacteria such as Burkholderia. The 
prevalence of this protein in these species would suggest that it may be important in 
protecting the cell against toxic molecules and so, if Sco3914 were to regulate it, then this 
would be of significant interest. This is a hypothesis which would warrant further 
investigation. In this study, the interactions between Sco3914 and this intergenic 
sequence were explored using Surface Plasmon Resonance (SPR). 
 
The results obtained for the biophysical, genetic and structural characterization of 
Sco3914 will be discussed in this chapter. 
 
3.2 Protein Expression and Purification 
The protein was cloned and expressed according to the method described in Chapter 2. 
Typically, Sco3914 elutes from the nickel affinity column with a fairly broad peak profile 
(Figure 3.2). The fractions containing the protein were analysed by SDS-PAGE pooled and 
 Amino acid sequence %ID DNA Sequence %ID 
Sco Sav  Ssc  Sgr  Sven  Sav  Ssc  Sgr  Sven  
Sco3914 Sav4281 
86% 
Scab4619
87% 
Sgr3665 
84% 
Sven3693 
84% 
Sav4281 
87% 
Scab46191 
85%  
Sgr3665 
82% 
Sven3693 
86% 
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applied to the size exclusion gel filtration column (GE Healthcare Superdex 75 16/60). The 
purity of the protein following the nickel affinity column purification and the size 
exclusion gel filtration chromatography column can be seen in Figure 3.2 and Figure 3.3.    
 
Figure 3.2 Elution profile of Sco3914 from nickel affinity column chromatography. The protein elutes at a 
concentration of ~100 mM imidazole. 
 
 
Figure 3.3  15% SDS-PAGE after nickel affinity column purification. The columns contain: (1) Lyzed pre-
induction pellet; (2) Lyzed post-induction pellet; (3) Supernatant; (4) Fraction A4; (5) A5; (6) A7; (7) A8; (8) 
A9.  
 22Feb2012Sco3914:1_UV  22Feb2012Sco3914:1_Conc  22Feb2012Sco3914:1_Fractions  22Feb2012Sco3914:1_Inject  22Feb2012Sco3914:1_Logbook
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The samples containing Sco3914 were pooled and the concentration of the sample 
determined to be 1.5 mg ml-1 by the Bradford assay. The optimum concentration for the 
His-tag cleavage with 3CP protease is between 1 and 2 mg ml-1, and so the sample was 
buffer exchanged into buffer A (Chapter 2) containing 2 mM β-mercaptoethanol (βME). 
 
3.2.1 His-tag cleavage with 3C PreScission Protease 
The His-tag was cleaved from the purified protein using HRV 3C protease (Chapter 2). The 
cleaved protein sample eluted from the column in the tag cleavage buffer (Figure 3.4) 
whilst the protease and the non-cleaved sample eluted after the application of 100% 
buffer B (500 mM imidazole). The cleaved sample was judged to be >95% pure by SDS-
PAGE analysis (Figure 3.5).  
 
 
 
Figure 3.4  Elution profile of Sco3914 from the nickel affinity column post-tag cleavage. Cleaved Sco3914 
elutes in fractions A2-A4 whilst the absorbance that is observed in fractions A12-B15 is mainly due to the 
imidazole in Buffer B. 
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Figure 3.5  15% SDS-PAGE after purification of tag-cleaved sample using nickel-affinity column purification. 
The columns contain: (1) Uncleaved Sco3914; (2) cleavage reaction sample (16 hours after start of reaction); 
(3) A2; (4) A6; (5) A13; (6) Sco3914 (tag cleaved sample from previous preparation).  
 
The cleaved protein samples were pooled and dialyzed into 20 mM Tris-HCl pH 7.5 and 
0.2 M NaCl buffer and applied to the Superdex 75 (16/60) gel filtration column (GE 
Healthcare). The protein elutes in two oligomeric states, of which the most abundant 
species (represented by the highest peak in Figure 3.6) corresponds to a protein of 45210 
Da (using the standard curve generated by the calibration of this column). Although this is 
larger than the calculated molecular weight of 33444 Da for the tag-cleaved dimer, it is in 
good agreement with gel filtration results for the tagged protein which eluted at a volume 
which corresponded to a molecular weight of ~ 55 kDa (calculated MW of tagged dimer is 
37416 Da). Dynamic light scattering (Figure 3.7) was also carried out on the tagged 
protein (method described in Chapter 2). The data were analyzed using the DYNAMICS V6 
software (Wyatt Technology Corp.) and showed a polydispersity of 26% and a molecular 
size estimate of 52 kDa, comparable to the 55 kDa estimated from the gel filtration 
column. All three values are larger than expected for the Sco3914 dimer, but this could be 
due to the shape of the protein. 
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Figure 3.6 Elution profile of Sco3914 following size exclusion gel purification.  
 
Item  R (nm) %Pd  
MW-R 
(kDa) %Int  %Mass  
Peak 1 3.2 26 52 62.1 99.9 
Peak 2 28.6 19.7 8624 17.7 0 
Peak 3 133.3 18.4 315461 14.4 0 
Peak 4 3619.4 0 7.14E+08 5.8 0 
 
Figure 3.7  Dynamic Light Scattering profile of Sco3914. The peaks represent the species of a particular size 
(radius) as a percentage of the total mass present in solution. There is a predominant species with an 
estimated size of 52 kDa present in the solution. 
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3.3 X-ray Crystallography and Data Collection 
3.3.1 Data collection 
Initial crystal screening of the His-tagged protein did not produce crystals in any of the 5 
screens tested.  An analysis of the tagged sequence was performed in order to determine 
the possible cause of this reluctance to crystallize. The sequence of Sco3914 plus the 6-
His tag is shown below:- 
 
 
 
MAHHHHHHSSGLEVLFQGPTATDPALTALSQGWCALSLLHGRIEAHIERALQTGHDLSVREYSLLDVLSRQHD
GDGGHLQMKQVADAVVLSQSATTRLVTRLEDRGLLERYLCPTDRRGIYTNVTPAGLQLLDEARPTNDTALREAL
DDAAANPDLAPLVRAVETLKAPVPA 
 
3CP proteolytic cleavage of the His-tag gives the following sequence which differs from 
the native sequence in that the initial methionine is replaced by two residues: a glycine 
and a proline:- 
GPTATDPALTALSQGWCALSLLHGRIEAHIERALQTGHDLSVREYSLLDVLSRQHDGDGGHLQMKQVADAVVL
SQSATTRLVTRLEDRGLLERYLCPTDRRGIYTNVTPAGLQLLDEARPTNDTALREALDDAAANPDLAPLVRAVET
LKAPVPA 
 
The Disopred server (http://bioinf.cs.ucl.ac.uk/disopred/) (Ward et al., 2004) predicted 
that there was a high probability of disorder in the first 24 residues at the N-terminus. 
Disorder prediction analysis of the tag cleaved sequence suggested that only the first five 
residues would be disordered.  
3CP cleavage site 
Chapter 3 – Sco3914 
 
88 
 
 
 
Figure 3.8  Disopred server predictions of the disorder probability of (a) tagged sequence of Sco3914; (b) 
tag cleaved sequence of Sco3914. This analysis suggests that removing the His-tag may decrease the 
disorder of the N-terminus and so increase the potential to crystallize the protein. 
 
Removing the tag yielded crystals (Figure 3.9) in several conditions of the PACT screen 
(Molecular Dimensions). The protein:well solution ratio was 1:1 (0.6 μl total volume) and 
a 
b 
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the protein was filtered prior to dispensing using a 0.1 μm Ultrafree-MC centrifugal filter 
device (Millipore).  
 
 
Figure 3.9 Crystals of Sco3914 grown in a variety of conditions in the PACT crystallization screen.  
 
The H9 condition (containing 25% PEG 3350, 0.1 M Bis-Tris propane pH7 and 0.2 M Na 
Malonate pH 5.5) was optimized in order to improve crystal quality. Optimizations were 
set up in 24-well hanging drop plates with 1 ml well solution. 1 μl of protein and 1 μl 
precipitant solution were combined in the hanging drop. 15% glycerol was added to the 
well solutions prior to crystallization in order to provide a cryoprotectant for the crystal. 
Sco3914 crystals tolerated this additive well and the diffraction of the crystals was slightly 
improved. The morphology of the crystals also seemed to improve as they appeared to be 
more robust than the ones from the initial screen (Figure 3.10). 
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Figure 3.10  Sco3914 crystals in the optimized PACT H9 condition (25% PEG 3350; 0.1 M Bis-Tris propane 
pH7; 0.2 M Na Malonate pH 5.5 and 15% glycerol). 
 
Many of these rod shaped crystals were grown from this condition and attempts were 
made to obtain derivative crystals for structural determination. These attempts included 
soaks with a variety of heavy atom compound solutions, co-crystallization and soaking 
with halide solutions and preparation of selenomethionine-substituted protein (described 
in Chapter 2). A successful derivative dataset was collected from a crystal which had been 
soaked for ~10 seconds in the well solution containing 1 M potassium iodide (Dauter et 
al., 2000). The incorporation of halide ions into the crystal occurs rapidly and so this 
substitution did not damage the crystal. This dataset was collected in-house using a 
Mar345 image-plate detector (MarResearch) mounted on a Rigaku RU-H3RHB rotating-
anode X-ray generator (operated at 50 kV and 100 mA) fitted with Osmic confocal optics 
and a copper target (Cu Kα; λ = 1.542 Å). Iodide has a significant anomalous signal at this 
wavelength (Evans & Bricogne, 2002). A highly redundant dataset comprising 2385 x 1° 
images (~6.6 full rotations) was then recorded to 2.44 Å resolution in-house. Sco3914 
crystals belonged to space group P1 with approximate cell parameters of a = 42, b = 59, c 
= 69 Å and α = 90, β = 95,  = 108°. The native data were collected on beamline i04 at the 
Diamond Light Source (UK) to a maximum resolution of 1.5 Å using an ADSC Quantum 315 
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CCD detector. The collection was carried out in two passes: a low resolution pass at 2.5 Å 
resolution and a high resolution pass at 1.5 Å resolution.  
 
 
Figure 3.11   (a) Diffraction image of Sco3914 native crystal (data collected at Diamond Light Source 
Synchrotron station i04); (b) native crystal in the loop. The crystal was approximately 700 x 75 x 50 µm in 
size. The red box indicates the dimensions of the beam. 
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3.3.2 Structural determination 
All data were processed using MOSFLM (Leslie et al., 2007) and integrated using SCALA 
(Evans, 2006). The native and iodide datafiles were fed into PHENIX (Adams et al., 2010) 
which used the AutoSol wizard (Terwilliger et al., 2009) to solve the structure by the 
Single Isomorphous Replacement with Anomalous Scattering (SIRAS) method. This wizard 
uses the datafiles containing the amplitudes of structure factors and identifies the heavy 
atom sites (using HySS) and calculates the associated phases (using SOLVE). Three good 
iodide sites were identified, giving a figure of merit of 0.793 to 2.46 Å resolution following 
density modification (using RESOLVE). There are 4 copies of the monomer in the 
asymmetric unit (giving a corresponding solvent content of 48%). These phases were then 
fed into AutoBuild (Terwilliger et al., 2008) which, through many cycles of building and 
refinement, generated a partial model. This partial model was quite incomplete (401 
residues had been fitted) yet the predominantly α-helical structure characteristic of MarR 
family proteins was apparent. However, the electron density was quite fragmented, even 
though the existing density was of a reasonable quality, and this would make a manual 
rebuild of the four chains quite time-consuming.  
 
The density modification performed by RESOLVE had not determined the NCS operators 
for the expected four-fold NCS and so the next step was to determine these NCS 
operators in order to improve phases by density modification using four-fold averaging. 
Several structural templates had already been generated by the PHYRE server (Kelley & 
Sternberg, 2009) during previous attempts at solving the structure by molecular 
replacement. One of these models was derived from HucR from Deinococcus radiodurans 
(PDB code 2FBK (Bordelon et al., 2006)). Using a combination of the SSM superpose 
(Rigali et al., 2006) option and manual superposition in COOT (Emsley et al.), four copies 
of this template were placed onto the partial model from PHENIX, giving two recognisable 
MarR-like dimers in the asymmetric unit. The experimental  phases from PHENIX were 
calculated to 2.46 Å resolution (the resolution of the iodide dataset), but it was possible 
to extend these phases to 1.5 Å resolution by running rigid body refinement with the 
partial model against the native dataset in REFMAC5 (Murshudov et al., 1997). The 
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phases were improved by density modification (the NCS operators were obtained from 
the four docked molecular replacement templates) using four-fold averaging in PARROT 
(Cowtan), giving a FOM of 0.553 to 1.5 Å resolution. These phases were used to calculate 
electron density maps which were improved enough to generate a model from scratch 
using BUCCANEER (Cowtan, 2006) with 578 residues and Rwork and Rfree values of 0.332 
and 0.358 respectively. This model was used to derive the NCS operators for another 
cycle of density modification in conjunction with the resultant phases, giving a FOM of 
0.800. Again, the electron density map was visibly improved and this time BUCCANEER 
was able to build a model of 609 residues from scratch with Rwork and Rfree values of 0.290 
and 0.312, respectively. This model and map were good enough to perform several 
iterations of model-building in COOT in combination with refinement in REFMAC5. Water 
molecules were fitted using Arp/wARP (Perrakis et al., 1999).  
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Figure 3.12  Structure solution steps for Sco3914 
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Following further refinement, extra density surrounding the cysteines (Cys16 and Cys95) 
on each monomer was observed (Figure 3.13). Attempts to model the extra density as 
oxidized cysteine residues did not account for all the residual density. It was postulated 
that these were β-mercaptoethanol (βME) adducts, as this was used as a buffer 
component for the His-tag cleavage with 3C protease. Using the modelling options in 
COOT, it was possible to edit the PDB file to incorporate these modifications, changing 
the cysteine (CYS) to S,S-(2-hydroxyethyl)thiocysteine (CME). Subsequent refinement 
reduced the difference density significantly and the modified residue fitted the electron 
density well. There is a small amount of negative density in the difference density map, 
but this may be due to radiation damage of some of these modified residues or even 
disorder that was not modelled. 
 
Figure 3.13  Extra electron density surrounding the cysteine 95 molecule (chain A) in Sco3914. (a) Map at 
early stages of refinement with Cys95; (b) final map with β-mercaptoethanol modified cysteine (CME95). 
2mFobs – dFcalc maps at 1.5 Å resolution and contoured at 1.0 σ. 
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Table 3.1  Summary of X-ray data for Sco3914 
Dataset Native   Iodide derivative 
Number of crystals 1 1 
Beamline I04, Diamond Light Source, UK Rigaku RU-H3RHB rotating-
anode X-ray generator 
Wavelength  (Å) 0.98 1.54 
Detector Quantum 315 CCD MAR 345 image plate 
Rotation range per image (°) 1.0/0.5 1.0 
Exposure time per image (s) 0.25/0.5 600 
Total rotation range (°) 360/360 2385 
Resolution range (Å) 38.38-1.50 (1.58-1.50) 22.89-2.44 (2.57-2.44) 
Space Group P1 P1 
Cell parameters (Å) a = 41.67, b = 59.28, c = 68.69 
α = 90.15, β = 95.17, γ = 107.88 
a = 41.77, b = 59.14, c = 68.91 
α = 89.66, β = 95.65, γ = 108.05 
Estimated mosaicity (°) 0.24 1.00 
Total no. of measured intensities 359794(52249) 542904(55481) 
Unique reflections 94894(13729) 21246(2342) 
Multiplicity 3.8 (3.8) 12.8 (12.3) 
Mean I/(I) 10.8 (3.4) 35.0 (13.8) 
Completeness (%)
 
95.1 (94.2) 90.9 (68.1) 
Rmerge
†
 0.071 (0.341) 0.095 (0.252) 
Rmeas
‡
 0.082 (0.396) 0.099 (0.263) 
Wilson B value (Å
2
) 19.1 25.5 
†
 Rmerge = ∑hkl ∑i |Ii(hkl)  I(hkl)|/ ∑hkl ∑iIi(hkl). 
‡ 
Rmeas = ∑hkl [N/(N  1)]
1/2
 × ∑i |Ii(hkl)  I(hkl)|/ ∑hkl ∑iIi(hkl), 
where Ii(hkl) is the ith observation of reflection hkl, I(hkl) is the weighted average intensity for all 
observations i of reflection hkl and N is the number of observations of reflection hkl.  
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Table 3.2  Summary of refined model parameters for Sco3914 
Resolution range (Å) 69.38 - 1.50 
Rwork/ Rfree
†
 0.1488/0.1918 
Ramachandran plot: 
favoured/allowed/disallowed
‡
 (%) 
98.7/100/0 
R.m.s. bond distance deviation (Å) 0.013 
R.m.s. bond angle deviation (º)  1.5 
No. of protein residues: chain A/chain 
B/chain C/chain D 
154/154/154/154 
No. of water molecules 602 
Mean B factors: protein/water/overall  (Å
2
) 20.5/32.4/21.9 
† The R-factors Rwork and Rfree are calculated as follows: R = (| Fobs - Fcalc |)/| Fobs | x 100, where 
Fobs and Fcalc are the observed and calculated structure factor amplitudes, respectively. 
‡ As 
calculated using MOLPROBITY (Chen et al., 2010, Davis et al., 2007). 
 
Structure validation was carried out using the validation tools in COOT and Molprobity 
(Chen et al., 2010, Davis et al., 2007). The Ramachandran plot (Figure 3.14) indicates that 
there are no outliers in the structure. The Molprobity analysis is good, scoring in the 98th 
percentile (Table 3.3). 
Table 3.3  Results from Molprobity analysis of Sco3914 structure. 
All-Atom 
Contacts 
Clashscore, all atoms: 3.62 96th percentile* (N=598, 1.50Å ± 0.25Å) 
Clashscore is the number of serious steric overlaps (> 0.4 Å) per 1000 atoms. 
Protein 
Geometry 
Poor rotamers 0.00% Goal: <1% 
Ramachandran outliers 0.00% Goal: <0.2% 
Ramachandran favored 98.64% Goal: >98% 
Cβ deviations >0.25Å 0 Goal: 0 
MolProbity score^ 1.15 98th percentile* (N=4836, 1.50Å ± 0.25Å) 
Residues with bad bonds: 0.00% Goal: 0% 
Residues with bad angles: 0.00% Goal: <0.1% 
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* 100
th
 percentile is the best among structures of comparable resolution; 0
th
 percentile is the worst.  
 
 
Figure 3.14  Ramachandran plot (from Molprobity) for the crystal structure of Sco3914. There are no 
residues in disallowed regions whilst 98.7% of residues are in favoured regions. 
 
Chapter 3 – Sco3914 
 
99 
 
 
 
3.3.3  Structural analysis 
Sco3914 has the typical MarR features: it is a helical-rich dimer with the triangular MarR 
shape (and there are two dimers present in the asymmetric unit of this structure). It has 
the topology α1-α2-α3-α4-β1-β2-α5-α6, with α4 constituting the recognition helix in the 
helix-turn-helix motif, whilst the wing consists of two antiparallel β-strands, β1 and β2 
and the intervening loop. These are the DNA-binding domains in most MarR homologues. 
The dimerization interface comprises the α1, α5 and α6 helices from each monomer 
which intertwine with each other.   
 
Figure 3.15 Secondary structure analysis of Sco3914 generated by PDBSum 
(http://www.ebi.ac.uk/pdbsum/)  (Laskowski, 2009).  
 
The total interface as detailed by the PISA server 
(http://www.ebi.ac.uk/pdbe/prot_int/pistart.html) differs between the two dimers in the 
asymmetric unit: the calculated interface area between A and B is 2841 Å (44% of 
residues) whilst for C and D, it is 2174 Å (37% of residues). These values are quite 
different and superposition of chains A and B (dimer 1) onto chains C and D (dimer 2) give 
a root mean square deviation (RMSD) of 1.0 Å although the conformations of the two are 
Chapter 3 – Sco3914 
 
100 
 
not obviously very different (Figure 3.16). For the superpositioning of structural 
homologues onto Sco3914, chains A and B were used for the dimer superposition whilst 
chain A1 was used for the monomer. The results for the secondary structure matching 
(SSM) are shown in Table 3.4 and the superpositions of some of the models are shown in 
Figure 3.17. Crystal contacts are reported between the two dimers: Chains B and C (from 
different dimers) make salt bridge and H-bond contacts through Asp115 (B) and Arg79 
(C). This is also observed between chains A and D. 
 
Figure 3.16  (a) Two Sco3914 dimers in the asymmetric unit; (b) Chains C and D (grey) superimposed onto 
chains A and B (green and cyan). The red colour indicates the position of the cysteines.  
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Sco3914 has a shape which is relatively flat compared to other MFRs. However, as the 
superpositions show (Figure 3.17), it could still potentially be in a conformation which is 
compatible with DNA binding.  The twist of the DNA recognition helices of Sco3914 is 
slightly different to the SlyA- and OhrR-DNA complexes, but the distance between the 
helices appears very similar, suggesting that it may be in a conformation for binding DNA. 
Although HypR. also has a dimeric shape which is relatively “flat” compared to other 
MFRs, superposition of the dimer was not possible due to its more unusual shape. The 
α4-α4’ helices in HypR shift only a small distance when comparing the reduced and 
oxidized forms of this protein: from 30 Å to 27 Å respectively. The superposition of the 
monomer can be seen in Figure 3.17 and the locations of the two cysteines on each 
protein molecule are quite different.  
 
Table 3.4  Structural homologues of Sco3914 
Protein  Source 
DNA or 
ligand 
PDB 
code 
Dali      
R.m.s. deviation (Å)/ 
aligned residues 
Reference 
        Z-score 
Alignment 
length 
Seq. 
ID 
(%) 
Subunit Dimer   
Transcrip
tional 
regulator 
Rhodococc
us jostii 
RHA1 
- 3FM5 8.6 110 32 1.5/109 2.0/226 
To be 
published 
ST1710  
Sulfolobus 
tokodaii 
salicylate 3GF2 7.8 107 24 1.8/105 3.4/204 
(Kumarevel et 
al., 2009) 
ST1710  
Sulfolobus 
tokodaii 
DNA 3GFI 7.7 108 24 2.3/106 5.5/195 
(Kumarevel et 
al., 2009) 
Probable 
regulator 
Pseudomon
as 
aeruginosa 
- 2NNN 7.2 114 22 1.8/111 3.0/221 
To be 
published 
SarZ 
Staphyloco
ccus aureus 
Sulfenic 
acid form 
3HRM 6.8 100 17 2.5/93 3.4/189 
(Poor et al., 
2009) 
SlyA 
Salmonella 
enterica 
DNA 3Q5F 6.8 112 24 2.0/110 2.4/220 
(Dolan et al., 
2011) 
SarZ 
Staphyloco
ccus aureus 
Mixed 
disulfide 
3HSR 6.7 99 17 2.4/97 3.4/189 
(Poor et al., 
2009) 
MarR E. coli salicylate 1JGS 6.5 114 17 2.2/112 2.9/145 
(Alekshun et 
al., 2001) 
OhrR 
Bacillus 
subtilis 
DNA 1Z9C 6.4 116 18 2.2/98 3.2/190 
(Hong et al., 
2005) 
BldR 
Sulfolobus 
Solfataricus 
- 3F3X 6.2 108 21 2.7/105 2.3/215 
(Di Fiore et 
al., 2009) 
SarZ 
Staphyloco
ccus aureus 
Reduced 
form 
3HSE 5.8 85 16 2.8/87 3.3/167 
(Poor et al., 
2009) 
MgrA 
Staphyloco
ccus aureus 
- 2BV6 5.5 113 13 2.7/92 4.0/203 Chen et al.  
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Figure 3.17  Superimpositions of structures of MFRs from other organisms (in grey) on Sco3914 (green and 
cyan). Views are from the front and, rotating by 90°, from underneath. The cysteines are in red (Sco3914) or 
magenta (HypR and MgrA).  
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Figure 3.18  Superposition of Sco3914 onto the crystal structures of SarZ reduced and SarZ mixed disulphide 
(Poor et al., 2009). The Sco3914 cysteines are in red; the SarZ cysteine is in magenta. 
 
SarZ is a global transcriptional regulator from Staphylococcus aureus which uses a single 
cysteine, Cys13, to sense peroxide stress (Poor et al., 2009). The superimposition of 
Sco3914 onto the three different SarZ forms reveals that, at the dimer level, Sco3914 
superimposes onto the reduced form better than the sulfenic acid or mixed disulphide 
forms. However, at the subunit level, superimposition upon the reduced SarZ monomer 
has the highest RMSD and the α4 helices appear to be in quite different positions 
compared to the superimposition upon the mixed disulphide form (Figure 3.18). These 
superimpositions also show that the cysteines (Cys16 on Sco3914 and Cys13 on SarZ) are 
located in a similar position, towards the N-terminus of the first α-helix on each 
monomer. Similarly, the cysteine in MgrA (Cys12), also a key global regulator in S. aureus, 
is located in this position. Single cysteine induction of transcriptional regulators is a 
mechanism used by many bacteria in defence against peroxide stress (see Chapter 1). 
Both MgrA and SarZ use this oxide sensing cysteine mechanism and so it is interesting 
that Sco3914 also appears to have a similarly conserved cysteine (even though it is not a 
single cysteine). The environment of Cys16 in Sco3914 (Figure 3.19) suggests that it could 
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hydrogen bond to the carbonyl oxygen of Gln13. The proximity of Trp15 could also 
stabilize this residue. In SarZ, the Cys13 is reported to be located in a pocket and 
surrounded by an extensive hydrogen bond network which can stabilize the sulfenic acid 
intermediate.  
  
Figure 3.19  The environment of cysteine 16 in Sco3914. 
 
However, taking a sequence alignment view of Cys16 compared to other MFRs containing 
an N-terminal cysteine which have been shown to be redox responsive regulators, it 
becomes apparent that Cys16 does not have the similarly conserved surrounding 
residues. 
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Figure 3.20  Sequence alignment of Sco3914 with other MFRs that utilize redox active cysteines. Sequence 
alignment was carried out using the PRALINE server (Simossis & Heringa, 2005). 
 
All of the sequences in the alignment, except Sco3914, show conservation of residues 
surrounding the N-terminal cysteine, suggesting that this is perhaps not a well conserved 
cysteine in Sco3914. Nevertheless, it is obviously reactive and worthy of further 
investigation. Cysteines in MFRs have been shown to initiate derepression by i) formation 
of intersubunit disulphide bonds resulting in a dramatic conformational rearrangement or 
ii) modification of a single cysteine residue by an effector molecule which is 
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communicated to the DNA binding domain. Most recently, a new mechanism of 
phosphorylation of these conserved cysteines in SarA, MgrA and SarZ has been shown to 
occur (Sun et al., 2012) and this again presents an interesting point for future work with 
Sco3914.  
 
3.4 Site-directed mutagenesis 
The modifications of the two cysteines suggested that these may be particularly reactive 
and so could potentially play a role in binding or recognition of DNA and/or of a ligand. 
Mutagenesis of these two cysteines was the logical next step to determining their roles. 
Initially, the decision was made to produce two mutants of both cysteines: a serine, to 
generate a structurally similar mutant, and an alanine. As described in Chapter 2, the 
oligos were designed to mutagenize these cysteines by PCR, using the Quikchange 
Lightning Site-Directed Mutagenesis Kit (Agilent Technologies).  However, this strategy 
proved unsuccessful after many attempts and variations of the method. To further 
progress with this, the Sco3914C16S gene cloned into the pOPINF expression vector was 
ordered from GenScript. Interestingly, GenScript also appeared to have difficulties in 
cloning this gene. The turnaround time for production was much longer than expected as 
they reported problems with mutations when they sequenced the gene.  
 
This was also the case with the C95S mutation, which was cloned into pUC19 (again by 
GenScript) but was problematic to subclone into pOPINF. It was decided to use pOPINF as 
the expression vector in an effort to keep as much of the overexpression and purification 
methods as similar as possible to the native protein. The gene was amplified with the 
pOPINF oligos using the pUC19 vector as a template and the PCR product checked by 
agarose electrophoresis. This step proved to be difficult as during several attempts, no 
bands of the correct size could be detected. The PCR reaction was optimized but the 
results were often inconsistent. A gradient PCR was also attempted but no product 
observed on agarose. Further optimization of the PCR method included a 20 times 
dilution of the primers which did result in a product (although this again was inconsistent 
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in further attempts, but it did give more product than had previously been achieved). 
Obtaining the PCR product was by no means the end of this problem: the next step was 
the InFusion reaction to clone the gene into pOPINF. Blue-white screening was carried out 
as described previously to detect successful transformants and these white colonies were 
checked by colony PCR to see if they had a band of the correct size. Subsequent 
sequencing performed by The Genome Analysis Centre (TGAC) returned many sequences 
which had insertions or deletions of random base pairs. These were predominantly at the 
beginning or the end of the sequence (where the primers anneal) although several were 
also detected in the middle of the sequence. It is still unclear as to why this gene has 
proved difficult to clone into an expression vector, but suggestions have included the 
possibility that the gene may be toxic to E. coli, which is why random mutations have 
been favoured. After screening many colonies by PCR and sequencing the purified vector 
from approximately 40 colonies, 6 of them proved to have the correct sequence and so it 
was possible to proceed with the relatively straightforward task of protein expression and 
purification. 
 
3.4.1  Overexpression and purification of Sco3914C16S and Sco3914C95S 
The mutants were overexpressed and purified as per the native protein: immobilized 
metal affinity chromatography followed by size exclusion gel filtration chromatography. 
The elution profiles and the SDS-PAGE analyses appeared to be much the same as for the 
native protein (Figure 3.21). 
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Figure 3.21  15% SDS-PAGE following nickel affinity purification of Sco3914C95S. The lanes contain: (1) 
Lyzed pellet; (2) Supernatant; (3) Fraction A4; (4) A7; (5) A8; (6) A9;( 7) A10; (8) A11.  
 
 
Figure 3.22 15% SDS-PAGE following tag cleavage with 3CP protease. Lane (1) Pre-reaction sample; (2) Post-
cleavage sample; (3) Flowthrough from nickel column; (4) Sample eluted with 500 mM imidazole; (5) 
Previous preparation of cleaved wild type Sco3914. 
 
3.4.2 Structural solution of Sco3914C16S 
Sco3914C16S crystallized in the same conditions as Sco3914. Morphologically, the crystals 
appeared similar (Figure 3.23) although this time, the space group was P212121 with cell 
dimensions of a = 58.4 Å, b = 68.6 Å, c = 77.1 Å.  
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Figure 3.23  Sco3914C16S crystal in the cryoloop at Diamond Light Source. 
 
Data were collected at station i04 at Diamond Light Source. Several initial attempts to 
collect data were aborted as the spots appeared to be split. A more successful crystal was 
also aborted as the diffraction was severely affected by radiation damage. Translating the 
beam approximately 50 μm along the crystal enabled the data collection to be resumed 
and 200 images were collected successfully. The images from both runs were combined 
(using SortMTZ from the CCP4 suite) following processing and prior to scaling and 
merging. The structure was solved by molecular replacement, using the native Sco3914 
model as the template. The data were processed using MOSFLM and scaled and merged 
using SCALA. Chain A of the Sco3914 model was used as the search model in PHASER, 
searching for two copies of the monomer in the asymmetric unit (giving a calculated 
solvent content of 47%). 
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Table 3.5  Summary of X-ray data for Sco3914 reduced form and Sco3914C16S 
Dataset Sco3914 reduced   Sco3914 C16S 
Number of crystals 1 1 
Beamline i02, Diamond Light Source, UK i04 
Wavelength  (Å) 0.91 0.9763 
Detector Pilatus 6M ADSC Q315r 
Crystal-to-detector distance (mm) 260.8 270.5 
Rotation range per image (°) 0.4 0.5 
Exposure time per image (s) 1.2 1.0 
Total rotation range (°) 280 250 
Resolution range (Å) 68.15-1.9 68.62-2.05 
Space Group P212121 P212121 
Cell parameters (Å) a = 60.28, b = 68.15, c = 76.37 a = 58.32,  b =  68.54,  c = 77.01 
Estimated mosaicity (°) 0.4 0.6 
Total no. of measured intensities 275576 (20377) 75186(5694) 
Unique reflections 25038 (1801) 18793(1363) 
Multiplicity 11.0 (11.3) 4.0(4.2) 
Mean I/(I) 13.9 (4.2) 11.0(2.5) 
Completeness (%)
 
99.9 (100.0) 97.0(96.4) 
Rmerge
†
 0.121 (1.07) 0.081(0.683) 
†
Rmerge = Shkl Si |Ii(hkl) - (I(hkl))| / Shkl Si Ii(hkl), where Ii(hkl) is the ith observation of reflection hkl and <I(hkl)>  
is the weighted average intensity for all observations of reflection hkl. 
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3.4.3 Analysis of the structures of Sco3914C16S and reduced form of native Sco3914 
Overall, the structure of the mutant protein, Sco3914C16S is closely similar to that of 
native Sco3914, with an RMSD value for the superposition of the two of 0.82 for the 
dimer and 0.65 for the monomer. It exhibits almost the exact same conformation: no 
apparent reorientation of any loops or helices is evident. However, there remains a 
modification of Cys95, which was expected as the protein was prepared in the same way 
as the native protein. Ser16 lacks this modification but this has not altered the positioning 
of any surrounding residues (Figure 3.24).  
 
 
Figure 3.24  Superimposition of Sco3914 (green and cyan) with Cys16-βME modification (red); Sco3914 
reduced form (magenta) with Cys16 (yellow); Sco3914C16S (grey) with Ser16 (blue and red). 
 
The reduced form of the protein was also crystallized under similar conditions (with the 
addition of 5 mM tris(2-carboxyethyl)phosphine (TCEP) as the reductant) and the 
structure solved using the native structure as the molecular replacement model. The 
reduced Sco3914 crystallized in space group P212121 with cell dimensions of a = 60.3 Å, b 
Chapter 3 – Sco3914 
 
112 
 
= 68.2 Å, c = 76.4 Å. This too exhibited a closely similar conformation to the native protein 
in the crystal structure and the RMSD values for superposition of the dimers and 
monomers are 0.73 Å and 0.52 Å respectively. As with Sco3914C16S, there is certainly no 
significant reorientation of any of the helices and no dramatic difference in the position of 
the α4 recognition helices. 
 
Figure 3.25  Superimposition of the C16S mutant and reduced Sco3914 (both structures in grey with the 
cysteines/serine in magenta) onto the original, cysteine modified model of Sco3914 (green and cyan with 
the cysteines in red).  
 
There is no obvious conclusion that can be drawn from this result but it is likely that the 
protein in solution exists in a state of constant flux but prefers to crystallize only in a 
certain conformation, despite giving different crystal forms. Perhaps the full picture 
cannot be seen in this structure alone.  
 
3.4.4 Confirmation of cysteine modification by mass spectrometry  
The Sco3914 sample at a concentration of 10 mg ml-1 in 25 mM HEPES, 0.5 M NaCl pH 7.5 
was submitted for intact mass analysis. The molecular weights of the proteins were 
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determined by MALDI-ToF MS (Bruker Reflex III MALDI-ToF mass spectrometer) and the 
spectrum is displayed in Figure 3.26. 
 
The results for the native protein indicate an intact mass of 16873.6 ±0.01 Da. The 
expected theoretical mass of the cleaved protein is 16721.8 ±0.03 Da: a difference of 
151.8 Da, which suggests a covalent modification of the protein. The initial hypothesis 
that the two cysteines in Sco3914 are highly reactive fits well with this mass increase as it 
could be explained by these two residues having a covalently attached β-
mercaptoethanol adduct. β-mercaptoethanol was used in the tag-cleavage buffer at a 
concentration of 2 mM and the individual molecules have a mass of 76 Da, corresponding 
to modification of both cysteines in each monomer. 
 
Figure 3.26 Intact mass analysis of Sco3914. The main peak indicates that the protein has a molecular 
weight of 16873.6 Da ±0.01. This corresponds to a difference of +151.8 Da from the expected molecular 
weight of the protein which is 16721.8 Da.  
 
Mass spectrometric analysis of Sco3914C16S was carried out to investigate this further, 
the expectation being that the single cysteine mutation should reduce the amount of 
modification to the protein by β-mercaptoethanol. The result displayed in Figure 3.28 
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shows that the protein has a mass difference of 76 Da from the expected value of 16705 
Da for the cleaved protein. This corresponds exactly to a single βME adduct on the 
solitary cysteine 95.  
 
 
Figure 3.27  Modification of cysteine by β-mercaptoethanol increases the mass by 76 Da. 
 
 
Figure 3.28 Intact mass analysis of Sco3914C16S. The main peak indicates that the protein has a molecular 
weight of 16781 Da ±0.03. This corresponds to a difference of +76 Da from the expected molecular weight 
of the protein which is 16705 Da.  
 
 
Chapter 3 – Sco3914 
 
115 
 
3.5 Protein-DNA Interactions 
3.5.1 Surface Plasmon Resonance 
 The preliminary stage of this experiment involved determining whether the protein 
would bind the entire intergenic sequence. The sco3914-3915 intergenic region (Figure 
3.29) was amplified by PCR (using the primers shown in Table 3.6) to incorporate a single-
stranded overhanging sequence which is complementary to the biotinylated ssDNA 
annealed to the streptavidin chip (details in Chapter 2). As described in Chapter 2, 
because of the high GC content of S. coelicolor, designing specific primers can be difficult. 
So, in order to minimize the possibility of non-specific PCR product, a PCR template was 
initially amplified from the S. coelicolor gDNA to incorporate ~150 base pairs flanking 
sequence either side of the sequence of interest. The PCR product from this reaction was 
purified and used as a template for the subsequent PCR reaction, the purpose of which 
was to introduce the “nested” sequence to the intergenic sequence.  
 
Sco3914-3915 Intergenic sequence  
CATGGAGGGGTACACCTTCCCAAACGATTGCAGGAGCGCTTTGCGTTCGCTCACAATAATTGCAC
ACGCGGGCTATATGCAAGCGCTGGCAATCGCGTGCCTGGTCTACCCTGGTCTCAGCCACTCCTGG
ACGGAGGATCCACATG 
Figure 3.29  The DNA sequence between sco3915 (divergently transcribed gene, the proposed start codon 
of which is highlighted in yellow) and sco3914, the start codon of which is highlighted in green.  
 
Table 3.6  Oligos used for the 3 step PCR amplification of the intergenic region. The nested sequence is in 
green and the sequence which is complementary to the biotinylated oligo is in blue. The reverse oligo from 
step 2 was used again in step 3. 
Oligo name Sequence 
Step 1 Forward CGAGCATCACACCGAGCGCGT 
Step 1 Reverse GACGTCGAGCAGGGAGTACTCGC 
Step 2 Forward TTATCAAAAAGAGTATTGACGGAGGGGTACACCTTCCCAAA 
Step 2 Reverse TCATGTGGATCCTCCGTCCAGG 
Step 3 Forward TTAGCGTTTGCGTATGCG/dSpacer/TTATCAAAAAGAGTATTGAC  
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Initial results (Figure 3.30) indicated that there is a significant interaction between the 
protein and the DNA, but only with the addition of 10 mM DTT. This was attempted under 
both “as prepared” (i.e. with β-mercaptoethanol) and reducing conditions (10 mM final 
concentration DTT in the running buffer). However, it was also noted that the protein had 
been exposed to β-mercaptoethanol in the tag cleavage buffer which, as shown in the 
crystal structure, forms adducts with cysteines 16 and 95. This modification appears to 
hinder DNA-binding, since the protein preparation which has not been exposed to β-
mercaptoethanol binds DNA both in the presence and absence of 10 mM DTT (Figure 
3.30). Although these results do not provide any strong evidence for the precise role of 
either cysteine in protein:DNA interactions, they do suggest that a βME modification of 
the cysteines hinders these interactions. 
 
Figure 3.30  Sensorgram showing Sco3914, at a range of concentrations (100 nM; 50 nM; 25 nM; 12.5 nM 6.25 
nM; 3.125 nM; 1.5625 nM and 0 nM), interacting with the PCR amplified intergenic DNA sequence. For this 
experiment, the sample of Sco3914 had been prepared with 2 mM β-mercaptoethanol in the buffer. 10 mM 
DTT was added to this sample which enabled DNA-binding. A concentration dependent interaction may be 
observed in this plot which indicates that there is a specific interaction between the protein and this DNA 
sequence.  
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3.5.2 Mutant binding 
Preliminary studies on the binding of Sco3914C16S and Sco3914C95S to a fragment of the 
intergenic sequence were also carried out. The initial hypothesis was that as the cysteines 
are reactive (based on the observations of the βME modifications in the crystal structure), 
then it was possible that they may participate in DNA recognition and interactions. 
Mutating each cysteine to a serine could prevent modification and thus affect DNA 
interactions or allosterically modulate DNA binding.  
 
A fragment of DNA which contained the putative MEME motif (and had been shown to 
elicit binding of Sco3914 in preliminary experiments not shown here) was ordered from 
Sigma and annealed to the chip surface. The sequence ordered was intergenic base pairs 
45-75:  CGCTCACAATAATTGCACACGCGGGCTATAT. This DNA was stripped between each 
cycle using 1 M NaCl and 50 mM NaOH. The results in Figure 3.31 show that samples 
prepared in the presence of β-mercaptoethanol have only a relatively small and transient 
interaction with the DNA, whereas the samples prepared in the absence of β-
mercaptoethanol have a stronger interaction. These interactions were not precisely 
quantified at this stage, and there is a difference in that the non-βME treated samples 
retain the 17 amino acid His-tag, but the concentrations of all three samples were 
equivalent (100 nM). From this experiment, it would appear that the C95S mutant has a 
faster association and dissociation than do the native protein and the C16S mutant. The 
binding profile of the C16S mutant resembles that of the native protein but the binding 
level of the mutant is approximately 40% more than that of the native protein. This could 
partially be due to inaccuracies in protein concentration determination, or it could 
suggest that in the reduced form, Cys16 enhances the binding of the protein. Clearly 
more work on this is required to reach a more definitive conclusion.  
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Figure 3.31  Sensorgram showing the binding of Sco3914; Sco3914C16S and Sco3914C95S (all at 100 nM 
concentration) to DNA (base pairs 45-75 in the upstream sequence). The samples were prepared with and 
without β-mercaptoethanol. 
 
3.5.3 DNA Footprinting – Stage 1 
The next step involved “fragmenting” the intergenic region in order to define the cognate 
binding sequence. The intergenic region of 140 base pairs was fragmented into 30 base 
pair sequences, incorporating a 22 bp overlap between each sequence as shown below 
(Figure 3.32). Oligos of this size were chosen as previous crystal structures of DNA-bound 
MFRs (Dolan et al., 2011) suggested that 22 base pairs was a reasonable number of base 
pairs to expect for a footprint and so the overlapping region needs to be long enough to 
ensure that the full binding site was not missed between adjacent fragments. The 
maximum length of 30 base pairs was chosen as DNA synthesis becomes expensive and 
less accurate above 50 bases (accounting for the extra 20 base pairs included on the 
reverse strand for annealing to the linker). The oligos were ordered from Sigma. The 
forward oligo included the 20 bp ssDNA sequence (Chapter 2) which is complementary to 
the ssDNA annealed to the streptavidin chip. In this experiment, the complementary 
ssDNA sequences were annealed by mixing 60 μl of the reverse oligo with 50 μl of the 
Chapter 3 – Sco3914 
 
119 
 
forward oligo to give a 45 μM stock solution (PCR program used for this is detailed in 
Chapter 2). A larger volume of the forward oligo was used in order to maximize the 
potential for all of the linker strand (reverse) to form dsDNA and to reduce the 
opportunities for ssDNA to anneal to the chip. This was diluted to the working 
concentration of 1 μM with HBS-EP+ buffer. Each dsDNA sequence was then captured on 
the chip by running it across the analytical flow cell containing the ssDNA linker (Chapter 
2). The full-length protein Sco3914 (including the His tag sequence) was then run across 
both the control and analytical flow cells and the results displayed as a percentage of the 
theoretical Rmax for each cycle (Figure 3.33).    
 
 
Figure 3.32 The sco3914-3915 intergenic region overlapping oligos as output by POOP (Le, unpublished 
work). The 30 base pair oligos include a 22 base pair overlap. The MEME motif is highlighted in pink. 
 
Prior to this experiment, a MEME analysis of the upstream intergenic regions of 33 
putative Sco3914 orthologues identified in reciprocal BLAST searches was performed and 
the following MEME motif found:- 
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This motif is contained entirely within sequence 7, and partially in sequences 4, 5, 6, 8, 9 
and 10. As the results in Figure 3.33 demonstrate, there is a distinctive interaction 
between the protein and sequence 7, a much weaker interaction with sequence 8 and 
very small interactions with sequences 5 and 6. These data support the bioinformatics 
analysis using MEME.  
 
Figure 3.33  Histogram plot of DNA sequence against the percentage of the calculated Rmax value for 3 
different concentrations of Sco3914 (replicates are shown). There is a small interaction between Sco3914 
and sequences 5 and 6, whilst there is a stronger and more significant interaction with sequence 7. This 
interaction drops off sharply with sequence 8.  
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Table 3.7  Raw data from the SPR experiment showing the amount of DNA captured at each cycle and the 
calculated Rmax for each cycle. The protein interaction was measured in response units which were then 
calculated as a percentage of the Rmax. There are replicates for each protein concentration. 
DNA Sequence Run 1    Run 2    
10 
nM 
MW 
dsDNA 
DNA 
Capture 
Theoretical 
Rmax 
Protein 
bound 
% 
Rmax 
DNA 
Capture 
Theoretical 
Rmax 
Protein 
bound 
% 
Rmax 
1 24410 385.4 460.8 0.2 0.0 408.5 488.4 -0.8 -0.2 
2 24409 414.2 495.2 -0.4 -0.1 424.7 507.8 -1.0 -0.2 
3 24410 426.1 509.4 -0.6 -0.1 434.9 520.0 -1.2 -0.2 
4 24409 344.1 411.4 -0.3 -0.1 353.1 422.2 -1.0 -0.2 
5 24408 396.2 473.7 -0.1 0.0 404.7 483.9 -0.8 -0.2 
6 24410 429.2 513.1 -0.2 0.0 438.0 523.7 -1.0 -0.2 
7 24407 422.2 504.8 205.6 40.7 429.2 513.2 175.5 34.2 
8 24411 406.5 486.0 9.5 2.0 414.8 495.9 11.6 2.3 
9 24412 411.2 491.6 -0.2 0.0 418.4 500.2 -0.6 -0.1 
10 24410 401.1 479.6 -0.2 0.0 408.7 488.6 -1.2 -0.2 
11 24412 442.6 529.1 -0.7 -0.1 450.7 538.8 -1.6 -0.3 
12 24411 411.9 492.4 -0.5 -0.1 418.7 500.6 -1.5 -0.3 
13 24411 435.4 520.5 -0.7 -0.1 441.6 528.0 -1.6 -0.3 
14 24412 411.2 491.6 -0.6 -0.1 427.6 511.2 -1.4 -0.3 
15 24411 440.2 526.3 -0.6 -0.1 445.9 533.1 -1.5 -0.3 
50 
nM 
         
1 24410 401.0 479.4 -0.3 -0.1 408.8 488.8 -1.1 -0.2 
2 24409 422.1 504.7 -0.5 -0.1 423.9 506.8 -1.1 -0.2 
3 24410 431.5 515.9 -0.6 -0.1 437.0 522.5 -1.4 -0.3 
4 24409 349.8 418.2 -0.5 -0.1 353.9 423.1 -1.1 -0.3 
5 24408 401.9 480.5 5.9 1.2 405.5 484.9 7.2 1.5 
6 24410 436.1 521.4 2.0 0.4 438.6 524.4 1.1 0.2 
7 24407 426.5 510.0 377.7 74.1 430.5 514.8 386.3 75.0 
8 24411 411.2 491.6 50.1 10.2 416.3 497.7 55.7 11.2 
9 24412 414.8 495.9 0.5 0.1 417.7 499.4 0.4 0.1 
10 24410 406.1 485.5 -0.1 0.0 409.1 489.1 -1.2 -0.2 
11 24412 446.4 533.7 -0.9 -0.2 449.7 537.6 -1.7 -0.3 
12 24411 416.1 497.5 -0.8 -0.2 418.4 500.2 -1.4 -0.3 
13 24411 438.4 524.1 -0.8 -0.2 442.9 529.5 -1.5 -0.3 
14 24412 418.6 500.4 -0.8 -0.2 428.0 511.7 -1.5 -0.3 
15 24411 444.1 530.9 -0.9 -0.2 447.4 534.9 -1.6 -0.3 
100 
nM 
         
1 24410 404.0 483.0 -0.3 -0.1 410.6 490.9 -1.1 -0.2 
2 24409 422.2 504.8 -0.4 -0.1 426.0 509.3 -1.1 -0.2 
3 24410 433.8 518.6 -0.5 -0.1 438.0 523.7 -1.4 -0.3 
4 24409 350.8 419.4 -0.4 -0.1 356.1 425.8 -1.1 -0.3 
5 24408 402.8 481.6 35.1 7.3 405.3 484.6 7.2 1.5 
6 24410 434.5 519.5 8.4 1.6 438.9 524.7 1.1 0.2 
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7 24407 427.2 510.8 425.8 83.4 431.0 515.4 386.3 75.0 
8 24411 413.9 494.8 106.6 21.5 416.2 497.6 55.7 11.2 
9 24412 415.7 497.0 1.8 0.4 419.8 501.9 0.4 0.1 
10 24410 406.6 486.1 -0.2 0.0 410.8 491.2 -1.2 -0.2 
11 24412 445.9 533.1 -1.0 -0.2 451.3 539.5 -1.7 -0.3 
12 24411 417.1 498.7 -0.8 -0.2 419.8 501.9 -1.4 -0.3 
13 24411 440.1 526.2 -0.9 -0.2 443.1 529.7 -1.5 -0.3 
14 24412 420.1 502.2 -0.9 -0.2 429.1 513.0 -1.5 -0.3 
15 24411 443.5 530.2 -0.9 -0.2 449.0 536.8 -1.6 -0.3 
 
The results shown here indicate that there is a significant interaction between the protein 
and the sequence number 7, and partially with sequence 8. As the interaction decreases 
sharply with sequence 8, the assumption is that within the eight base pairs lost from the 
left hand side of sequence 7, there are bases that are crucial for the binding of the 
protein. It is also fair to conclude from this that the extra bases added to the right hand 
side of the sequence in sequence 8 contribute nothing to the stability of the interaction 
either, and so this sequence is of no further interest. The next stage of the analysis 
involved probing this sequence further in order to establish the precise recognition 
sequence, or at least the minimum sequence required for the protein to bind. This next 
stage was carried out by taking the combined sequences of 6 and 7 and three base pairs 
from 8 as shown in Figure 3.34. 
 
3.5.4 DNA Footprinting Stage 2  
 
                       CGTTCGCTCACAATAATTGCACACGCGGGC:6 
                                      CACAATAATTGCACACGCGGGCTATATGCA:7 
                                                    TTGCACACGCGGGCTATATGCAAGCGCTGG:8 
                   CGTTCGCTCACAATAATTGCACACGCGGGCTATATGCAAGC    41 bp 
 Figure 3.34  The 3 DNA sequences from the sco3914-3915 intergenic region which elicited the highest 
response in the SPR experiment. Sequences 6 and 7 were combined with 3 base pairs from sequence 8 to 
arrive at the starting sequence for the Stage 2 base pair elimination round. The MEME motif is highlighted 
in pink.  
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The strategy was to eliminate 2 base pairs from each end in turn to narrow down the 
binding site. In order to account for any effects from the linker sequence (such as 
stabilization of binding due to the extra bases), the linker was subsequently attached to 
the 3’ end of the forward strand sequence for deletions from the left hand side (see 
Chapter 2). Two base pairs at a time were first removed from the right hand side of the 
sequence, followed by two base pairs at a time from the left. The sequences can be seen 
in Table 3.8. 
 
Table 3.8  Stage 2 DNA sequences for testing the binding of Sco3914 to its upstream DNA sequence. (a) 
Sequences to test the limits of the right hand boundary; (b) sequences to test the limits of the left hand 
boundary. Sequences highlighted in yellow gave the most significant interactions with the protein in SPR. 
(a) Sco3914 RH boundary 
Name Sequence 
3914_RH_F CGTTCGCTCACAATAATTGCACACGCGGGCTATATGCAAGC 
3914_RH_R GCTTGCATATAGCCCGCGTGTGCAATTATTGTGAGCGAACGcctaccctacgtcctcctgc 
3914_RH_minus2_F CGTTCGCTCACAATAATTGCACACGCGGGCTATATGCAA 
3914_RH_minus2_R TTGCATATAGCCCGCGTGTGCAATTATTGTGAGCGAACGcctaccctacgtcctcctgc 
3914_RH_minus4_F CGTTCGCTCACAATAATTGCACACGCGGGCTATATGC 
3914_RH_minus4_R GCATATAGCCCGCGTGTGCAATTATTGTGAGCGAACGcctaccctacgtcctcctgc 
3914_RH_minus6_F CGTTCGCTCACAATAATTGCACACGCGGGCTATAT 
3914_RH_minus6_R ATATAGCCCGCGTGTGCAATTATTGTGAGCGAACGcctaccctacgtcctcctgc 
3914_RH_minus8_F CGTTCGCTCACAATAATTGCACACGCGGGCTAT 
3914_RH_minus8_R ATAGCCCGCGTGTGCAATTATTGTGAGCGAACGcctaccctacgtcctcctgc 
3914_RH_minus10_F CGTTCGCTCACAATAATTGCACACGCGGGCT 
3914_RH_minus10_R AGCCCGCGTGTGCAATTATTGTGAGCGAACGcctaccctacgtcctcctgc 
3914_RH_minus12_F CGTTCGCTCACAATAATTGCACACGCGGG 
3914_RH_minus12_R CCCGCGTGTGCAATTATTGTGAGCGAACGcctaccctacgtcctcctgc 
3914_RH_minus14_F CGTTCGCTCACAATAATTGCACACGCG 
3914_RH_minus14_R CGCGTGTGCAATTATTGTGAGCGAACGcctaccctacgtcctcctgc 
3914_RH_minus16_F CGTTCGCTCACAATAATTGCACACG 
3914_RH_minus16_R CGTGTGCAATTATTGTGAGCGAACGcctaccctacgtcctcctgc 
 
(b) Sco3914 LH boundary 
Name Sequence 
3914_LH_F, GCTTGCATATAGCCCGCGTGTGCAATTATTGTGAGCGAACG 
3914_LH_R, CGTTCGCTCACAATAATTGCACACGCGGGCTATATGCAAGCcctaccctacgtcctcctgc 
3914_LH_minus2_F, GCTTGCATATAGCCCGCGTGTGCAATTATTGTGAGCGAA 
3914_LH_minus2_R, TTCGCTCACAATAATTGCACACGCGGGCTATATGCAAGCcctaccctacgtcctcctgc 
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3914_LH_minus4_F, GCTTGCATATAGCCCGCGTGTGCAATTATTGTGAGCG 
3914_LH_minus4_R, CGCTCACAATAATTGCACACGCGGGCTATATGCAAGCcctaccctacgtcctcctgc 
3914_LH_minus6_F, GCTTGCATATAGCCCGCGTGTGCAATTATTGTGAG 
3914_LH_minus6_R, CTCACAATAATTGCACACGCGGGCTATATGCAAGCcctaccctacgtcctcctgc 
3914_LH_minus8_F, GCTTGCATATAGCCCGCGTGTGCAATTATTGTG 
3914_LH_minus8_R, CACAATAATTGCACACGCGGGCTATATGCAAGCcctaccctacgtcctcctgc 
3914_LH_minus10_F, GCTTGCATATAGCCCGCGTGTGCAATTATTG 
3914_LH_minus10_R, CAATAATTGCACACGCGGGCTATATGCAAGCcctaccctacgtcctcctgc 
3914_LH_minus12_F, GCTTGCATATAGCCCGCGTGTGCAATTAT 
3914_LH_minus12_R, ATAATTGCACACGCGGGCTATATGCAAGCcctaccctacgtcctcctgc 
3914_LH_minus14_F, GCTTGCATATAGCCCGCGTGTGCAATT 
3914_LH_minus14_R, AATTGCACACGCGGGCTATATGCAAGCcctaccctacgtcctcctgc 
3914_LH_minus16_F, GCTTGCATATAGCCCGCGTGTGCAA 
3914_LH_minus16_R, TTGCACACGCGGGCTATATGCAAGCcctaccctacgtcctcctgc 
 
These sequences were annealed and the 1 μM working solution prepared as described in 
Chapter 2. Again, three concentrations of the protein were run and the interactions 
plotted as a percentage of the calculated Rmax (Figure 3.35). 
 
Figure 3.35 DNA Footprinting Stage 2 Results. A sharp drop in binding may be observed when 8 base pairs 
are eliminated from the right hand side of the sequence and when 10 base pairs are eliminated from the 
left hand side.  
There is a clear decrease in the affinity of the protein for the sequence when 8 base pairs 
are removed from the right hand side and 10 base pairs from the left hand side:- 
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RH 
CGTTCGCTCACAATAATTGCACACGCGGGCTATATGCAAGC  25 bp 
 
LH 
GCTTGCATATAGCCCGCGTGTGCAATTATTGTGAGCGAACG 
 
Sco3914 will tolerate RH-6 and LH-10, which would give the footprint as:- 
                      CAATAATTGCACACGCGGGCTATAT          25 bp 
This is one base pair longer than the motif suggested by MEME:- 
AATAATTGCACACGCGGGCTATAT  24 bp 
 
Stage 3 of the footprinting assay involved quantifying the affinity of the protein for this 
sequence. Anticipating that the 25mer may not elicit the strongest response (as the LH-6 
sequence had a stronger response than the LH-10), the following DNA sequences were 
ordered from Sigma:- 
Table 3.9  The oligos that were used for Stage 3 of the footprinting assay.  
25mer_F     CAATAATTGCACACGCGGGCTATAT           
25mer_R    ATATAGCCCGCGTGTGCAATTATTGcctaccctacgtcctcctgc 
29mer_F CTCACAATAATTGCACACGCGGGCTATAT 
29mer_R ATATAGCCCGCGTGTGCAATTATTGTGAGcctaccctacgtcctcctgc 
 
The sequences were annealed as described previously to give a final concentration of 1 
μM.  
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3.5.5 DNA Footprinting Stage 3 
The affinity of Sco3914 for this particular sequence was investigated using a similar 
approach to the method described in stages 1 and 2, but this time less of the ssDNA-linker 
was loaded onto the flow cells so that the affinities could be measured more accurately  
(52 RU on flow cell 3 and 150 RU on flow cell 4). A lower loading of ligand and high flow 
rate minimizes mass transport effects (Buckle, 2001). On flow cell 3 (the reference cell), a 
ssDNA sequence which was complementary to the ssDNA linker sequence was captured 
in order account for any non-specific interactions with the linker. The sequence being 
tested (the 25mer or the 29mer) was captured on flow cell 4 and the chip was 
regenerated after each cycle. This time the protein was injected across the DNA at a flow 
rate of 100 μl min-1 for a period of 210 seconds to allow saturation of the DNA to occur. A 
dilution series was set up to include concentrations of protein from 200 mM to 0.391 mM 
and each concentration was tested in triplicate. Both DNA sequences were tested and it 
was observed that the protein had a greater affinity for the 29mer.  
 
Figure 3.36  Stage 3 25mer. KD = 120 ± 9 nM 
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Figure 3.37 Stage 3 29mer. Kd = 55 ± 6 nM 
 
The actual values determined for the affinity of Sco3914 for these sequences shows that 
this is a significant interaction. Whilst not quite into the nanomolar range, the KD value for 
the 29mer is 55 ± 6 nM which indicates that there is reasonably tight binding occurring 
between the protein and this specific sequence. These data lead to the conclusion that 
the binding site for Sco3914 is contained within the 29mer sequence. It is possible that 
the 25mer defines the actual footprint (and this agrees closely with the output from the 
MEME server) and that the extra bases in the 29mer lend the protein support to further 
stabilize binding. Further investigations could define this further, but for the purpose of 
this study, the footprint has been defined as CAATAATTGCACACGCGGGCTATAT. This 
sequence is not obviously palindromic and there are no apparent repeats, but it has a GC 
content of 44%, which is low compared to the average GC content of 72% for the S. 
coelicolor genome.  
 
3.6 Determination of pKas of cysteines 16 and 95 
Sco3914 has two cysteines: Cys16 and Cys95. Cys16 is located in what would appear to be 
a putative ligand binding site, as this is where salicylate has been observed in published 
MarR structures (Kumarevel et al., 2009, Saridakis et al., 2008) and also the region of 
conserved cysteines in several redox active MFRs (Chen et al., 2008, Chen et al., 2006, 
Chen et al., 2009, Newberry et al., 2007, Panmanee et al., 2006, Soonsanga et al., 2007, 
Hong et al., 2005). Cys95 is located on the loop which could potentially make contacts 
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with DNA. In an attempt to understand their relative reactivities, the pKas of each of the 
cysteines in Sco3914 were determined using the DTNB assay (detailed in Chapter 2). This 
information, combined with knowledge about any effector molecules, could also suggest 
the relevance of these cysteines to ligand detection and DNA-binding.  
 
Each cysteine reacts with the DTNB molecule to form a mixed thiol and releases the TNB2- 
anion. The absorbance of released TNB anion was measured at 412 nm and used to 
calculate the rates at each pH. The results from this experiment, along with their 
associated errors, are displayed in Figure 3.38 and Figure 3.39.  
 
 
Figure 3.38  Rates obtained from the titration of Sco3914C95S with buffers across a range of pH values 
containing 20 μM DTNB. The results shown here indicate that cysteine 16 has a pKa of 9.1. 
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Figure 3.39  Rates obtained from the titration of Sco3914C16S with buffers across a range of pH values 
containing 20 μM DTNB. The results shown here indicate that cysteine 95 has a pKa of 7.0. 
 
The respective pKa values for cysteine 16 and cysteine 95 are 9.1 ± 0.2 and 7.0 ± 0.1 (free 
cysteine has a pKa of 8.3). These results support what is observed in the crystal structure 
in that Cys16 sits in a relatively hydrophobic pocket of the protein which would 
potentially destabilize the ionized form of this residue. The pKa of this cysteine is 
significantly higher than that determined for redox-sensing cysteines in other MFRs: the 
reactive Cys14 in HypR has a lower pKa value of 6.36 (Palm et al., 2012) whilst for Cys15 in 
BsOhrR, the value is 5.2 (Hong et al., 2005). The cysteines in these other structures are 
stabilized by a hydrogen bonding network provided by neighbouring tyrosines.  
Conversely, Cys95 is located on a solvent exposed loop (the wing region) and so it would 
be expected that the deprotonated form of the residue could be stabilized by solvent 
interactions and also by Tyr93 and Tyr103.  This residue could potentially make contacts 
with the DNA.  
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3.7 PCR-Targeted Gene Disruption 
The M145sco3914 gene deletion strain was generated using the Redirect protocol (Gust 
et al., 2003) detailed in chapter 2. The sco3914 gene is contained on the StQ11 cosmid 
(base pairs 20697-21206 with a total cosmid length of 33873 bp). Cosmids were checked 
for rearrangements by restriction digest with BamHI and compared to the predicted 
digest fragment sizes by DNA gel electrophoresis (using the restriction tool on 
Streptomyces.org.uk). The primers used to amplify the disruption cassette from pIJ773 
are displayed in Table 3.10. The gene deletion was confirmed by PCR using the P1 and P2 
flanking primers (Chapter 2) as well as the gene specific checking primers (Table 3.11).  
Table 3.10  Primers used to amplify the pIJ773 disruption cassette. The sequence which is complementary 
to the disruption cassette is shown in red whilst the gene specific sequence is in black. 
 
Forward ACCCTGGTCTCAGCCACTCCTGGACGGAGGATCCACATGATTCCGGGGATCCGTCGACC 
Reverse  TAGAACGGGCCGACGCCAGGTTGCCCGGACAGGCTCTATGTAGGCTGGAGCTG CTTC 
 
Table 3.11  Primers used to verify positive transformants using PCR. 
Forward CGTTCCGATCCCGAAGGCCC 172 bp upstream of gene 
Reverse ACCCTGAGGCGTTCGAAGGC    170 bp downstream of gene 
 
The mutagenized cosmid was then introduced into S. coelicolor by conjugation (detailed 
in Chapter 2) to undergo genetic recombination with the chromosomal DNA and so 
replace the sco3914 gene with the disrupted gene. Successful mutants were detected by 
replica-plating on SFM agar plates supplemented with 1) apramycin and 2) apramycin + 
kanamycin. Those colonies which are kanamycin sensitive were then further verified by 
PCR (using both the gene specific checking primers and the F1 and F2 flanking primers.) 
Spore stocks of the mutant strains were then prepared as detailed in chapter 2. 
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3.7.1 Screening the successful mutants 
The prepared spore stocks were screened for visibly detectable phenotypes by plating on 
a variety of media supplemented with different carbon sources (details in chapter 2). 
Twenty different conditions were tested in total and the observations for each mutant 
were monitored over the course of a week. Sco3914 did not exhibit an observable 
phenotype under any of the 20 conditions tested. It was decided not to investigate this 
further during this project.  
 
3.8 Conclusions 
It is still very much speculative that Sco3914 may also regulate the divergently transcribed 
Sco3915 (a putative efflux pump), but its operator is virtually in the middle of this 
intergenic sequence which could potentially hinder the transcription start sites of both 
genes. If this hypothesis were correct, then knocking out Sco3914 would allow the 
upregulation of Sco3915. Pushing these hypotheses further, if the role of Sco3915 were to 
remove toxic molecules from the cell, thus protecting it, then it would be difficult to 
observe a phenotype by deleting Sco3914 without knowledge of the “toxic” conditions. 
Also, removing the putative repressor would cause the pump to be upregulated and so a 
phenotype may not be seen even in the presence of a specific toxic effector. The next 
step would be to make a sco3915 deletion mutant or, if more were known about a 
specific effector of Sco3914, to make a Sco3914 mutant which was unresponsive to the 
presence of this effector but was still capable of binding its cognate DNA. Further 
investigation of Sco3915 would be useful to uncover its function, and also to probe the 
role of Sco3914 on its regulation. The presence of four modifiable cysteines in the 
Sco3914 dimer also presents an interesting place to begin looking for potential ligands for 
this regulator, particularly as these residues are so well conserved in homologues of 
Sco3914. The pKa of Cys95, which is located in the wing motif, suggests that this residue 
would be reactive at a physiological pH whereas Cys16, which is buried, would not be 
reactive. This warrants further investigation to reveal the biological relevance of these 
cysteines. The crystal structures of the C16S mutant and the reduced form of Sco3914 did 
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not uncover any significant conformational differences to the βME modified protein. 
However, MFRs are typically very flexible and so perhaps the only way to determine any 
conformational rearrangements is to obtain the crystal structure of Sco3914 bound to the 
operator DNA or with a specific ligand. There are many avenues to explore with Sco3914 
which could yield some very useful information about the nature of repressor-DNA 
interactions as well as further insights into its biological role in S. coelicolor.  
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4.1 Introduction 
Sco5413 is a putative transcriptional regulator from S. coelicolor belonging to the MarR 
family of proteins. It is predicted to be a mainly helical protein of 169 amino acids and has 
several orthologues in other species of streptomycete. This protein has been cloned, 
expressed and purified by nickel affinity and size exclusion chromatography. A truncated 
version of the protein has been crystallized and the structure solved to 1.25 Å resolution 
using the Single Isomorphous Replacement with Anomalous Scattering method (with 
mercury as the heavy atom providing the anomalous signal). A phenotype has been 
observed in the deletion mutant in the host organism and there is scope for more work in 
this area. However, several different experimental approaches have failed to detect any 
significant binding to the intergenic DNA sequence between sco5413 and sco5412, which 
encodes an upstream hypothetical protein on the same coding strand. To date, whether 
Sco5413 requires a ligand/cofactor to bind to DNA and where it may bind in the whole of 
the genomic DNA sequence remains to be determined.  The structure of the truncated 
version of this protein reveals no obvious ligand, although the pocket may be 
compromised due to the truncation of the N-terminal helix. However, when 
superimposed onto the OhrR-DNA complex (Hong et al., 2005), it would appear to be in a 
DNA-binding conformation. 
 
Figure 4.1  A representation of the location of sco5413 in the Streptomyces coelicolor  genome 
(http://strepdb.streptomyces.org.uk). 
 
The sco5413 gene is 510 bp in length and has a GC content of 69%. It is an extremely well 
conserved gene amongst streptomycetes and has 68 orthologues amongst 112 
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actinobacterial genomes and E. coli and Bacillus subtilis (bioinformatics analysis done by 
Govind Chandra, John Innes Centre). Its close homology to orthologues in other published 
sequences of Streptomycetes can be seen in Table 4.1 below.  
 
Table 4.1  The sequence identities shared between the orthologues from other Streptomycetes and 
Streptomyces coelicolor Sco5413. Sav – Streptomyces avermitilis; Ssc – Streptomyces scabius; Sgr – 
Streptomyces griseus: Sven – Streptomyces venezuelae. 
 
Interestingly, the Streptomyces avermitilis orthologue, sav2834, is 25 amino acids shorter 
than sco5413. However, this could be a misannotation of the start codon in the 
sequencing of Streptomyces avermitilis as this sequence may be extended by 75 base 
pairs to give a very similar alternative starting point. This includes a potential helix at the 
N-terminus which features later in this chapter, relating to the crystallization of Sco5413.  
 
The results obtained for the biophysical, genetic and structural characterization of this 
protein will be discussed in this chapter.  
  
 Amino acid sequence %ID DNA Sequence %ID 
Sco Sav  Ssc  Sgr  Sven  Sav  Ssc  Sgr  Sven  
Sco5413 Sav2834 
90% 
Scab28331 
90% 
Sgr2122 
89% 
Sven5067 
91% 
Sav2834 
87% 
Scab28331 
88% 
Sgr2122 
88% 
Sven5067 
89% 
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4.2 PCR-Targeted Gene Disruption 
The M145sco5413 gene deletion strain was generated using the REDIRECT© technology 
protocol (Gust et al., 2003), detailed in Chapter 2. The sco5413 gene is contained on the 
St8F4 cosmid (Redenbach et al., 1996)(base pairs 20697-21206 with a total cosmid length 
of 33873 bp). Cosmids were checked for rearrangements by restriction digest and 
compared to the predicted digest fragment sizes by DNA gel electrophoresis (using the 
restriction tool on Streptomyces.org.uk). St8F4 was digested with BamHI. The primers 
used to amplify the disruption cassette from pIJ773 are displayed in Table 4.2. The pIJ773 
(aac(3)IV, oriT) cassette contains an apramycin resistance selectable marker and oriT 
which allows the PCR targeted cosmid DNA to be introduced into S. coelicolor through 
conjugation. The gene deletion was confirmed by PCR using the P1 and P2 flanking 
primers (Chapter 2) as well as the gene specific checking primers (Table 4.3). The size of 
the fragment expected from amplification of the successfully disrupted cosmid using the 
checking primers (Table 4.3) is 1643 base pairs, whereas the wild type should result in a 
fragment of 771 base pairs. PCR was used as the method of checking both the cosmids 
before conjugation and the genomic DNA following conjugation.  
Table 4.2  Primers used to amplify the pIJ773 disruption cassette. The sequence which is complementary to 
the disruption cassette is shown in red; the S.  coelicolor genomic specific sequence is in black. 
Forward TGACCGGCATGTGACCGGCCGGTAAGGTCTCTTGCCGTGATTCCGGGGATCCGTCGACC  
Reverse  GTCGGGCGACTCGCCGGGCCCGCCCGGCCCGCGCGCTCATGTAGGCTGGAGCTGCTTC 
 
Table 4.3  Primers used to verify positive transformants using PCR (Checking primers). 
Forward GTGTGACGGACGGTCTCACG 135 bp upstream of gene 
Reverse GGTGACGTACGCCATGACCC 126 bp downstream of 
gene 
pIJ773_P1 ATTCCGGGGATCCGTCGACC  Disruption cassette For 
pIJ773_P2 TGTAGGCTGGAGCTGCTTC  Disruption cassette Rev 
5413F_39Flank TGACCGGCATGTGACCGGCCGGTAAGGTCTCTTGCCGTG  39 upstream of start 
(including start codon) 
5413R_39Flank GTCGGGCGACTCGCCGGGCCCGCCCGGCCCGCGCGCTCA  39 downstream of stop 
(including stop codon) 
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The mutagenized cosmid was then introduced into S. coelicolor by conjugation (detailed 
in Chapter 2) to undergo genetic recombination with the chromosomal DNA and thus 
replace the sco5413 gene with the disrupted gene. Successful mutants were detected by 
replica-plating on SFM agar plates supplemented with (1) apramycin and (2) apramycin + 
kanamycin. Those colonies which are kanamycin sensitive were then further verified by 
checking the gDNA by PCR (using both the gene specific checking primers and the F1 and 
F2 flanking primers.) Figure 4.2 shows that the fragments generated by the PCR 
amplification of the mutants are all ~1600 base pairs in length. The expected length for 
these fragments is 1643 base pairs. The length of the fragment from the wild type is ~780 
base pairs and the expected length is 771 base pairs. These results in conjunction with the 
replica-plating for antibiotic resistance selection suggest that: i) the insertion of the 
disruption cassette into the cosmid was successful and ii) the recombination event to 
insert this disrupted gene into the M145 genomic DNA was also successful. Spore stocks 
of the mutant strains were then prepared as detailed in Chapter 2. 
 
Figure 4.2 1% agarose DNA gel to check mutated genomic DNA against the wild type M145 gDNA. The first 
two lanes contain wild type gDNA amplified with (1) sco3914 specific checking primers; (2) sco5413 specific 
checking primers. Lanes 3-6 contain the M145∆sco3914gDNA, amplified with the sco3914 specific checking 
primers. Lanes 7-10 contain M145∆sco5413 gDNA, amplified with the sco5413 specific checking primers. 
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4.2.1 Phenotypic screening of the successful mutants 
The prepared spore stocks were screened for visibly detectable phenotypes by plating on 
a variety of solid media. All media were prepared according to Kieser et al. Spore stocks, 
which had been titred prior to this experiment, were streaked for single colonies onto 
Mannitol soya flour medium (SFM); Minimal medium (MM); R5 medium; Difco nutrient 
agar (DNA) and L agar, which were supplemented with different carbon sources (precise 
details in Chapter 2). Twenty different conditions were tested in total and the 
observations for each mutant were monitored over the course of a week. The sco5413 
knockout exhibited an interesting media-dependent phenotype on SFM supplemented 
with either 10 mM N-acetyl glucosamine (GlcNAc), 1% glucose or 1% glycine: it differed 
from the wild type in that it produced pigmented antibiotic prematurely and ectopically 
whilst the colonies appeared to be smaller in size than the wild type. Typically, the wild 
type single colonies, which were visible after two days, appeared to be very white at first, 
turning grey as they sporulated. The mutant single colonies were not visible until day 3, 
when they appeared very small and strikingly dark red in colour. Sporulation was also 
delayed in these mutants compared to the wild type, but did occur by day 5. These 
culture conditions were repeated in triplicate (the wild type in duplicate) and the same 
phenotype was observed in all replicates.  
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b SFM + 1% Glycerol 
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Figure 4.3  M145 wild type and M145∆sco5413 cultivated on SFM (a) 1% Glucose; (b) 1% Glycerol; (c) 10 
mM GlcNAc. Left hand plates – top view; right hand – view from underneath. The precocious and ectopic 
production of pigmented antibiotic in the mutant can be observed under all three conditions. The mutant 
colonies are also smaller than the Wild type and slower to grow.  
 
c 
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The pictures of the plates in Figure 4.3 show how the growth of the mutant is affected 
three days after culturing.  The dense lawn appears to be darker than that of the wild 
type in all conditions, most notably on SFM supplemented with 10 mM GlcNAc. The 
mutant seems to struggle with growth in this condition and the production of antibiotic is 
most pronounced here (as with the wild type), particularly looking at the underside of the 
plates where the dark blue in the vegetative mycelium can be seen. This is due to the 
antibiotic-inducing effect of GlcNAc (see later). When the medium is supplemented with 
1% glucose or glycerol, the wild type lawn and colonies are a fairly grey in colour whilst 
the mutant is darker. In all conditions, the ectopic expression of antibiotic is evident in 
the mutant single colonies where its appearance on the surface of the colony may be 
observed.  
 
Figure 4.4  M145 Wild type and M145∆sco5413 cultivated on SFM (a) 1% Glucose; (b) 1% Glycerol; (c) 10 
mM GlcNAc. The differences between the mutant colonies and the wild type are still evident after 5 days 
growth.  
 
Five days after plating, the differences between the wild type and mutant are less 
pronounced but still evident (Figure 4.4). The mutant single colonies are smaller and the 
overproduction of pigmented antibiotic can be seen surrounding the colonies. On SFM 
with 1% glucose, the differences at this stage are much less pronounced than on media 
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supplemented with 1% glycerol, where the mutant still exhibits delayed growth and 
excessive production of pigment. On media supplemented with 10 mM GlcNAc, M145 
appears to be whiter than usual. The mutant colonies are slightly darker and again, the 
overproduction of pigment is particularly evident.  
 
Interestingly, N-acetylglucosamine is a product of autolytic degradation of vegetative 
mycelium. At high concentrations, GlcNAc can act as an allosteric effector of DasR (Colson 
et al., 2008) (a pleiotropic transcriptional repressor in Streptomyces coelicolor) which 
regulates pathway-specific activators involved in antibiotic synthesis and it is essential for 
development (Rigali et al., 2006). GlcNAc has the effect of increasing antibiotic production 
and this is a common feature on streptomycetes (Rigali et al., 2008). In S. coelicolor, 
during times of “feast”, GlcNAc is present in the cell in its polymeric form, chitin (a 
component of fungi and insect cell walls). Chitin is metabolized by chitinases, which are 
part of the DasR regulon, and the presence of GlcNAc under these conditions actually 
blocks development and antibiotic production. However, during times of famine, DasR is 
inactivated by the presence of GlcNAc in its monomeric form, which is a sign of famine as 
it is derived from the hydrolysis of the bacterium’s own cell walls. Studies conducted on 
the transport systems for both chitobiose (GlcNAc2) and monomeric GlcNAc indicate that 
both transporters are DasR dependent and the model presented suggests that the cell is 
able to distinguish between these two forms of GlcNAc and so determine whether to 
switch on the developmental genes or not (Colson et al., 2008). The M145∆sco5413 
mutant also presented a phenotype different to the wild type on minimal media with 10 
mM GlcNAc (Figure 4.5). Under this condition, the single mutant colonies appear to be 
producing pigmented antibiotic prematurely compared to the wild type single colonies 
which do not. This effect was not observed on minimal media which has been 
supplemented with other carbon sources.  
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Figure 4.5  M145 wild type and M145∆sco5413 cultured on minimal medium (MM) supplemented with 10 
mM GlcNAc. After 3 days of growth, the single colonies of the mutant can be seen to be producing 
pigmented antibiotic whereas the wild type colonies do not. 
 
The cultures were also grown in liquid media to monitor the growth of the strains over 
several days. This was done in minimal liquid medium which had been supplemented with 
10 mM GlcNAc (again, liquid SFM posed a problem with the many aggregates which 
would interfere with the optical density measurements). The cells were pre-germinated 
according to the procedure described in Chapter 2 and used to inoculate three 50 ml 
replicates. Samples (1 ml) were then collected at 6 hour intervals over the course of 3 
days and the optical density at 450 nm measured. A growth curve to compare the 
development of M145 wild type to the disruption mutant strain was generated from 
these observations. 
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Figure 4.6 Growth of M145 wild type and M145∆sco5413 in minimal liquid medium supplemented with 10 
mM GlcNAc at 30°C.  Three replicate cultures were set up and samples were extracted at 10, 16, 22, 28, 34, 
40, 46, 58 and 64 hours following inoculation. The mean of the replicates and the standard deviation error 
bars were calculated (Excel).  
 
The resultant growth curve (Figure 4.6) shows that the growth of the mutant under these 
conditions is comparable to that of the wild type. There are no apparent differences and 
so the conclusion is that there is no difference in visibly measurable phenotype under 
these growth conditions. The total protein content was also assessed by extracting the 
protein and measuring the absorbance of the supernatant at 750 nm (data not shown), 
but this reveals a similar trend.  
 
Many studies have concluded that the production of secondary metabolites generally 
occurs in conjunction with the formation of aerial hyphae (Bibb, 1996, Kelemen et al., 
1998). Therefore, these results present an interesting observation of Streptomyces 
development, but an observation that is not easily interpreted. As a transcriptional 
regulator, Sco5413 could have one or many recognition sites within the S. coelicolor 
genome and to know where to begin looking for its possible site of regulation is one task. 
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To uncover the implications of deleting this gene on other regulatory networks is quite 
another and, unfortunately, this was not within the scope of this work.  
 
4.3 Protein Expression and Purification 
The protein was cloned into the pOPINF expression vector and expressed according to the 
method described in chapter 2. Typically, the protein elutes from the nickel affinity 
column with a double peak profile (Figure 4.7), the first of which contains several 
contaminating proteins. The fractions containing the contaminating proteins are disposed 
of and the second peak fractions pooled and applied to the size exclusion gel filtration 
column (GE Healthcare Superdex 75 16/60). The purity of the protein following the nickel 
affinity column purification and the size exclusion gel filtration chromatography column 
can be seen in Figure 4.8 and Figure 4.10.   
 
Figure 4.7 Elution profile of Sco5413 from nickel affinity column chromatography. The double peak is 
characteristic of Sco5413 with the first peak containing contaminant proteins. The red line indicates the 
contaminated first peak whilst the blue line indicates the relatively pure second peak. 
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Figure 4.8   15% SDS-PAGE after nickel affinity column purification. The lanes contain: (1)Lyzed pellet; (2) 
Supernatant; (3) Fraction A4; (4) A7; (5) A8; (6) A9; (7) A10; (8) A11. The contaminated fractions from the 
first peak are demarcated by the red line whilst the relatively pure samples from the second peak are 
marked by the blue line. 
 
Figure 4.9 Elution profile of Sco5413 from size exclusion gel filtration chromatography. The first peak contains 
the protein in a higher oligomeric state whilst the second peak also contains Sco5413. 
 
The elution profile for the size exclusion gel filtration column typically displays two peaks. 
Both peaks contain Sco5413, although from the SDS-PAGE gel (Figure 4.10) it would 
appear that the first peak may contain a small amount of contaminant proteins whereas 
the second peak was judged to be more pure. Using the standard curve generated from 
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the column calibration, the elution volumes for both the first and second peaks 
correspond to molecular weights of 118 kDa and 59 kDa respectively. Sco5413 has a 
predicted molecular weight of 20.4 kDa and so these peaks would suggest that the 
protein elutes as a hexamer and a trimer. DLS analysis of the protein in solution was fairly 
inconclusive (data not shown) as it appears to be very polydisperse and so it is uncertain 
how the protein actually behaves in solution, although it is fair to conclude that it is 
certainly a dimer in the crystal form. As discussed later in this chapter, the dimer interface 
is quite substantial (34% of residues) and there is also a salt bridge connecting the 
monomers. 
 
Figure 4.10  15% SDS-PAGE after size exclusion gel filtration column purification. The lanes contain: (1) 
Pooled fractions A9-A11 from nickel column; (2) Fraction A11; (3) B8; (4) B6; (5) B4; (6) B1; (7) Peak 1 
(fractions A4-A8 pooled) from nickel column.  
 
4.3.1  Truncation of Sco5413 
As mentioned previously, Sco5413 has an orthologue in Streptomyces avermitilis 
(Sav2834; UniProtKB entry Q82JC1) which is predicted to be shorter (by the annotation in 
the StrepDB server) by 25 amino acids (Figure 4.11). As Sco5413 did not crystallize (even 
with the tag removed), the full-length sequence was analysed using the Disopred server 
(http://bioinf.cs.ucl.ac.uk/disopred/) (Ward et al., 2004) and this predicted that this 
sequence had a high probability of disorder at the N-terminus (Figure 4.12).  
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Figure 4.11 Amino acid sequences of Sco5413 and Sav2834 as annotated in the StrepDB server. Sequence 
alignment was carried out using Needleman-Wunsch global alignment by Emboss Needle 
(http://www.ebi.ac.uk/Tools/psa/emboss_needle/). The former is longer by 25 amino acids at the N-
terminus. 
 
Therefore, the protein was truncated at the N-terminus in an attempt to improve 
crystallizability.  In choosing the transcriptional start site for Sco5413, removal of any 
predicted disordered regions, without disrupting any potential secondary structural 
elements, was the main objective. Bioinformatic analysis of the Sco5413 amino acid 
sequence was used to guide the choice of construct. The DISOPRED server 
(http://bioinf.cs.ucl.ac.uk/disopred/) (Ward et al., 2004)  predicted disorder for residues 
1-12. The PSIPRED server (http://bioinf.cs.ucl.ac.uk/psipred/) (Buchan et al.) predicted 
that residues 11-22 and 27-51 were α-helical whilst the Sco5413 orthologue in 
Streptomyces avermitilis (Sav2834), with which it is 90% identical, is annotated as having 
a transcriptional start site corresponding to residue 26 of Sco5413. 
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Figure 4.12 Sco5413 (a) and Sco5413tr (b) disorder prediction (produced using DISOPRED (Ward et al., 
2004)). The results presented here suggest that removing the initial 12 amino acids may decrease the 
disorder. 
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Figure 4.13 Structure prediction for Sco5413 and Sco5413tr generated by PSIPRED 
(http://bioinf.cs.ucl.ac.uk/psipred/)  (Murshudov et al., 1997). 
 
A start site was therefore chosen in the loop region between the two predicted N-
terminal helices that corresponded to the Sav2834 N-terminus.  Hereafter the truncated 
Sco5413 will be referred to as Sco5413tr. The truncation was achieved by amplifying the 
sco5413 gene from S. coelicolor M145 genomic DNA using primers containing the pOPINF 
ligation independent cloning sequences (Forward 
AAGTTCTGTTTCAGGGCCCGGGTGTGCCCTCCATGG and reverse 
ATGGTCTAGAAAGCTTTAGTCCTCGTCGAAGTCGCCCGC). The sequence was cloned into the 
pOPINF expression vector (Berrow et al., 2007) using the In-FusionTM cloning system 
(Clontech Laboratories, Inc.). The pOPINFsco5413tr construct encoded residues 25-169 of 
the wild-type Sco5413 sequence with an N-terminal, 3C protease-cleavable, His6-tag of 
sequence MAHHHHHHSSGLEVLFQGP. This construct was introduced into BL21(DE3)pLysS 
cells by transformation and the protein was expressed in the same way as full-length 
Sco5413.  
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4.4 Crystallography and Data Collection 
Crystallization screening was carried out in 96-well sitting-drop MRC plates using a variety 
of commercial screens (Molecular Dimensions and Qiagen). The protein:well solution 
ratio was 1:1 (0.6 μl total volume).  Many small rhombic dodecahedral crystals were 
grown from 0.2 M potassium nitrate and 25% PEG 3350 and optimizations of this 
condition were carried out in 24-well hanging drop plates. Further small crystals were 
generated. In order to improve these crystals, this condition was subjected to an additive 
screen (Hampton Research). Out of the 96 additives screened, it was observed that the 
addition of 0.1 M spermidine generated larger crystals. Further optimization trials 
revealed that the addition of 2-Methyl-2,4-pentanediol (MPD) also improved crystal size 
whilst the crystal form was not affected by the addition of 10% glycerol (used for 
cryoprotectant). The final condition consisted of 0.2 M potassium nitrate; 25% PEG 3350; 
6% MPD; 10% glycerol and 1 mM spermidine. Hexagonal crystals with approximate 
dimensions of 200 μm x 200 μm x 150 μm grew from these conditions in less than 24 
hours.  
 
Figure 4.14 Sco5413tr crystals. (a) In the hanging drop; (b) in the litholoop on beamline i02 at the Diamond 
Light Source synchrotron.  
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Mercury derivatized crystals were obtained by soaking the native crystals in a mother 
liquor solution containing a saturating amount of thimerosal for 4 hours. Crystals were 
backsoaked into the well-solution for 20 minutes prior to flash-freezing in liquid nitrogen. 
The crystals were transferred between solutions and frozen in liquid nitrogen for X-ray 
data collection using litholoops (Molecular Dimensions).   
 
4.4.1  Native crystal data collection 
The native data were collected at beamline i02 at Diamond Light Source synchrotron 
(Diamond) using an ADSC Quantum 315 CCD detector. It was established from test images 
that the crystal was orthorhombic with approximate cell parameters of a = 63, b = 66, c = 
70 Å, and the crystal diffracted X-rays to very high resolution. A low-dose medium 
resolution pass was collected before collecting to the maximum resolution, to ensure that 
the low resolution reflections were well measured (i.e. not saturated). For the medium 
resolution pass, 130 x 2.25° images were collected with the detector resolution set to 2.3 
Å; for the high resolution pass, 500 x 0.3° images were collected with the detector 
resolution set to 1.20 Å. All data from both passes were integrated and merged together 
using the 3d option in Xia2 and, after inspection of the resultant statistics, the resolution 
was limited to 1.25 Å. The final data set was 100% complete at this resolution, with an 
overall Rmerge of 0.088 (data collection statistics are summarized in Table 4.4). An 
inspection of systematic absences indicated that the most likely space group was P212121.  
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Figure 4.15  Diffraction image for Sco5413tr showing diffraction to 1.2 Å resolution. 
 
4.4.2  Heavy atom derivative crystal data collection 
Derivative data were collected at beamline i24 at Diamond Light Source using a Pilatus 
6M detector (Dectris).  A fluorescence scan was taken around the mercury LIII absorption 
edge to confirm the presence of Hg in this crystal (Figure 4.16). 5000 x 0.2° oscillation 
diffraction images were collected in a continuous sweep at a single wavelength of 1.0072 
Å, corresponding to the LIII edge of Hg, to a maximum resolution of 2.32 Å. The derivative 
dataset indexed as spacegroup P212121 with cell dimensions a = 62.66, b = 63.10, c = 
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68.71, using the 3d option in Xia2. The statistics from this processing were good, yielding 
a dataset that was 97.4% complete and 32-fold redundant at 2.32 Å resolution. 
 
Figure 4.16  Fluorescence scan of mercury derivative crystal taken around the mercury LIII absorption edge. 
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Table 4.4  Summary of X-ray data for Sco5413tr 
Dataset Native  Thimerosal derivative 
Number of crystals 1 1 
Beamline I02, Diamond Light Source, UK I24, Diamond Light Source, UK 
Wavelength  (Å) 0.9100 1.0072 
Detector Quantum 315 CCD Pilatus 6M 
Crystal-to-detector distance (mm) 375.2/159.8 501.1 
Rotation range per image (°) 2.25/0.3 0.2 
Exposure time per image (s) 0.25/1.00 0.2 
Beam transmission (%) 76/100 23 
Total rotation range (°) 292.5/150 1000 
Resolution range (Å) 69.72 - 1.25 (1.28 - 1.25) 31.55 - 2.26 (2.32 - 2.26) 
Space Group P212121 P212121 
Cell parameters (Å) a = 63.40, b = 65.65, c = 69.72 a = 62.66, b = 63.10, c = 68.71 
Estimated mosaicity (°) 0.2 0.3 
Total no. of measured intensities 669686 (35277) 415840 (17449) 
Unique reflections 81107 (5923) 12870 (724) 
Multiplicity 8.3 (6.0) 32.3 (24.1) 
Mean I/(I) 11.5 (2.6) 26.3 (5.4) 
Completeness (%)
 
100.0 (100.0) 97.4 (77.5) 
Rmerge
†
 0.088 (0.709) 0.095 (0.943) 
Rmeas
‡
 0.096 (0.868) 0.098 (0.983) 
Wilson B value (Å
2
) 14.6 49.6 
†
 Rmerge = ∑hkl ∑i |Ii(hkl)  I(hkl)|/ ∑hkl ∑iIi(hkl). 
‡ 
Rmeas = ∑hkl [N/(N  1)]
1/2
 × ∑i |Ii(hkl)  I(hkl)|/ ∑hkl ∑iIi(hkl), 
where Ii(hkl) is the ith observation of reflection hkl, I(hkl) is the weighted average intensity for all 
observations i of reflection hkl and N is the number of observations of reflection hkl. 
#
 Collected in two 
passes at medium/high resolution.  
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4.4.3   Structural determination 
The native and derivative data were combined to solve the structure by the Single 
Isomorphous Replacement with Anomalous Scattering (SIRAS) method using the Autosol 
wizard in PHENIX (Adams et al., 2010) which used SOLVE for phasing and RESOLVE 
(Terwilliger, 2000, Terwilliger & Berendzen, 1999) for density modification. Autosol found 
two clear mercury sites and this solution gave a figure of merit (FOM) of 0.318 to 2.29 Å 
which increased to 0.671 following density modification.  The solution assumed two 
copies of the Sco5413tr monomer in the asymmetric unit (ASU) with a solvent content of 
46%. These phases were then fed into Autobuild (Terwilliger et al., 2008) which produced 
a partial model comprised of 238 residues with Rwork and Rfree values of 0.283 and 0.345, 
respectively, and a FOM of 0.616 at 2.29 Å resolution. Although this partial model 
comprised of two subunits, these did not resemble the typical MarR structure but this 
was amended by applying the appropriate symmetry operator to one of the subunits. 
Restrained refinement using REFMAC5 (Murshudov et al., 1997)  against the 1.25Å  native 
dataset gave Rwork and Rfree values of 0.306 and 0.323 respectively, and a FOM of 0.553. 
The phases calculated from this model were density modified in PARROT (Cowtan, 2010) 
with two-fold averaging using the NCS operators derived from the dimer model. This gave 
a FOM of 0.755 to 1.25 Å resolution. The model was then rebuilt from scratch using 
BUCCANEER (Cowtan, 2006), yielding a model consisting of 286 residues with Rwork and 
Rfree values of 0.279 and 0.299 respectively, and a FOM of 0.802. Water molecules were 
fitted with Arp/WARP (Perrakis et al., 1999), giving a model with Rwork and Rfree values of 
0.206 and 0.236 respectively, and a FOM of 0.863. This model then underwent several 
iterations of rebuilding in COOT (Emsley et al.) and restrained refinement in REFMAC5 
(with anisotropic temperature factors) resulting in a final model with 279 residues (96% of 
annotated sequence), 372 water molecules and 2 chloride ions. The final Rwork and Rfree 
values are 0.147 and 0.175 respectively, and a FOM of 0.920 at 1.25 Å resolution (final 
statistics in Table 4.5).  
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Figure 4.17  Structure solution steps for Sco5413tr 
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Table 4.5  Summary of refined model parameters for Sco5413tr 
Resolution range (Å) 69.72 - 1.25 
Rwork/ Rfree
†
 0.147/0.175 
Ramachandran plot: 
favoured/allowed/disallowed
‡
 (%) 
100/0/0 
R.m.s. bond distance deviation (Å) 0.01 
R.m.s. bond angle deviation (º)  1.41 
No. of protein residues: chain A/chain B 140/139 
No. of water molecules/chloride ions 372/2 
Mean B factors: protein/water/overall  (Å
2
) 17.7/31.5/19.8 
† The R-factors Rwork and Rfree are calculated as follows: R = (| Fobs - Fcalc |)/| Fobs | x 100, where 
Fobs and Fcalc are the observed and calculated structure factor amplitudes, respectively. 
‡ As 
calculated using MOLPROBITY (Davis et al., 2007, Chen et al., 2010). 
 
4.4.4 Structural Validation using Molprobity 
The model was evaluated using Molprobity (http://molprobity.biochem.duke.edu/) (Chen 
et al., 2010) and 100% of the fitted residues were in the favoured region of the 
Ramachandran plot (Figure 4.18).  
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Figure 4.18 Ramachandran plot for Sco5413tr. 
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4.4.5  Structural Analysis of Sco5413tr 
The structure of Sco5413tr has the typical MarR features: α2 and α3 constitute the helix-
turn-helix domain whilst the wing consists of two antiparallel β-strands, β2 and β3, which 
are connected by a loop (Figure 4.19). These are the DNA-binding domains in most MarR 
homologues. The wing is usually not well-resolved in other MFR structures which are not 
complexed with DNA, due to its innate flexibility. It is fairly well-resolved in this structure, 
although there are still a few residues from this region which are missing (86-89 in chain A 
and 87-89 in chain B). The wing is important for DNA interactions and it is better resolved 
in proteins which have been solved in complex with their cognate DNA sequences. 
Sco5413tr has the triangular shape typical of MarR family members and the dimer 
interface that is comprised of the N- and C- terminal helices, α1, α5 and α6. The PISA 
server (http://www.ebi.ac.uk/pdbe/prot_int/pistart.html) indicates that 48 residues (34% 
of total) of each monomer are located at the dimer interface: a total area of 2015 Å2. 
There is also a salt bridge between Arg13 and Asp141’ on each chain which connect the 
two monomers at the interface via the N- and C-terminal helices (although the N-terminal 
helix in this model is probably the second helix in the full-length protein). These could act 
as hinges around which the individual monomers could rotate whilst maintaining the 
connection at the dimer interface and contributing to the stability of the dimer. This salt-
bridge could be disrupted by binding of an effector molecule. Again, this is speculative 
and worthy of further investigation once more is known about cognate ligands for this 
protein.  
 
Other significant features of this structure are the α4 DNA recognition helices which, 
when superimposed onto the α4 recognition helices of the OhrR-DNA complex structure 
using Secondary Structure Matching (Krissinel & Henrick, 2004), have an RMSD of 0.9 Å 
(this value is for the superimposition of the α-recognition helices only).  This would 
suggest that in this structure, Sco5413tr is in a conformation that may allow DNA binding. 
However, superimposing the Sco5413tr α4 recognition helices onto the SlyA-DNA 
complex α4 recognition helices, the RMSD is 2.1 Å.  Superimposing the monomers onto 
each other (Sco5413tr onto both the SlyA- and OhrR-DNA complexes) produces similar 
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results, whereas superimposing the dimers it becomes apparent that the fit is much 
better with OhrR-DNA complex. A closer inspection of the conformation of the DNA in 
both structures shows that it differs slightly and so it is difficult to speculate about the 
positions of the Sco5413tr recognition helices as they relate to DNA binding. However, 
they do appear to be appropriately disposed relative to one another to engage with 
adjacent major grooves of the DNA helix.  
 
 
Figure 4.19  Structure of Sco5413tr dimer. The intertwining of the N- and C- terminal helices can be seen in 
this model.  
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Figure 4.20  Structural homologues superimposed onto Sco5413tr (viewed head on and from underneath). 
Sco5413tr is coloured in yellow and cyan and the comparison structures are in grey with pale brown 
recognition helices.  
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Table 4.6  Structural homologues of Sco5413 
Protein Source DNA or 
ligand 
PDB 
code 
Dali    R.m.s. deviation (Å)/ 
aligned residues 
Reference 
    Z-
score 
Alignment 
length 
Seq. 
ID 
(%) 
Subunit Dimer  
          
BldR Sulfolobus 
Solfataricus 
- 3F3X 16.2 129 19 1.9/126 2.7/246 (Di Fiore et 
al., 2009) 
SarZ Staphylococcus 
aureus 
Sulfenic 
acid form 
3HRM 15.9 129 16 1.5/125 1.9/249 (Poor et al., 
2009) 
OhrR Bacillus subtilis DNA 1Z9C 15.6 132 17 1.8/114 1.9/226 (Hong et al., 
2005b) 
SlyA Salmonella 
enterica 
DNA 3Q5F 15.4 130 15 1.7/126 2.8/254 (Dolan et al., 
2011) 
ST1710 Sulfolobus 
tokodaii 
salicylate 3GF2 16.6 135 16 2.2/126 2.6/245 (Kumarevel et 
al., 2009) 
MTH313 Methanobacteri
um 
thermoautotrop
hicum 
salicylate 3BPX 15.4 132 15 2.3/124 2.5/244 (Saridakis et 
al., 2008) 
MarR E. coli salicylate 1JGS 14.5 127 20 2.3/109 3.8/202 (Alekshun et 
al., 2001) 
SlyA  salicylate 3DEU 13.8 129 16 2.5/124 2.8/248 unpub 
HucR Deinococcus 
radiodurans 
- 2FBK 13.2 132 20 2.1/1.25 2.2/256 (Bordelon et 
al., 2006) 
 
Also unknown is whether Sco5413tr has a ligand binding site. However, as the protein 
was truncated, it lacks the primary N-terminal helix. Using a HucR homology model 
generated by the PHYRE server, the N-terminal helix of this model was superimposed 
onto the Sco5413tr model to see where it may be in the structure. In HucR, an MFR from 
Deinococcus radiodurans, this N-terminal helix is referred to as an “extra” helix (Bordelon 
et al., 2006). MarR structures typically comprise six α-helices, whereas HucR has seven 
and Sco5413 is predicted to have seven. As discussed in Chapter 6, Sco4122 also falls into 
this subcategory of MarR homologues which have an extra N-terminal helix, the purpose 
of which is still unknown. Recent work has proposed the existence of a subfamily of MarR 
homologues, the urate responsive transcriptional regulator (UrtR) (Perera & Grove, 2011), 
which have a common mechanism of urate-mediated attenuation of DNA-binding. The 
study reports that all of these UrtRs have an N-terminal extension as a “salient” feature, 
along with the conservation of several residues involved in urate interactions, particularly 
the conserved tryptophan in the N-terminal helix. This residue also appears to be 
conserved in Sco5413 in the alignment generated by the PRALINE server (Simossis & 
Heringa, 2005) shown in Figure 4.21. This alignment also shows how the full-length 
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Sco5413 may be expected to adopt the “extra” N-terminal helix present in the UrtR 
homologues and Sco4122. Whether or not this is of any biological significance remains to 
be determined, but it is nevertheless interesting that the presence of an extra N-terminal 
helix has been reported as a feature in this subfamily of MFRs.  
 
Figure 4.21  Sequence alignments generated by the PRALINE server (Simossis & Heringa, 2005). (a) 
secondary structure prediction; (b) conservation of amino acids. 
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As with Sco3914, this protein underwent His-tag cleavage with 3CP protease which 
included 2 mM β-mercaptoethanol in the cleavage buffer. Again, a cysteine modification 
may be observed in the native structure, although this is a surface cysteine which is not 
located within a pocket or on the wing, as was the case with Sco3914. It is not a well 
conserved cysteine either and so is not considered particularly important in terms of the 
function of this protein.  
 
An electrostatic surface map (Figure 4.23, generated in PyMOL) indicates a cleft located 
close to the dimer interface on the “shoulder” on each monomer. This putative pocket is 
lined mainly with neutral residues, with charged residues nearer the surface. Further 
structural analysis performed by PDBSum (Laskowski, 2001) suggests that there are two 
substantial clefts (one on each monomer in roughly equivalent positions) which extend 
from the one observed in Pymol through to the DNA interaction domains. However, no 
ligand is reported to be bound and there is no unexplained density in the structure and so 
it remains uncertain as to whether this is a ligand binding pocket. Superpositioning of the 
HucR model onto Sco5413tr presents an interesting theory: the additional N-terminal α-
helix 1 sits over the cleft in Sco5413tr. In HucR, this helix contains Trp20 which, as 
discussed previously, is important for interactions with the substrate urate and this 
residue is conserved in full-length Sco5413 (Figure 4.21).  
 
Figure 4.22  (a) HucR (grey) superimposed onto Sco5413tr; (b) the extra N-terminal helix from HucR 
superimposed onto Sco5413tr. 
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Figure 4.23 Electrostatic surface representation of Sco5413tr dimer (negative charge coloured in red; 
positive charge in blue). Figure created using PyMOL (The PyMOL Molecular Graphics System, Version 
1.5.0.4 Schrödinger, LLC). (a) shows the front view of Sco5413tr; the putative ligand pocket is magnified in 
(b). The DNA binding domains can be visualised in (c) and here the residues are evidently more positively 
charged.  
 
 
a b 
c 
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Figure 4.24  (a) View of the putative binding site on Sco5413 with salicylate from the MTH313 structure 
superimposed (circled in white); the modified cysteine may also be seen (circled in yellow); (b) magnified 
view, including superimposed extra helix from a homology model of full-length Sco5413 based on HucR 
(generated by the PHYRE server (http://www.sbg.bio.ic.ac.uk/phyre2).  
 
Relatively little is known about effector molecules of MFRs, yet much of the work has 
focused on salicylate as E. coli MarR was crystallized with salicylate bound and it has been 
shown to induce the multiple antibiotic resistance phenotype (Alekshun & Levy, 1999, 
Alekshun et al., 2001, Martin & Rosner, 1995). MTH313 from Methanobacterium 
thermoautotrophicum (Saridakis et al., 2008) and ST1710 from Sulfolobus tokodaii 
(Kumarevel et al., 2009) are just two of the MFRs which have been co-crystallized with 
salicylate but whether or not this is the natural ligand for any of these proteins remains to 
be determined. However, these structures have shed light upon some of the features of 
the binding pockets and the superposition of one of the bound salicylates (SAL1) from 
MTH313 on Sco5413tr (Figure 4.24) shows that such an amphipathic molecule could 
possibly be accommodated in this cleft. There is some evidence, therefore, to suggest 
that this is a putative ligand binding pocket and crystallization of the full-length protein 
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and knowledge of the effector molecule would be useful to further investigate this 
hypothesis.   
 
4.5 Western Blot to detect expression of Sco5413 in vivo 
The expression of Sco5413 in vivo was monitored across a series of selected time points 
during several days of growth in liquid cultures (minimal liquid medium + 1% glucose). 
The proteins were incubated with an antibody against Sco5413 derived from rabbit sera 
then incubated with anti-rabbit IgG secondary antibody. A protein of ~17 kDa can be 
observed in the wild type but not in the mutant. Sco5413 is expected to be 18413 Da 
based on the sequence obtained from StrepDB. However, as mentioned in Section 5.1, 
Sco5413 has an orthologue in S. avermitilis (Sav2834) which has an expected size of 
15669 Da and if Sco5413 were to be translated from the second potential start codon 
(base pair 76), then it would have a theoretical molecular weight of 15589 Da. Another 
explanation is that the protein runs anomalously on the SDS-PAGE gel. It is of course also 
possible that this is not Sco5413 and maybe a downstream protein which is affected by 
the mutation. For example, Sco5413 could negatively regulate another transcriptional 
repressor and, in the absence of Sco5413, this repressor is upregulated and so its target 
gene is downregulated. It is therefore very difficult to speculate what effects the removal 
of a putative transcriptional repressor might have. 
 
The antibody is evidently not specific for Sco5413 and it is therefore significant that the 
other proteins which have an affinity for this antibody are present in what appear to be 
equal amounts in both samples. Also labelled are purified, tagged Sco5413 and Sco4961. 
This shows that the antibody has some affinity for Sco4961 (33% sequence identity to 
Sco5413) and it is therefore plausible that it may also have an affinity for many other 
proteins being expressed at these time points, hence the many bands on the Western 
blot (Figure 4.25). Also apparent are several bands for the purified Sco5413 which is the 
result of overloading the sample which also accentuates the contaminant proteins 
present in the sample. These may also be breakdown products of Sco5413.  
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Figure 4.25  Time course analysis of Sco5413 expression using Western Blot.  A series of samples were taken 
at the times indicated on the blot. Sample A – M145 WT; Sample B – M145∆sco5413. A band which 
corresponds to a protein of size ~17 kDa can be observed in the wild type but not in the mutant. It is 
possible that this could be Sco5413 or maybe a downstream protein, the expression of which is regulated 
either directly or indirectly by Sco5413.  
 
4.6 DNA Interactions 
4.6.1   Electrophoretic Mobility Shift Assay 
As many prokaryotic transcription factors are self-regulating, it was necessary to check if 
Sco5413 would bind its own intergenic region. The first experimental approach employed 
was an electrophoretic mobility shift assay in which the protein is incubated with 
radiolabelled DNA fragments in order to detect any retardation of the DNA fragments on 
a non-denaturing polyacrylamide gel. The whole of the intergenic regions between 
sco5412-5413 and sco4961-4962 were amplified using the oligos shown in Table 4.7. The 
sco4961-4962 intergenic region was used as a control. 
Table 4.7  Oligos used to amplify the intergenic regions between sco5412-5413 and sco4961-4962. 
CGCCACCTCGCCCCCTGACCGTGCCGGTGG Int54125413_F 
ACTGAGGGGCTTCGGCACGGCAAGAGACCT Int54125413_R 
GGCGGTCGTCATGTCCATCGACATTTCAGG Int49614962_F 
CGCTGTGCTGTAGCTCATAGCTCCAGCATC Int49614962_R 
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5 μl of the PCR products (~ 100 ng) were labelled with [32P-]-ATP and incubated with 
differing concentrations of protein for the binding reaction (detailed in Chapter 2). 
Sco5413 was in a 25 mM Tris pH8, 100 mM NaCl buffer. Figure 4.26 shows that there was 
no retardation of the fragments on the gel when incubated with the protein, suggesting 
that Sco5413 does not bind either of these intergenic regions under the experimental 
conditions. 
 
Figure 4.26  Electrophoretic Mobility Shift Assay using purified (tagged) Sco5413 and the amplified 
intergenic regions of sco4961-4962 and sco5413-5414. The concentrations of each protein sample are 
indicated above each lane. The image shows that Sco5413 did not bind to either of the intergenic fragments 
under these conditions. 
It is not certain whether the protein required incubation in a different buffer in or the 
addition of a specific cofactor in order to bind these sequences, or whether it is as simple 
as Sco5413 does not bind these intergenic sequences. However, a single EMSA was not 
conclusive enough to rule out the possibility that Sco5413 was autoregulatory and so 
further experiments were pursued to test this hypothesis. 
 
4.6.2  ChIP on Chip 
ChIP on chip was used to identify potential operator sites for Sco5413 within the 
Streptomyces coelicolor genome and thereby define its regulon. Sco5413 was chosen for 
this experiment as it was the only protein in this project that exhibited a visible 
phenotype in the deletion mutant strain. The samples sent to Oxford Gene Technology 
(OGT) for this experiment were the wild type M145 genomic DNA and the M145Δsco5413 
genomic DNA. All the samples were prepared as detailed in Chapter 2 by growing up the 
cells and cross-linking any proteins attached to the genomic DNA using formaldehyde. 
0 125
2 
250 500 0 125
2 
250 500 
Sco5413 
(nM) 
sco4961-4962 int sco5413-5412 int 
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The cells were lysed and the genomic DNA was fragmented by sonication into fragments 
of ~500 bp. The Sco5413 specific antibody (prepared by Cambridge Research 
Biochemicals) was used to immunoprecipitate this protein from the cell lysate and the 
DNA was purified from this extraction. The purified DNA fragments were then labelled 
and hybridized to an OGT ChIP microarray. (This stage was carried out by OGT).  
 
Two time points were selected for the experiment: a sample was cross-linked at 16 hours 
and another sample at 90 hours. The selection of these time points was based on the 
mutant phenotypes as there was no apparent difference between the wild type and the 
mutant until at least 48 hours. It was therefore hoped that these time points would allow 
a distinct difference between the two strains to be detected in the microarray data. A 
screenshot of some of the results as displayed in the OGT Ltd ChIP Browser is shown in 
Figure 4.27. 
 
Figure 4.27 A screenshot of the OGT ChIP Browser with the microarrays for each of the four samples (Wild 
type and mutant at two different time points) displayed. This window shows the region of Sco5413 and 
there are no obvious peaks detected between the microarrays. Each spot refers to the DNA probe which is 
attached to the chip surface.  
 
WT  
16 hours 
∆sco5413 
16 hours 
WT  
90 hours 
∆sco5413 
90 hours 
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Yet, as the results show, there was no discernable difference between the two: no 
obvious peaks in the microarray data and so what conclusions can be drawn from this? 
Firstly, perhaps the wrong time points were selected. As a transcriptional regulator, it is 
possible that Sco5413 does not necessarily need to bind its cognate sequence at these 
specific time points and so it was unfortunate that the appropriate window may have 
been missed. Secondly, there may have been impurities with the antibody. Although the 
protein was purified before it was sent to CRB for the antibody generation, it is of course 
possible that it contained undetected amounts of contaminating proteins from the 
expression E. coli strain. Another possibility is that there is enough similarity between 
Sco5413 and other S. coelicolor proteins for the antibody to be able to bind several other 
proteins in the immunoprecipitation step. A Western Blot (see section 4.5) demonstrated 
that in the native producer, the antibody targeted several other proteins and so it is 
conceivable that this could have been an issue. This would introduce a lot of noise into 
the experiment and so potentially mask any otherwise significant signal. 
 
Another potential problem with this experiment was that the phenotype was manifested 
on SFM (mannitol soya flour) solid medium which had been enriched with 1% glucose/1% 
glycerol or 10 mM GlcNAc. It was considered too difficult to attempt to extract the 
samples from liquid SFM as this medium has many large, aggregated particles which could 
hinder the extraction of protein and/or DNA. The liquid medium used was 50:50 
TSB:YEME (Chapter 2). Under these conditions it is possible that Sco5413 was not 
expressed (or at least not in any quantity sufficient for the success of this experiment).  
 
4.6.3   Surface Plasmon Resonance 
 The purpose of the experiment was to determine whether the protein binds its own 
intergenic region and the precise DNA sequence to which the protein binds. This would 
then hopefully give some indication as to whether or not the protein is self-regulating and 
opens up the potential to uncover other putative binding sites in the genome. Although 
the EMSA experiment had given a negative result, it was important to ensure that this 
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was not due to the conditions of the experiment. The advantage of using this approach 
over the EMSA method was that this technology requires very little protein and also 
eliminates the need for radioactive labelling. SPR also offers the potential to explore the 
kinetics of the interactions.  
 
The preliminary stage of this experiment involved determining whether the protein would 
bind the whole intergenic sequence. The sco5413-5412 intergenic region was amplified by 
PCR (using the primers shown in Table 4.8) to incorporate a single-stranded overhanging 
sequence which is complementary to the biotinylated ssDNA annealed to the streptavidin 
chip (details in Chapter 2). Unlike with Sco3914 and Sco4122, the first step to generate a 
template was not required as non-specific binding was not as much of an issue. This 
whole intergenic sequence was used as a preliminary check to see if the protein would 
bind. Initial results (Figure 4.28) indicate that there is a negligible interaction between the 
protein and the DNA. The response unit values are all less than 10 RU and the reponses 
drop off immediately at the end of the protein injection, signifying a negligible 
interaction. This was attempted under both normal and reducing conditions (10 mM final 
concentration dithiothreitol (DTT) in the running buffer). The increased response 
observed for the 10 mM DTT sample is most likely an effect of the DTT rather than an 
enhanced protein interaction. 
Table 4.8  Oligos used for the 2 step PCR amplification of the intergenic region. The nested sequence is in 
green and the sequence which is complementary to the biotinylated oligo is in blue. The reverse oligo from 
step 2 was used again in step 3. 
Oligo name Sequence 
Step 2 Forward TTATCAAAAAGAGTATTGACCCGTGCCGGTGGGCGG 
Step 2 Reverse CACGGCAAGAGACCTTACCGGC  
Step 3 Forward TTAGCGTTTGCGTATGCG/dSpacer/TTATCAAAAAGAGTATTGAC  
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Figure 4.28  Sensorgram showing Sco5413 (and Sco5413tr) interacting with the PCR amplified intergenic 
DNA sequence. Sco3914 (as prepared and with 10 mM DTT) and Sco4122 were used as controls to indicate 
that there may be some small interaction between Sco5413 and this specific sequence. However, it is likely 
that this is transient and perhaps not significant given the immediate dissociation at the end of the 
injection. 
 
The next step involved “fragmenting” the intergenic region in order to see if there is any 
specific interaction (or indeed any interaction). The intergenic region of 76 base pairs was 
fragmented to incorporate a 25 bp overlap between each sequence as shown below and 
the oligos were ordered from Sigma. The forward oligo included the 20 bp ssDNA 
overhang which is complementary to the ssDNA annealed to the streptavidin chip. In this 
experiment, the complementary ssDNA sequences were annealed by mixing 60 μl of the 
reverse oligo with 50 μl of the forward oligo to give a 45 μM stock solution (PCR program 
used for this is detailed in the materials and methods chapter). This was diluted to the 
working concentration of 1 μM with HBS-EP+ buffer. Each dsDNA sequence was then 
captured on the chip by running it across the analytical flow cell containing the ssDNA 
linker. This is detailed in Chapter 2. The full-length protein Sco5413 (including the His-tag 
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sequence) was then run across both the control and analytical flow cells and the results 
for this are shown in Table 4.9. 
 
Prior to this experiment, a MEME analysis of the upstream intergenic regions of several 
top orthologues in reciprocal BLAST searches was performed and the following MEME 
motif found:- 
 
 
 
sco5413-5414 Intergenic sequences  
TGACCGTGCCGGTGGGCGGTGGTATCGAAGGGCGAGACGGAGCTGACCGGCATGTGACCGGCCGGTAAGGTCTCTTGCCGTG 
   
0-40 CCGTGCCGGTGGGCGGTGGTATCGAAGGGCGAGACGGAGC 
                                 16-55    GTGGTATCGAAGGGCGAGACGGAGCTGACCGGCATGTGAC 
                     31-70 GAGACGGAGCTGACCGGCATGTGACCGGCCGGTAAGGTCT 
                      46-76 GGCATGTGACCGGCCGGTAAGGTCTCTTGCC 
Figure 4.29  The 76 base pair intergenic region between sco5413 and sco5414 and the four fragments used 
in the experiment. The MEME motif is highlighted in pink. 
 
This motif is contained within sequences 3 and 4 and so the expectation was that if there 
was to be any binding, it would be within these sequences. However, as can be seen in 
the results shown in Table 4.9, no apparent preferential binding of either sequence was 
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observed. In fact, there was no apparent binding of any of the sequences. The interaction 
of the protein with each sequence was calculated as a percentage of the Rmax value for 
each DNA sequence captured and plotted as a histogram. The plot quite clearly shows 
that there was no protein:DNA interaction with any of the sequences or any of the 
concentrations of protein. The figures shown in the table are the calculated percentages 
of the Rmax and the negative values would suggest that there is in fact slightly more 
interaction of the protein with the control flow cell (fc1) which contains the linker 
sequence alone.  
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Table 4.9  Raw data from the SPR experiment showing the amount of DNA captured at each cycle and the 
calculated Rmax for each cycle. The protein interaction was measured in response units which were then 
calculated as a percentage of the Rmax. There are two replicates for each protein concentration. 
Run 1 Run 2 
100 
nM 
MW DNA 
Capture 
Theoretical 
Rmax 
Protein 
bound 
%Rmax DNA 
capture 
Theoretical 
Rmax 
Protein 
bound 
%Rmax 
1 30590 444.0 462.4 -1.0 -0.2 446.3 464.8 -1.1 -0.2 
2 30586 460.6 479.8 -1.0 -0.2 462.3 481.5 -1.3 -0.3 
3 30587 438.2 456.4 -0.9 -0.2 441.6 460.0 -1.2 -0.3 
4 25024 463.9 590.6 -0.9 -0.2 465.2 592.3 -1.3 -0.2 
50 
nM  
  
      
1 30590 446.3 464.8 -0.9 -0.2 447.1 465.6 -1.1 -0.2 
2 30586 461.3 480.5 -0.9 -0.2 461.9 481.1 -1.2 -0.2 
3 30587 440.1 458.4 -0.9 -0.2 441.5 459.9 -1.1 -0.2 
4 25024 465.2 592.3 -1.0 -0.2 466.6 594.0 -1.3 -0.2 
10 
nM  
  
      
1 30590 445.5 464.0 -0.9 -0.2 448.6 467.2 -1.0 -0.2 
2 30586 462.2 481.4 -1.0 -0.2 462.7 482.0 -1.2 -0.2 
3 30587 440.6 458.9 -0.8 -0.2 442 460.4 -1.2 -0.3 
4 25024 465.5 592.6 -1.0 -0.2 466.9 594.4 -1.2 -0.2 
 
The results shown here indicate that there is no significant interaction between the 
protein and the DNA and therefore further interrogation of this intergenic region will not 
be pursued. 
 
4.7 Conclusions  
Sco5413 has been shown in this study to possess the physical characteristics of a MarR 
family regulator (MFR): it is a dimer with a winged-helix DNA-binding domain and the 
dimerization domain consists of the N- and C- terminal helices interacting at the dimer 
interface. However, as a putative transcriptional regulator, it has not been shown that it is 
capable of binding DNA and there is more work to be done in this area.  
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There are many potential reasons as to why the ChIP on Chip experiment did not yield 
any positive results and, although frustrating in terms of trying to find a function for 
Sco5413, it does support the previous findings in the EMSA and SPR experiments, which 
also failed to detect any significant DNA interactions. Perhaps Sco5413 requires a ligand 
or cofactor to bind to DNA. Perhaps it only binds under specific conditions which have yet 
to be assayed. It could be that this protein is not expressed at the time points selected, 
but as it does not self-regulate, it cannot be detected at all. This experiment was carried 
out prior to the SPR experiment and so, apart from the negative result from the EMSA, 
there was no reason to suspect that this experiment would not yield useful results. 
Nevertheless, in the interests of presenting all of the work done on this protein as a 
confirmation of its lack of DNA-binding capability, these negative results are included. 
 
The structure of truncated Sco5413, which was solved to 1.25 Å, is the highest resolution 
structure of a MarR homologue to date. This structure reveals a distinct channel which is 
lined by well conserved residues and this is possibly a binding site for ligands which may 
regulate the affinity of the protein for its cognate DNA sequence. Interestingly, a 
structure prediction for the full-length protein indicates that it would likely have the extra 
N-terminal helix seen in HucR and Sco4122 (see Chapter 5). It also has a tryptophan in this 
putative helix which appears to be conserved in HucR and interacts with its substrate 
urate. The modified cysteine does not appear to be well conserved and so it was not 
investigated further. Additionally, comparisons with other MFR structures indicate that 
Sco5413tr is in a conformation which is compatible with DNA-binding.  
 
One final point of speculation about Sco5413 is that despite the lack of evidence for it 
binding DNA, it is still a protein worth more investigation. It is highly represented in the 
genomes of other bacteria and as such, it is most likely to have some important function. 
The distinct phenotype in the gene deletion strain is also a further indication of its 
potential to yield some very useful information relating to actinomycete development.  
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5.1 Introduction 
Sco4122 is predicted to be a 22 kDa protein which is divergently transcribed to Sco4121, a 
possible integral membrane protein (Figure 5.1). As another putative member of the 
MarR family of transcriptional regulators (MFRs), this protein shares a sequence identity 
of 22% with the MarR homologue from Deinococcus radiodurans, HucR (Bordelon et al., 
2006). Biophysical analysis of its DNA-binding capabilities revealed that it is capable of 
specific binding to its own promoter region and so the assumption is that this protein is 
also autoregulatory. 
 
The sco4122 gene is 549 bp in length and has a GC content of 71%. It has 15 orthologues 
amongst 112 actinobacterial genomes and E. coli and Bacillus subtilis (bioinformatics 
analysis done by Govind Chandra, John Innes Centre). Its close homology to orthologues 
in other published sequences of streptomycetes can be seen in Table 5.1 below.  
 
Table 5.1  The sequence identities shared between the orthologues from other streptomycetes and 
Streptomyces coelicolor Sco4122. Sav – Streptomyces avermitilis; Ssc – Streptomyces scabius; Sgr – 
Streptomyces griseus: Sven – Streptomyces venezuelae. 
 
 
 
 
 
 Amino acid sequence %ID DNA Sequence %ID 
Sco Sav Ssc  Sgr  Sven  Sav  Ssc  Sgr  Sven  
Sco4122 Sav4105 
91% 
Scab49171 
87% 
Sgr3909 
80% 
Sven38764
80% 
Sav4105 
87% 
Scab49171
86% 
Sgr3909 
81% 
Sven38764 
83% 
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Figure 5.1  A representation of the location of sco4122 in the Streptomyces coelicolor genome 
(http://strepdb.streptomyces.org.uk).  
 
Sco4122 has been cloned, expressed, purified and crystallized and the structure solved to 
2.35 Å resolution. A gene disruption mutant was generated in the host organism but no 
visible phenotype observed under the conditions tested.  
 
Bioinformatic analysis of this intergenic region also revealed several putative MEME 
motifs, the first of which corresponded to a significant response in SPR experiments. The 
DNA footprint of Sco4122 has been determined in this work using Surface Plasmon 
Resonance. There is the opportunity for further studies to be carried out regarding this 
particular footprint as there is a suggestion that there may be some form of cooperative 
binding occurring in this region. Cooperative binding of transcriptional repressors has 
been shown in other cases: OhrR in Streptomyces coelicolor binds cooperatively to the 
ohrR-ohrA intergenic region under reducing conditions (Oh et al., 2007), repressing the 
transcription of the divergently transcribed OhrA (an organic hydroperoxide resistance 
protein). Sco4122 is transcribed divergently to Sco4121, a possible integral membrane 
protein which shares a strong sequence identity with putative integral membrane 
proteins from other streptomycetes as well as various other actinobacteria. 
There is also the potential for Sco4122 to be crystallized with its cognate sequence in 
order to identify the precise protein-DNA interactions.  
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The results obtained for the biophysical, genetic and structural characterization of this 
protein will be discussed in this chapter.  
 
5.2  Protein Expression and Purification 
The N-terminally His-tagged protein was cloned into the expression vector pOPINF 
(Berrow et al., 2007) and expressed in BL21 (DE3) pLysS cells according to the method 
described in chapter 2. Sco4122 elutes from the nickel affinity column with a shouldered-
peak profile (Figure 5.2), the first part of which contains several contaminating proteins. 
The fractions were pooled and applied to the size exclusion gel filtration column (GE 
Healthcare Superdex 75 16/60). The purity of the protein following the nickel affinity 
column purification and the size exclusion gel filtration chromatography column can be 
seen in the SDS-PAGE analyses (Figure 5.3 and Figure 5.5). 
 
 
Figure 5.2  Elution profile of Sco4122 from nickel affinity column chromatography. The peak has a slight 
shoulder as the protein tends to elute with some contaminating proteins. (The UV absorbance continues to 
increase after the protein has eluted as the imidazole used absorbs UV light at 280 nm). 
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Figure 5.3  15% SDS-PAGE after nickel affinity column purification. The lanes  contain: (1) Lyzed pellet; 
(2) Supernatant; (3) Fraction A4; (4) A5; (5) A7; (6) A8; (7) A9; (8) A11; (9) previous preparation of 
Sco4122.  
 
 
Figure 5.4 Elution profile of Sco4122 from size exclusion gel filtration chromatography. The first peak 
contains the protein in a higher oligomeric state whilst the second peak also contains Sco4122 (calculated 
to be slightly larger than a dimer at 52 kDa). 
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Figure 5.5  15% SDS-PAGE after size exclusion gel filtration column purification. The lanes contain: (1) 
Pooled fractions A9-A11 from nickel column; (2) Fraction A13; (3) B12; (4) B5; (5) B4; (6) B2; (7) C8; (8) 
previous preparation of Sco4122. 
 
The standard curve generated by the calibration of the gel filtration column was used to 
calculate the estimated molecular weight of the protein eluted from the column. The 
largest peak (eluted at 56.26 ml) corresponds to a molecular weight of 52 kDa. The 
predicted molecular weight of the Sco4122 dimer is 44.326 kDa. This includes the 17 
amino acid 6xHis tag, highlighted in yellow on the full-length sequence below:-  
MAHHHHHHSSGLEVLFQGPGDTSGAGEPTLEEQIAAYQREFQDLDPQVEKIVSALSRLNRRMNVAY
GRQTAELGISNTDWEVLKALVLSGAPYRLGPGDLAKRLGLTPAAMTHRIDRMVTEGLVTRERDETNR
VRVIVAVTAEGREKWLAAMRLATVFEEDLLQDLSADDRTALGDVLTRLLRRVEHAQPDAGGRLSDLD 
As with Sco3914 and Sco5413, this value is slightly larger than the predicted molecular 
weight but both of these were shown to be dimers in the crystal structures. Nevertheless, 
DLS was performed on this protein and demonstrates that it is most likely a dimer in 
solution. The experiment recorded a peak indicating that there is a predominant species 
with a radius corresponding to molecular mass of 35 kDa. This is closely similar to the 
predicted 44 kDa and therefore it is assumed that Sco4122 is a dimer. 
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Item  R (nm) %Pd  MW-R (kDa) %Int  %Mass  
Peak 1 2.7 13.2 35 61.7 100 
Peak 2 37 36.6 15697 35.7 0 
Peak 3 220.7 0 1026160 2.6 0 
 
Figure 5.6  Dynamic Light Scattering profile of Sco4122. The peaks represent the species of a particular size 
(radius) as a percentage of the total mass present in solution. Sco4122 is present in solution as a dimer. 
 
5.2.1  Expression and Purification of Selenomethionine substituted protein 
For the preparation of selenomethionine substituted protein, the growth cultures were 
subjected to metabolic inhibition and supplemented with the appropriate stocks of amino 
acids and selenomethioine prior to induction with 1 mM IPTG (details in Chapter 2). The 
protein was purified using the same methods as with the native protein, but the yield was 
much lower (as would be expected): approximately 0.4 mg l-1. However, this protein 
eluted with less contaminants than the native protein and so gel filtration was not 
performed to avoid further loss of sample.  
 
Chapter 5 – Sco4122 
 
187 
 
 
Figure 5.7  15% SDS-PAGE after nickel affinity column purification of selenomethionine substituted 
Sco4122. The lanes contain: (1) uninduced pellet; (2) induced pellet; (3) to (8) fractions containing Sco4122 
(all of which were pooled).  
 
Sco4122 has five methionines in its sequence and these are highlighted in cyan the 
sequence below (including the N-terminal methionine of the His-tagged sequence shown 
below in yellow).  
MAHHHHHHSSGLEVLFQGPGDTSGAGEPTLEEQIAAYQREFQDLDPQVEKIVSALSRLNRRMNVAY
GRQTAELGISNTDWEVLKALVLSGAPYRLGPGDLAKRLGLTPAAMTHRIDRMVTEGLVTRERDETNR
VRVIVAVTAEGREKWLAAMRLATVFEEDLLQDLSADDRTALGDVLTRLLRRVEHAQPDAGGRLSDLD 
 
Successful incorporation of selenomethionine in Sco4122 was confirmed by mass 
spectrometry. Electrospray ionization (Micromass Q-ToF 2 mass spectrometer) was used 
to determine the molecular weight of the proteins (native and selenomethionine-
substituted). The spectra, shown in Figure 5.8, indicate that several main components 
existed in the selenomethionine-substituted protein preparation. The molecular masses 
of these components correspond to different amounts of selenomethionine in the 
sequence. The native protein has a molecular mass of 22031 Da. This is 132 Da less than 
the theoretical 22163 Da for the Sco4122 monomer, but this may be explained by the 
possible absence of the N-terminal methionine which would leave 4 methionines in the 
sequence. The spectra for the SeMet derivative protein has 4 different species present, 
the first of which corresponds to the native protein (22031 Da), suggesting that there is 
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some native protein present in the sample. The most abundant species in the sample 
have molecular weights of 22219 Da and 22397 Da; a mass increase on the native protein 
of 188 Da and 366 Da respectively. There is a mass difference of 47 Da between sulphur 
and selenium. Taking the first species of 22219 Da, the extra 188 Da corresponds to 4 x 47 
Da, suggesting that all four methionines are in fact selenomethionines. The larger species 
could have the N-terminal (seleno)methionine intact which would account for the extra 
366 Da: (4 x 47 Da) + 178 Da = 366 Da (selenomethionine has a molecular weight of 178 
Da).  
 
 
Figure 5.8  Spectra showing the molecular weights of the proteins as determined using electrospray mass 
spectrometry (ESMS). The top figure shows data for native Sco4122 and the lower figure shows the data for 
selenomethionine-substituted protein (Sco4122 SeMet).  
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5.3 Crystallography and Data Collection 
Crystallization screening was carried out in 96-well sitting-drop MRC plates using a variety 
of commercial screens (details in Chapter 2). The protein:well solution ratio was 1:1 (0.6 
μl total volume).  Many small needle-like crystals grew from 0.2 M ammonium nitrate and 
25% PEG 3350 (JCSG-plus™ Molecular Dimensions) after 5 days. Crystal growth usually 
began with precipitate which then formed oily-looking globules in the drops before 
forming microcrystals, some of which then developed into needle-like clusters (Figure 
5.9). Optimizations of this condition were carried out in 24-well hanging drop plates. 
Further small crystals were generated (Figure 5.10), although crystal growth was 
inconsistent and could take up to 7-10 days. Sometimes the crystals did not grow well in 
conditions that had already generated crystals, perhaps an indication of how sensitive this 
protein is to the smallest perturbations. Further optimization trials revealed that the 
addition of 0.4% (v/v) 2-Methyl-2,4-pentanediol (MPD) slightly improved crystal size, 
whilst crystal growth was negatively affected by the addition of 10-15% glycerol. Some 
crystals were grown in the presence of 10% ethylene glycol, but the resultant diffraction 
was not good enough for structural solution. The final condition consisted of 0.2 M 
ammonium bromide; 15% PEG 3350; 0.4% (v/v) MPD. This condition was arrived at 
following unsuccessful attempts to obtain a halide derivative crystal by cocrystallization. 
Needle-like crystals with approximate dimensions of 200 μm x  15 μm x 15 μm grew from 
these conditions in approximately 7 days. The crystals were soaked briefly (~ 10 seconds) 
in this condition supplemented with 15% (v/v) ethylene glycol prior to flash-freezing in 
liquid nitrogen.  
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Figure 5.9  The growth of Sco4122 crystal in the sitting drop crystallization screen plate over the course of 
13 days. The crystal growth begins with precipitation leading to phase separation, formation of 
microcrystals and culminating in growth of very delicate needle-like crystals. These thin crystals extend and 
thicken slightly after 2 weeks. 
 
Figure 5.10  Sco4122 crystals obtained by optimization of the original conditions from the crystallization 
screen (0.2M Ammonium nitrate, 20% w/v PEG 3350). It was possible to obtain more disperse and thicker 
crystals with slight variations of this condition. 
 
Structural determination was attempted using molecular replacement with a template 
model based on HucR (2FBK) generated by the PHYRE server 
(http://www.sbg.bio.ic.ac.uk/phyre2/) (Kelley & Sternberg, 2009), but this was 
unsuccessful, although not surprising given the low identity (23%). Attempts were made 
to generate derivative crystals using co-crystallization (ammonium bromide) and heavy 
atom soaking techniques (details in Chapter 2). These soaks often resulted in the cracking 
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or complete destruction of the crystal, but it was possible to collect data from a few of 
the survivors. Data were collected for a variety of these crystal soaks (platinum, gold and 
bromide) close to their respective x-ray absorption edges, but no significant anomalous 
signal was detected. The native data were collected on station i02 at the Diamond Light 
Source Synchrotron (Oxfordshire) to a resolution of 2.35 Å. The unit cell dimensions of a = 
44.91, b = 92.64, c = 93.33, α = 90.00°,  β = 95.67°,  λ = 90.00° were consistent with the 
space group, P21. Statistics for these data are shown in Table 5.2. For the anomalous 
dataset, selenomethionine substituted protein crystals were obtained by metabolic 
inhibition (Chapter 2). Crystals were cryoprotected by soaking briefly (~10 seconds) in the 
well solution containing 15% ethylene glycol and then immediately the crystals were 
flash-frozen in liquid nitrogen. The crystals were transferred between solutions and 
frozen in liquid nitrogen for X-ray data collection using litho-loops (Hampton Research).  A 
fluorescence scan was taken around the selenium K absorption edge to confirm the 
presence of selenium in the protein (Figure 5.12). The data were collected to 2.8 Ǻ 
resolution at a wavelength of 0.9796 Å corresponding to the absorption peak. A first pass 
consisted of 500 images and a second pass in a different part of the crystal consisted of 
600 images. These images were combined and processed using Xia2 to 3.0 Ǻ resolution. 
The cell parameters for the SeMet crystal were  = 44.86 Å, b = 103.37  Å, c = 81.78 Å,  α = 
90.00°,  β = 96.21°,  λ = 90.00°, consistent with the space group P21 but with a different 
cell to the native dataset. Examples of the diffraction images from each data collection 
are shown in Figure 5.11. 
 
Figure 5.11  Diffraction images from Sco4122 (a) SeMet crystal and (b) native crystal. 
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Table 5.2  Data collection summary for Sco4122. Values in parentheses are for the outer resolution shell.  
Dataset Native  Selenomethionine derivative 
Number of crystals 1 1 
Beamline i02, Diamond Light Source, UK i04, Diamond Light Source, UK 
Wavelength  (Å) 0.97 0.9796 
Detector ADSC Q315r detector ADSC Q315r detector 
Crystal-to-detector distance (mm) 345.5 422.0 
Rotation range per image (°) 1.0 1.0 
Exposure time per image (s) 1.5 0.6 
Beam transmission (%) 44.73 100 
Total rotation range (°) 300 660 
Resolution range (Å) 92.87-2.35 (2.41-2.35) 81.30-3.00 (3.08-3.00) 
Space Group P21 P21 
Cell parameters (Å) a = 44.91, b = 92.64, c = 93.33 
β = 95.67 
a = 44.86, b = 103.37, c = 81.78 
β = 96.21 
Total no. of measured intensities 200232 (14242) 302458 (21418) 
Unique reflections 31769 (2310) 14947 (1084) 
Multiplicity 6.3 (6.2) 20.2 (19.8) 
Mean I/(I) 13.5 (2.4) 13.1 (3.4) 
Completeness (%)
 
99.9 (99.8) 100 (100) 
Rmerge
†
 0.108 (0.811) 0.215 (1.087) 
Rmeas
‡
 0.129 (0.977) 0.227 (1.146) 
†
 Rmerge = ∑hkl ∑i |Ii(hkl)  I(hkl)|/ ∑hkl ∑iIi(hkl). 
‡ 
Rmeas = ∑hkl [N/(N  1)]
1/2
 × ∑i |Ii(hkl)  I(hkl)|/ ∑hkl ∑iIi(hkl), 
where Ii(hkl) is the ith observation of reflection hkl, I(hkl) is the weighted average intensity for all 
observations i of reflection hkl and N is the number of observations of reflection hkl.  
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Figure 5.12  A fluorescence scan taken at the selenium K-edge at the Diamond Light Source Synchrotron, 
station i04. The energy at the peak is 12657 eV, where f’’ = 6.15 e and f’ = -8.07 e. 
 
5.3.1  Structural determination 
The diffraction images were initially processed using the 3dii option in Xia2. The SeMet 
datafiles were fed into PHENIX (Adams et al.) which used the AutoSol wizard (Terwilliger 
et al., 2009) to solve the structure by the Single Wavelength Anomalous Dispersion (SAD) 
method. This wizard starts with the datafiles containing the amplitudes of structure 
factors and identifies the heavy atom sites (using HySS) and calculates the associated 
phases (using SOLVE). Fifteen good selenium sites were identified, giving a figure of merit 
of 0.34 to 3.0 Å resolution following density modification (using RESOLVE). There are 4 
copies of the monomer in the asymmetric unit (728 residues in total expected) with an 
estimated solvent content of 48%. These phases were then fed into AutoBuild which 
generated a partial model. This partial model was very incomplete: 376 residues had been 
built, of which 53 residues had been sequenced. Yet, as with Sco3914, the predominantly 
α-helical structure characteristic of MarR family proteins was apparent. Four copies of a 
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template MarR model based on HucR (PDB code 2FBK) (generated by the PHYRE server) 
were docked onto this partial model in COOT (Emsley et al., 2010), using a combination of 
SSM superpose (Krissinel & Henrick, 2004) and manual fitting. This gave two dimers in the 
asymmetric unit with 432 residues in total and this model was refined (restrained 
refinement) in REFMAC5. The phases from this model were then combined with the 
unmodified experimental phases using SIGMAA from the CCP4 Suite (Winn et al., 2011). 
The combined phases were then four-fold averaged in PARROT (Cowtan, 2010). The 
output from PARROT was used by BUCCANEER (Cowtan, 2006) to rebuild the model from 
scratch. 640 residues were sequenced with a figure of merit (FOM) of 0.692 at this stage. 
This model was improved in COOT, rebuilding the most complete chain and copying this 
to the other chains, before refinement in REFMAC5 resulting in a FOM of 0.724. This 
seemed a reasonable model to use as a molecular replacement template to solve the 
structure with the native dataset. PHASER used the monomer from this model to search 
for four copies in the native dataset at 4.5 Å resolution, yielding a model which consisted 
of two dimers in the ASU. After 20 cycles of restrained refinement with automatic NCS 
restraints, the FOM had increased to 0.785 with an Rwork of 0.275 and Rfree of 0.293. 
Further iterations of rebuilding, refinement and solvent addition using ARP/wARP 
(Perrakis et al., 1999) gave a model with 616 residues and 104 waters fitted with an Rwork 
of 0.209, Rfree of 0.245 and FOM of 0.849.  
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Figure 5.13  Structure solution steps for Sco4122 
 
Table 5.3  Summary of refined model parameters for Sco4122 
Resolution range (Å) 92.87-2.35 
Rwork/ Rfree
†
 0.20/0.25 
Ramachandran plot: 
favoured/allowed/disallowed
‡
 (%) 
98.2/100/0 
R.m.s. bond distance deviation (Å) 0.01 
R.m.s. bond angle deviation (º)  1.40 
No. of protein residues: chain A/chain 
B/chain C/chain D 
160/153/152/152 
No. of water molecules 105 
Mean B factors: protein/water/overall  (Å
2
) 36.7/35.5/36.7 
†
 The R-factors Rwork and Rfree are calculated as follows: R = (| Fobs - Fcalc |)/| Fobs | x 100, where Fobs and 
Fcalc are the observed and calculated structure factor amplitudes, respectively. 
‡
 As calculated using 
MOLPROBITY (Davis et al., 2007, Chen et al., 2010). 
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Structural validation was carried out using Molprobity (Chen et al., 2010, Davis et al., 
2007). The Molprobity score is respectable (in the 97th percentile) and the Ramachandran 
plot (Figure 5.14) shows that there are no outliers in the structure. 
 
Figure 5.14  Ramachandran plot for Sco4122  
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5.3.2 Structural analysis 
 
Figure 5.15  The two Sco4122 dimers in the ASU. Chains A and B (coloured blue and pink) were used for the 
superimpositions with other MFRs. 
 
The structure has been refined to 2.35 Å resolution and displays the features which are 
characteristic of MFRs, being mainly α-helical with a winged helix-turn-helix motif. It 
resembles the structure of HucR (2FBK) in that it possesses the additional α1 helix which 
braces the amino-terminal end of α2 helix. The purpose of this “extra” helix in Sco4122 is 
unknown and it is difficult to speculate without the protein-DNA complex or having a 
ligand bound, but it is apparent that there are quite a few contacts between this helix and 
other helices in the protein which would likely serve to stabilize the structure. An 
alignment of the sequences of 2FBK and Sco4122 was performed by the PRALINE server 
(Simossis & Heringa, 2005) and can be seen in Figure 5.16. The secondary structure 
prediction alignment suggests that the conserved Trp20 in HucR has been substituted for 
Tyr19 in Sco4122 
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Figure 5.16  Sequence alignment of 2FBK (HucR) with Sco4122. Alignment performed by the PRALINE server 
(Simossis & Heringa, 2005). (a) Secondary structure prediction; (b) conservation of amino acids. 
 
This alignment shows that there are some well conserved residues between the two 
sequences and some perhaps interesting substitutions, but it is difficult to specify if these 
have any functional significance in Sco4122. For example, Trp20 in HucR is important for 
interactions with the substrate urate and the equivalent residue in Sco4122 is Tyr19. Its 
position in the first N-terminal helix appears to be similar as well, but again, this is 
speculation about its significance. There are evidently some well conserved residues 
between the two structures and, despite having an overall low sequence identity, there 
also seems to be good conservation of structural features too, which can be observed in 
the superposition of 2FBK onto Sco4122 (superposed using SSM superpose in COOT). The 
RMSD for this superposition is 2.5 Å and the α5 recognition helices appear to be in quite 
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different orientations (Figure 5.17). Other structural homologues which were generated 
by PHYRE2 (http://www.ebi.ac.uk/msd-srv/ssm/cgi-bin/ssmserver) were superimposed 
onto Sco4122 and the results are shown in Figure 5.18. 
 
 
Figure 5.17  HucR (grey) superimposed onto Sco4122 (green and cyan). 
 
Table 5.4  Structural homologues of Sco4122 
Protein
  
Source 
DNA or 
ligand 
PDB 
code 
Dali      
R.m.s. deviation 
(Å) 
Reference 
        
Z-
score 
Alignment 
length 
Seq. 
ID 
(%) 
Subunit Dimer   
MepR Staphylococcus 
aureus 
- 3ECO 9.6 133 19 1.9 2.9 (Kumarasw
ami et al., 
2009) 
YusO Bacillus subtilis - 1S3J 9.3 137 18 1.7 2.8 unpub. 
MexR Pseudomonas 
aeruginosa 
ArmR 3ECH 9 124 21 2.1 2.7 (Wilke et 
al., 2008) 
ST1710 Sulfolubus 
tokodaii 
salicylate 3GF2 6 131 27 2.6 2.5 (Kumarevel 
et al., 2009) 
SlyA Salmonella 
enterica 
DNA 3Q5F 5.5 133 16 3.3 3.5 (Dolan et 
al., 2011) 
TcaR Staphylococcus 
epidermis 
penicillin 3KP2 5 116 22 2.6 3.7 (Chang et 
al., 2010) 
 
The superimposition with SlyA in its DNA-bound configuration has a relatively high RMSD 
at both the monomer and the dimer level, suggesting that Sco4122 is not in a suitable 
conformation for DNA binding. At a dimer level, it superimposes best with salicylate-
bound ST1710 and MexR in complex with the peptide effector, ArmR, both of which are 
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assumed to be in a conformation which is also incompatible with DNA binding. However, 
the current lack of structures in the Protein Data Base (PDB) of MFRs in complex with 
DNA or effector molecules makes it particularly difficult at this point to speculate about 
the predisposition of Sco4122 to DNA-binding in this conformation.  
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Figure 5.18  Superpositions other MFRs (grey), which are structural homologues of Sco4122, onto Sco4122 
chains A and B (blue and pink).  
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5.4 DNA Interactions 
As with Sco3914 and Sco5413, the upstream intergenic sequence was selected as a 
starting point to investigate protein:DNA interactions, autoregulation being a key feature 
of over half of all characterized MarR homologues to date (Wilkinson & Grove, 2006).  
 
5.4.1  Surface Plasmon Resonance  
In order to determine whether the protein would bind the whole sco4121-4122  
intergenic sequence (Figure 5.19),  this region was amplified by 3 PCR steps (using the 
primers shown in Table 5.5) to incorporate a single-stranded overhanging sequence which 
is complementary to the biotinylated ssDNA annealed to the streptavidin chip (details in 
Chapter 2). The final PCR product with the single-stranded overhang was annealed to the 
biotinylated linker using the wizard for immobilization on the Biacore T100.  
 
sco4121-4122 Intergenic sequence 
CATTGCCCTGGTCACGTTCACCCTCTCTTGATCTCTCGGATCGTCCGCTCCAGCCGTTAGAGCTGA
AGACTTAGAAGCTAAAGTTCGAAGGTGAAGAGTACATATCGAAGGACTTCAAAGCAAAGGAGTT
GCGTGCCATACTGCGGCCATG 
Figure 5.19  The DNA sequence between sco4121 (divergently transcribed gene, the proposed start codon 
of which is highlighted in yellow) and sco4122, the start codon of which is highlighted in green.  
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GCCACATAGACGTACAGGTAGGGGACCGTGAAGCCGAGTCCGAACGCGCTGAGTGCG 
TTGCCCACGTGGATCCGGCGCATCGCCGCGCCCATTGCCCTGGTCACGTTCACCCTCTCTTGATCT
CTCGGATCGTCCGCTCCAGCCGTTAGAGCTGAAGACTTAGAAGCTAAAGTTCGAAGGTGAAGAG
TACATATCGAAGGACTTCAAAGCAAAGGAGTTGCGTGCCATACTGCGGCCATGGGCGACACCTCC
GGCGCCGGCGAGCCGACACTCGAAGAGCAGATCGCC 
Figure 5.20  The initial template (288 bp) which was amplified from the genomic DNA. The intergenic region 
is highlighted in yellow whilst the oligo sequences are highlighted in cyan (the reverse complement was 
taken for the 3’ end). 
 
Table 5.5  Oligos used for the 3 step PCR amplification of the intergenic region. The nested sequence is in 
green and the sequence which is complementary to the biotinylated oligo is in blue. The reverse oligo from 
step 2 was used again in step 3. 
Oligo name Sequence 
Step 1 Forward GCCACATAGACGTACAGGTAGG  
Step 1 Reverse GGCGATCTGCTCTTCGAGTG 
Step 2 Forward TTATCAAAAAGAGTATTGACCGCCCATTGCCCTGGTCA 
Step 2 Reverse CCGGAGGTGTCGCCCATG 
Step 3 Forward TTAGCGTTTGCGTATGCG/dSpacer/TTATCAAAAAGAGTATTGAC  
 
The protein was injected across the chip (the control flow cell contained a random DNA 
sequence of 150 base pairs – see Chapter 2) and binding was observed. Unlike Sco3914, 
the binding of Sco4122 to its intergenic sequence was unaffected by the addition of 10 
mM DTT to the running buffer. Sco4122 contains no cysteines in its sequence and so it did 
not contain the β-mercaptoethanol adducts, thereby supporting the theory that these 
adducts affected the binding of Sco3914. Once binding had been confirmed, a series of 
dilutions were prepared in order to see if the interaction was concentration dependent. 
The sensorgram in Figure 5.21 shows that there is a concentration dependent interaction 
between Sco4122 and its intergenic DNA sequence which drops off sharply below 25 nM 
of protein. The next step was to determine the precise region of interaction in the 
sequence. 
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Figure 5.21  Sensorgram showing Sco4122 interacting with the PCR amplified intergenic DNA sequence 
sco4121-4122.  
 
5.4.2 DNA Footprinting – Stage 1 
The intergenic region was “fragmented” in order to see if there is any specific interaction 
with a particular sequence. The intergenic region of 145 base pairs was fragmented to 
incorporate a 22 bp overlap between each 35 bp sequence as shown below and the oligos 
(forward and reverse) were ordered from Sigma. The forward oligo included the 20 bases 
ssDNA which is complementary to the ssDNA annealed to the streptavidin chip. In this 
experiment, the complementary ssDNA sequences were annealed by mixing 60 μl of the 
forward oligo with 50 μl of the reverse oligo to give a 45 μM stock solution (PCR program 
used for this is detailed in Chapter 2). This was diluted to the working concentration of 1 
μM with HBS-EP+ buffer. Each dsDNA sequence was then captured on the chip by running 
it across the analytical flow cell containing the ssDNA linker. The full-length protein 
Sco4122 (including the His tag sequence) was then run across both the control and 
analytical flow cells and the results for this are shown in Figure 5.23 and Table 5.6. 
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Figure 5.22  The sco4121-4122 intergenic region overlapping oligos as output by POOP (Le, to be published). 
The 35 base pair oligos include a 22 base pair overlap. The MEME motif 1 is highlighted in yellow and MEME 
motif 2 in cyan. 
 
Prior to this experiment, a MEME analysis of the intergenic regions of 15 top orthologues 
in reciprocal BLAST searches was performed and the following MEME motifs were found:- 
MEME motif 1 
 
MEME motif 2 
 
Motif 1 is contained in its entirety within sequence 5 and so the expectation was that if 
there was to be any binding, it would be within this sequence with perhaps lesser 
responses from the flanking sequences. The interaction of the protein with each 
sequence was calculated as a percentage of the theoretical Rmax value for each DNA 
sequence captured and plotted as a histogram. The results shown in Figure 5.23 and 
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Table 5.6 support this hypothesis and demonstrate that there is significant binding 
(almost 100% of the calculated Rmax at 100 mM of protein) to sequence 5 with a lesser 
response for the flanking sequences, 4 and 6. Surprisingly, there was a significant 
response (~ 60% of Rmax at 100 mM protein) with sequence number 7, which shares only 9 
base pairs overlapping sequence number 5 (and only 7 of the MEME motif 1). This 
suggests a possible second binding site for Sco4122. However, this sequence does contain 
most of MEME motif 2, but as the response decreases dramatically with sequence 8, this 
implies that there is perhaps some element of the MEME motif 1 required for the 
interaction. This result raises important questions regarding the possible cooperativity 
that may exist between these two sites. It is notable that there is a significant drop-off in 
affinity for site 2 as the few base pairs from site 1 are omitted (sequence 8). (Note that 
sequence 8 also has the first base from the MEME motif 2 omitted). Investigating these 
two sites was the next logical step. 
 
Figure 5.23  Histogram plot of DNA sequence against the percentage of the calculated Rmax value. The bars 
represent the protein:DNA interaction (as a percentage of Rmax) to the sequence at a given concentration.  
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Table 5.6  Raw data from the SPR experiment showing the amount of DNA captured at each cycle and the 
calculated Rmax for each cycle. The protein interaction was measured in response units which were then 
calculated as a percentage of the Rmax. There are replicates for each protein concentration. 
Protein 
conc. 
(nM) 
DNA 
sequence 
Run1 Run2 
  DNA 
MW 
DNA 
capture 
Theoretical 
Rmax 
Protein 
bound 
%Rmax DNA 
capture 
Theoretical 
Rmax 
Protein 
bound 
%Rmax 
10 nM 1 27500 408.0 513.0 -0.7 -0.1 412.7 518.9 -0.9 -0.2 
 2 27500 392.8 493.8 -0.6 -0.1 396.8 498.9 -1.0 -0.2 
 3 27501 407.1 511.8 -0.7 -0.1 413.0 519.2 -0.9 -0.2 
 4 27499 426.1 535.7 -0.7 -0.1 430.8 541.6 -1 -0.2 
 5 27495 334.3 420.4 132.1 31.4 337.8 424.8 135.5 31.9 
 6 27494 357.7 449.8 4.2 0.9 361.4 454.5 4.4 1.0 
 7 27496 423.6 532.6 7.1 1.3 428.8 539.2 7.1 1.3 
 8 27495 405.8 510.3 -0.4 -0.1 411.2 517.1 -0.7 -0.1 
 9 27497 413.9 520.4 -0.8 -0.2 415.2 522.1 -1.1 -0.2 
 10 27502 432.0 543.1 -0.9 -0.2 434.7 546.5 -1.2 -0.2 
50 nM 1 27500 408.5 513.6 0.0 0.0 414.6 521.3 -0.6 -0.1 
 2 27500 396.1 498.0 -0.1 0.0 397.5 499.8 -0.7 -0.1 
 3 27501 407.6 512.4 -0.3 -0.1 410.5 516.1 -0.7 -0.1 
 4 27499 427.3 537.2 4.9 0.9 430.1 540.8 4.4 0.8 
 5 27495 334.8 421.0 339.9 80.7 338.7 425.9 347.9 81.7 
 6 27494 358.1 450.3 35.8 7.9 361 454.0 35.8 7.9 
 7 27496 424.8 534.2 139.1 26.0 427.9 538.1 137.2 25.5 
 8 27495 408.1 513.2 11.2 2.2 410.2 515.8 10.1 2.0 
 9 27497 414.8 521.6 -0.2 0.0 416.7 523.9 -1 -0.2 
 10 27502 432.1 543.2 -0.4 -0.1 436.7 549.0 -1.2 -0.2 
100 nM 1 27500 409.8 515.2 0.6 0.1 414.5 521.1 -0.1 0.0 
 2 27500 394.5 496.0 0.6 0.1 397.6 499.9 -0.1 0.0 
 3 27501 408.3 513.3 0.5 0.1 411.1 516.8 -0.3 -0.1 
 4 27499 428.4 538.6 28.8 5.3 431.3 542.3 25.8 4.8 
 5 27495 336.3 422.9 405.2 95.8 338.8 426.0 404 94.8 
 6 27494 358.6 450.9 77.8 17.3 361.7 454.8 66.4 14.6 
 7 27496 424.9 534.3 318.7 59.7 428.3 538.6 307.7 57.1 
 8 27495 407.7 512.7 43.8 8.5 410.3 515.9 38 7.4 
 9 27497 415.6 522.6 0.4 0.1 415.4 522.3 -0.5 -0.1 
 10 27502 433.7 545.2 0.3 0.1 437.8 550.4 -0.7 -0.1 
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5.4.3 DNA Footprinting - Stage 2 
It was decided to investigate both sites for stage 2 to ensure that the precise footprint 
could be determined. For site 1, sequence 5 was combined with 3 base pairs from 
sequence 6 as shown below in Figure 5.24. For site 2, sequences 6 and 7 were combined 
with 5 base pairs from sequence 8 
Site1 
Start from DNA 5 LH and 3 bp of DNA 6 
                  GTTAGAGCTGAAGACTTAGAAGCTAAAGTTCGAAG:5 
                                                   ACTTAGAAGCTAAAGTTCGAAGGTG 
                       
                  GTTAGAGCTGAAGACTTAGAAGCTAAAGTTCGAAGGTG  38 bp 
Site2 
Start with DNA 7 and 3 bp from DNA 8. 
  AGTTCGAAGGTGAAGAGTACATATCGAAGGACTTC:7 
                               AGAGTACATATCGAAGGACTTCAAA 
 
  AGTTCGAAGGTGAAGAGTACATATCGAAGGACTTCAAA   38 bp 
 
Figure 5.24  The DNA sequences from the sco4121-4122 intergenic region which elicited the highest 
response in Stage 1 of the SPR experiment. In order to define the footprint, these sequences were 
combined with several base pairs from the subsequent sequence for Stage 2 of the experiment. MEME 
motif 1 is highlighted in yellow; MEME motif 2 in cyan. 
 
As with Sco3914, the strategy was to eliminate 2 base pairs from each end in turn to 
define the recognition sequence. In order to account for any effects from the linker 
sequence (such as stabilization of binding due to the extra bases), the linker was also 
attached to the forward strand sequence for deletions from the left hand side. Two base 
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pairs at a time were first removed from the right hand side of the sequence, followed by 
two base pairs at a time from the left. The sequences can be seen in Table 5.7. 
 
Table 5.7  Stage 2 DNA sequences for testing the binding of Sco4122 to its upstream DNA sequence. (a) 
Sequences to test the limits of the site 1 right hand boundary; (b) sequences to test the limits of the site 1 
left hand boundary; (c) sequences to test the limits of site 2 right hand boundary; (d) sequences to test the 
limits of site 2 left hand boundary. Sequences that complement the immobilized linker are in lower case.  
(a) Sco4122 Site 1 RH boundary 
Name Sequence 
Site1_RH_F GTTAGAGCTGAAGACTTAGAAGCTAAAGTTCGAAGGTG 
Site1_RH_R CACCTTCGAACTTTAGCTTCTAAGTCTTCAGCTCTAACcctaccctacgtcctcctgc 
Site1_RH_minus2_F GTTAGAGCTGAAGACTTAGAAGCTAAAGTTCGAAGG 
Site1_RH_minus2_R CCTTCGAACTTTAGCTTCTAAGTCTTCAGCTCTAACcctaccctacgtcctcctgc 
Site1_RH_minus4_F GTTAGAGCTGAAGACTTAGAAGCTAAAGTTCGAA 
Site1_RH_minus4_R TTCGAACTTTAGCTTCTAAGTCTTCAGCTCTAACcctaccctacgtcctcctgc 
Site1_RH_minus6_F GTTAGAGCTGAAGACTTAGAAGCTAAAGTTCG 
Site1_RH_minus6_R CGAACTTTAGCTTCTAAGTCTTCAGCTCTAACcctaccctacgtcctcctgc 
Site1_RH_minus8_F GTTAGAGCTGAAGACTTAGAAGCTAAAGTT 
Site1_RH_minus8_R AACTTTAGCTTCTAAGTCTTCAGCTCTAACcctaccctacgtcctcctgc 
Site1_RH_minus10_F GTTAGAGCTGAAGACTTAGAAGCTAAAG 
Site1_RH_minus10_R CTTTAGCTTCTAAGTCTTCAGCTCTAACcctaccctacgtcctcctgc 
Site1_RH_minus12_F GTTAGAGCTGAAGACTTAGAAGCTAA 
Site1_RH_minus12_R TTAGCTTCTAAGTCTTCAGCTCTAACcctaccctacgtcctcctgc 
Site1_RH_minus14_F GTTAGAGCTGAAGACTTAGAAGCT 
Site1_RH_minus14_R AGCTTCTAAGTCTTCAGCTCTAACcctaccctacgtcctcctgc 
Site1_RH_minus16_F GTTAGAGCTGAAGACTTAGAAG 
Site1_RH_minus16_R CTTCTAAGTCTTCAGCTCTAACcctaccctacgtcctcctgc 
 
(b) Sco4122 Site 1 LH boundary 
Name Sequence 
Site1_LH_F CACCTTCGAACTTTAGCTTCTAAGTCTTCAGCTCTAAC 
Site1_LH_R GTTAGAGCTGAAGACTTAGAAGCTAAAGTTCGAAGGTGcctaccctacgtcctcctgc 
Site1_LH_minus2_F CACCTTCGAACTTTAGCTTCTAAGTCTTCAGCTCTA 
Site1_LH_minus2_R TAGAGCTGAAGACTTAGAAGCTAAAGTTCGAAGGTGcctaccctacgtcctcctgc 
Site1_LH_minus4_F CACCTTCGAACTTTAGCTTCTAAGTCTTCAGCTC 
Site1_LH_minus4_R GAGCTGAAGACTTAGAAGCTAAAGTTCGAAGGTGcctaccctacgtcctcctgc 
Site1_LH_minus6_F CACCTTCGAACTTTAGCTTCTAAGTCTTCAGC 
Site1_LH_minus6_R GCTGAAGACTTAGAAGCTAAAGTTCGAAGGTGcctaccctacgtcctcctgc 
Site1_LH_minus8_F CACCTTCGAACTTTAGCTTCTAAGTCTTCA 
Site1_LH_minus8_R TGAAGACTTAGAAGCTAAAGTTCGAAGGTGcctaccctacgtcctcctgc 
Site1_LH_minus10_F CACCTTCGAACTTTAGCTTCTAAGTCTT 
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Site1_LH_minus10_R AAGACTTAGAAGCTAAAGTTCGAAGGTGcctaccctacgtcctcctgc 
Site1_LH_minus12_F CACCTTCGAACTTTAGCTTCTAAGTC 
Site1_LH_minus12_R GACTTAGAAGCTAAAGTTCGAAGGTGcctaccctacgtcctcctgc 
Site1_LH_minus14_F CACCTTCGAACTTTAGCTTCTAAG 
Site1_LH_minus14_R CTTAGAAGCTAAAGTTCGAAGGTGcctaccctacgtcctcctgc 
Site1_LH_minus16_F CACCTTCGAACTTTAGCTTCTA 
Site1_LH_minus16_R TAGAAGCTAAAGTTCGAAGGTGcctaccctacgtcctcctgc 
Site1_LH_minus18_F CACCTTCGAACTTTAGCTTC 
Site1_LH_minus18_R GAAGCTAAAGTTCGAAGGTGcctaccctacgtcctcctgc 
 
(c) Sco4122 Site 2 RH boundary 
Name Sequence 
Site2_RH_F AGTTCGAAGGTGAAGAGTACATATCGAAGGACTTCAAA 
Site2_RH_R TTTGAAGTCCTTCGATATGTACTCTTCACCTTCGAACTcctaccctacgtcctcctgc 
Site2_RH_minus2_F AGTTCGAAGGTGAAGAGTACATATCGAAGGACTTCA 
Site2_RH_minus2_R TGAAGTCCTTCGATATGTACTCTTCACCTTCGAACTcctaccctacgtcctcctgc 
Site2_RH_minus4_F AGTTCGAAGGTGAAGAGTACATATCGAAGGACTT 
Site2_RH_minus4_R AAGTCCTTCGATATGTACTCTTCACCTTCGAACTcctaccctacgtcctcctgc 
Site2_RH_minus6_F AGTTCGAAGGTGAAGAGTACATATCGAAGGAC 
Site2_RH_minus6_R GTCCTTCGATATGTACTCTTCACCTTCGAACTcctaccctacgtcctcctgc 
Site2_RH_minus8_F AGTTCGAAGGTGAAGAGTACATATCGAAGG 
Site2_RH_minus8_R CCTTCGATATGTACTCTTCACCTTCGAACTcctaccctacgtcctcctgc 
Site2_RH_minus10_F AGTTCGAAGGTGAAGAGTACATATCGAA 
Site2_RH_minus10_R TTCGATATGTACTCTTCACCTTCGAACTcctaccctacgtcctcctgc 
Site2_RH_minus12_F AGTTCGAAGGTGAAGAGTACATATCG 
Site2_RH_minus12_R CGATATGTACTCTTCACCTTCGAACTcctaccctacgtcctcctgc 
Site2_RH_minus14_F AGTTCGAAGGTGAAGAGTACATAT 
Site2_RH_minus14_R ATATGTACTCTTCACCTTCGAACTcctaccctacgtcctcctgc 
Site2_RH_minus16_F AGTTCGAAGGTGAAGAGTACAT 
Site2_RH_minus16_R ATGTACTCTTCACCTTCGAACTcctaccctacgtcctcctgc 
 
(d) Sco4122 Site 2 LH boundary 
Name Sequence 
Site2_LH_F TTTGAAGTCCTTCGATATGTACTCTTCACCTTCGAACT 
Site2_ LH_R AGTTCGAAGGTGAAGAGTACATATCGAAGGACTTCAAAcctaccctacgtcctcctgc 
Site2_ LH_minus2_F TTTGAAGTCCTTCGATATGTACTCTTCACCTTCGAA 
Site2_ LH_minus2_R TTCGAAGGTGAAGAGTACATATCGAAGGACTTCAAAcctaccctacgtcctcctgc 
Site2_ LH_minus4_F TTTGAAGTCCTTCGATATGTACTCTTCACCTTCG 
Site2_ LH_minus4_R CGAAGGTGAAGAGTACATATCGAAGGACTTCAAAcctaccctacgtcctcctgc 
Site2_ LH_minus6_F TTTGAAGTCCTTCGATATGTACTCTTCACCTT 
Site2_ LH_minus6_R AAGGTGAAGAGTACATATCGAAGGACTTCAAAcctaccctacgtcctcctgc 
Site2_ LH_minus8_F TTTGAAGTCCTTCGATATGTACTCTTCACC 
Site2_ LH_minus8_R GGTGAAGAGTACATATCGAAGGACTTCAAAcctaccctacgtcctcctgc 
Site2_ LHminus10_F TTTGAAGTCCTTCGATATGTACTCTTCA 
Site2_LH_minus10_R TGAAGAGTACATATCGAAGGACTTCAAAcctaccctacgtcctcctgc 
Chapter 5 – Sco4122 
 
211 
 
Site2_LH_minus12_F TTTGAAGTCCTTCGATATGTACTCTT 
Site2_LH_minus12_R AAGAGTACATATCGAAGGACTTCAAAcctaccctacgtcctcctgc 
Site2_LH_minus14_F TTTGAAGTCCTTCGATATGTACTC 
Site2_LH_minus14_R GAGTACATATCGAAGGACTTCAAAcctaccctacgtcctcctgc 
Site2_LH_minus16_F TTTGAAGTCCTTCGATATGTAC 
Site2_LH_minus16_R GTACATATCGAAGGACTTCAAAcctaccctacgtcctcctgc 
Site2_LH_minus18_F TTTGAAGTCCTTCGATATGT 
Site2_LH_minus18_R ACATATCGAAGGACTTCAAAcctaccctacgtcctcctgc 
 
The experiment was run using a similar method to stage 1 (using replicates of 3 different 
protein concentrations) and the results are displayed in Figure 5.25.  
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Figure 5.25  The results for Stage 2 of the footprinting experiment. Site 1 is shown in the top histogram and 
site 2 in the lower histogram. 
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For site 1, the results are clearer to interpret than for site 2. There is a pronounced 
decrease in binding of Sco4122 when 8 base pairs are removed from the right hand side 
of the sequence. The left hand side is slightly anomalous in that there is a marked 
increase in the binding when 6 base pairs are removed (> 100% of theoretical Rmax) which 
decreases significantly when 8 base pairs are removed. The limit has therefore been 
determined as 6 base pairs from either side (although it is entirely possible that it could 
be 5 or 7).  
Site 1 
RH -6 GTTAGAGCTGAAGACTTAGAAGCTAAAGTTCGAAGGTG 
LH -6  GTTAGAGCTGAAGACTTAGAAGCTAAAGTTCGAAGGTG 
This gives the footprint for site 1 as determined by this experiment as:- 
GCTGAAGACTTAGAAGCTAAAGTTCG  (26 bp) 
 
Site 2 is more complex: this was expected as the binding at stage 1 was ~50% of the 
theoretical Rmax at 100 nM and barely significant at 10 nM. Here, it is observed that there 
is virtually no binding at 10 nM and so the focus for this site shall be on 100 nM. 
Additionally, there is evidence for linker effects occurring as the binding of the full-length 
sequence when it is reversed (LH) is less than half of the Rmax obtained for the RH 
sequence.  
 
Site 2  
RH -0 AGTTCGAAGGTGAAGAGTACATATCGAAGGACTTCAAA 
LH -8 AGTTCGAAGGTGAAGAGTACATATCGAAGGACTTCAAA 
 
RH-0 is evidently favoured, but Sco4122 will tolerate RH-4. Strangely, whilst LH-0 is 
favoured, so is LH-8. The binding for these two sequences is very similar.  
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So either the whole sequence, or:- 
 GGTGAAGAGTACATATCGAAGGACTTCAAA (30 bp) 
or maybe even:- 
          GGTGAAGAGTACATATCGAAGGACTT  (26 bp) 
 
There is also the possibility that there may be elements of cooperative binding occurring 
whereby the proteins may associate laterally via the DNA-binding domains (Perera & 
Grove, 2010). This is purely speculative at this stage and requires much more detailed 
investigation as these data are not clear enough to be able to deduce the stoichiometry 
with any confidence.  
 
The main conclusion from this experiment is that site 1 contains the main footprint which 
has been defined as a 26 base pair sequence: GCTGAAGACTTAGAAGCTAAAGTTCG. This 
sequence is relatively AT rich at 58%: it has a GC content of just 42%, compared to 71% 
for the whole genome. A closer inspection of this sequence as it compares to site 1 
reveals that there are similarities between the two sites which could account for the 
binding at this second site at higher concentrations of protein. Sequence alignments of 
either the full-length site 2 or the 26 bp site 2 with the defined footprint sequence from 
site 1 indicate that there are similarities:- 
Taking the full length of Site 2 gives 42% identity for the following sections:- 
 G C T G A A G A C T T A G A A G C T A A A G T T C G   ( 2 6  b p )  
              A G T T C G A A G G T G A A G A G T A C A T A T C G A A G G A C T T C A A A (38 bp) 
Or 50% for the 26 bp sequence omitting 8 base pairs from the LH and 4 from the RH:- 
G C T G A A G A C T T A G A A G C T A A A G T T C G   ( 2 6  b p )  
G G T G A A G A G T A C A T A T C G A A G G A C T T   ( 2 6  b p )  
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Site 2 also overlaps the second motif found by MEME:- 
 
The location of these MEME motifs (of which there are 3) within the intergenic region is 
shown in Figure 5.26 and it is apparent that these two motifs are in close proximity 
(separated by only 5 base pairs).  However, as the binding is very small at this second 
motif, it was not investigated further in this study. Another interesting feature of these 
motifs is that none of them appear to have any obvious palindromicity, whereas several 
MarR homologues which have already been characterised tend to bind palindromic or 
pseudopalindromic sequences. HucR binds a pseudopalindromic sequence: two 8 base 
pair half sites which are separated by 2 base pairs approximately in the middle of a 101 
base pair intergenic sequence (Wilkinson & Grove, 2004). These are inverted imperfect 
repeats as opposed to direct repeats. This 2004 study concludes that the position of the 
binding site of HucR suggests that it may simultaneously repress the divergent hucR and 
uricase genes via a steric inhibition of RNA polymerase mechanism and so this has 
implications for the role of Sco4122. Like MEME motif 1 for Sco3914, motif 1 for Sco4122 
is located towards the centre of this intergenic region and so the question still exists as to 
whether Sco4122 represses its own transcription along with that of the divergently 
transcribed gene, sco4121. This remains an interesting hypothesis as sco4121 encodes a 
possible membrane protein which, according to the annotation in StrepDB, has a weak 
similarity to multidrug resistance proteins. This in itself does not imply a role for Sco4122 
in cellular defence mechanisms, but it does offer opportunities for further investigation.  
 
Figure 5.26  The location of the MEME motifs within the sco4121-sco4122 intergenic region.  
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5.5 PCR-Targeted Gene Disruption 
The M145sco4122 gene deletion strain was generated using the Redirect protocol (Gust 
et al., 2003), detailed in Chapter 2. The sco4122 gene is contained on the StD72a cosmid. 
Cosmids were checked for rearrangements by restriction digest and compared to the 
predicted digest fragment sizes by DNA gel electrophoresis (using the restriction tool on 
Streptomyces.org.uk). StD72a was digested with SacI. 
 
The primers used to amplify the disruption cassette from pIJ773 are displayed in Table 
5.8. The gene deletion was confirmed by PCR using the P1 and P2 flanking primers 
(Chapter 2) as well as the gene specific checking primers (Table 5.9).  
Table 5.8  Primers used to amplify the pIJ773 disruption cassette. The sequence which is complementary to 
the disruption cassette is shown in red. 
Forward CTTCAAAGCAAAGGAGTTGCGTGCCATACTGCGGCCATGATTCCGGGGATCCGTC
GACC  
Reverse  CCCGCAGAGGGCTGTCAAGCGTCGCTGTCAAGATCTTTATGTAGGCTGGAGCTGC
TTC 
 
Table 5.9  Primers used to verify positive transformants using PCR. 
Forward CCCACGTGGATCCGGCGCA 177 bp upstream of gene 
Reverse GTTACGGTCCCGTGGCAA 73 bp downstream of gene 
 
The mutagenized cosmid was then introduced into S. coelicolor by conjugation (detailed 
in Chapter 2) to undergo genetic recombination with the chromosomal DNA and so 
replace the sco4122 gene with the disrupted gene. Successful mutants were detected by 
replica-plating on SFM agar plates supplemented with 1) apramycin and 2) apramycin + 
kanamycin. Those colonies which are kanamycin sensitive were then further verified by 
PCR (using both the gene specific checking primers and the F1 and F2 flanking primers). 
Spore stocks of the mutant strains were then prepared as detailed in Chapter 2. 
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5.5.1 Screening the successful mutants 
The prepared spore stocks were screened for visibly detectable phenotypes by plating on 
a variety of media supplemented with different carbon sources (details in Chapter 2). 20 
different conditions were tested in total and the observations for each mutant were 
monitored over the course of a week. Sco4122 did not exhibit an observable phenotype 
which differed to that of the wild type on any of the conditions tested. This particular 
investigation was pursued no further.  
 
5.6 Conclusions 
The structure of Sco4122 shows distinct structural similarities to that of HucR, a urate 
responsive MarR homologue from Deinococcus radiodurans, despite their fairly divergent 
sequences. It is interesting that both structures exhibit the additional N-terminal α-helix, 
α1, the purpose of which remains to be determined, although the conservation of Trp20 
in HucR which interacts with the substrate urate would suggest that the presence of this 
helix is necessary to the function of the protein. Interestingly, at the equivalent position in 
Sco4122 is Tyr19, which could also participate in π-stacking to orientate an aromatic 
ligand, if this were to be the mechanism at work in HucR. Also of note is the interaction of 
Asp61 with Arg99, which mirrors the interaction between the Asp in α-helix 3 (α3) and 
the Arg in α-helix 5 (α5) in HucR. The disruption of this salt-bridge interaction in HucR by 
binding of urate is crucial to the reorientation of the DNA recognition helix. In Sco4122, 
there are also clear interactions between Trp62 in α3 and Trp130 in α5, and Thr60 (α3) 
and Arg96 (α5), all of which could also potentially communicate the presence of a ligand 
to the DNA-binding domain. Although at this point this conjecture is hugely speculative in 
the absence of any ligand-bound structural information for either protein, it is worth 
noting for future investigations with Sco4122.  Compared to other structural homologues, 
it would appear that Sco4122 is not preconfigured for DNA binding. Obtaining a structure 
of the protein-DNA complex would be another challenge for this particular regulator.  
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This study has also made significant progress towards the determination of the DNA-
footprint of Sco4122. One site has been shown to elicit strong binding and this site 
coincides with the first sequence reported by the MEME server, whilst there is the 
suggestion that there may be a second, lesser site, which may or may not have biological 
relevance. It does, however, correspond approximately to the second MEME motif and 
also has some sequence similarity to the first motif. The lack of an obvious palindromic 
repeat in this sequence is noteworthy as many MFRs have been shown to bind 
(pseudo)palindromic sequences. As with Sco3914, and HucR, the operator site for 
Sco4122 would appear to be located in the centre of the intergenic region and so could 
potentially block RNA polymerase at two operator sites. Thus the question remains as to 
whether Sco4122 regulates not only its own transcription but also that of the divergently 
transcribed sco4121, which encodes a possible transmembrane protein. Such an 
investigation would offer further insights into the role of this regulator and opportunites 
to uncover implications for other MFRs.   
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The work presented in this thesis describes three MarR family regulators (MFRs) from 
Streptomyces coelicolor on biophysical, genetic and structural levels. These repressors are 
clearly well represented in the S. coelicolor genome and Sco5413 is particularly well 
represented across the genomes of other actinomycetes. Therefore, uncovering details 
regarding their respective structures and DNA footprints can inform future investigations 
into other MFRs, from streptomycetes and other organisms. In this study, the structures 
of all three MFRs have been determined using anomalous dispersion methods. The DNA 
footprints for Sco3914 and Sco4122 have been defined and a phenotype observed for the 
deletion mutant of Sco5413.  
 
The structures presented in this thesis confirm that these MFRs are dimers and that they 
possess the characteristic features of MFRs: they have the typical topology α1-α2-α3-α4- 
(α5)-β1-β2-α5-α6, with α4 (or α5 in Sco4122) constituting the recognition helix in the 
helix-turn-helix motif, whilst the wing consists of the two antiparallel β-strands, β1 and β2 
and the intervening loop (Sco5413 has three β-strands). These are the DNA-binding 
domains in most MarR homologues. The dimerization interface comprises the α1, α5 and 
α6 (or α1, α6 and α7 in Sco4122) helices from each monomer which intertwine with each 
other. The dimer interface is rich in hydrophobic residues in all three structures. Whilst 
there are the obvious structural similarities between them, they also exhibit features 
which are unique to themselves. Sco3914, for example, has the slightly flatter shape 
which is reminiscent of HypR, with the reactive cysteines which may or may not be 
functionally relevant. Sco4122 is interesting in that it has the “extra” N-terminal helix 
seen in HucR and potentially required for the stabilization of a ligand. Sco5413tr has been 
truncated but bioinformatic analysis of the full-length structure would suggest that this 
protein also has an extra N-terminal helix with a conserved tryptophan residue which 
corresponds to part of the urate binding signature of HucR (Perera & Grove, 2011).  
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The structure of truncated Sco5413 (Sco5413tr), which was solved to 1.25 Å, is the 
highest resolution structure of a MarR homologue to date. Due to inherent flexibility of 
these proteins, which it has been proposed is critical to their function, Sco5413 was 
truncated in order to crystallize this protein, but a structure prediction for the full-length 
protein indicates that it would likely have the extra N-terminal helix seen in HucR and 
Sco4122. It also has a tryptophan in this putative helix which appears to be conserved in 
HucR and interacts with its substrate urate. The modified cysteine in Sco5413tr, which at 
first was anticipated may have some functional significance, does not appear to be well 
conserved and so it was not investigated further.  
 
The structures of all three MFRs were aligned (using Sco5413tr as the reference structure) 
with SSM Superpose (Krissinel & Henrick, 2004) and the results are displayed in Table 6.1. 
Table 6.1  Superimposition of Sco3914 and Sco4122 with Sco5413tr as the reference structure 
 
R.m.s. deviation (Å)/aligned residues 
Protein name Subunit Dimer 
Sco3914 1.8/99 3.4/198 
Sco4122 3.0/123 3.2/239 
 
 
Figure 6.1  Superimpositions of Sco3914 (pink and red) and Sco4122 (light blue and blue) onto Sco5413 
(reference structure in green) at both the subunit and dimer levels.  
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The positions of the DNA recognition helices were also measured (from the 
corresponding C-alpha atoms of the approximate mid-point residue of the helix) in order 
to estimate whether the proteins may be in conformations which would enable DNA-
binding. Sco3914 had a distance of 29.3 Å between the corresponding residues; Sco4122 
had a distance of 24.6 Å and in Sco5413tr the distance was 24.6 Å. Interestingly, 
Sco5413tr and Sco4122 exhibited identical distances despite the slightly different 
orientations of their respective helices exhibited in the superimpositions. The distance 
between major grooves in B-DNA is ~34 Å, thus Sco3914 would appear to be in a 
conformation suitable for DNA-binding whereas Sco4122 and Sco5413tr are perhaps not 
in such optimal conformations for interacting with the major grooves. However, the 
superimposition of Sco5413tr on the OhrR-ohrA complex looks reasonable, but the 
superimposition onto the SlyA-DNA complex suggests that there would be clashes 
between this helix and the DNA. Again, without more structures of MFRs in complex with 
their cognate DNA sequences, it is difficult to reach a firm conclusion about the 
predisposition towards DNA binding of this particular MFR. The positioning of the 
recognition helices in Sco4122 with respect to the DNA of the SlyA complex is much more 
dramatic: clashes are visually apparent and so the conclusion is that Sco4122 is not in a 
conformation which is compatible with DNA-binding.  
 
None of the structures present any indication of a specific ligand, but taking all three 
structures together and superimposing them with HucR and the first salicylate site from 
MTH313 (Saridakis et al., 2008), a putative pocket/ligand binding site may be 
hypothesized. The full-length Sco5413 has a tryptophan which may be the equivalent of 
Trp20 in HucR, which in HucR is required for the interaction with its effector ligand, urate.  
However, there the similarity appears to end as Sco5413 does not possess the other 
conserved residues which have been proposed to constitute a urate binding signature. 
The structure of Sco5413tr reveals a distinct channel which is lined by well conserved 
residues and this is possibly a binding site for ligands which may regulate the affinity of 
the protein for its cognate DNA sequence. This putative binding site may also be accessed 
from “underneath”, where there also appears to be a cleft. The extra N-terminal helix in 
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both HucR and Sco4122 appear to be well-anchored to the structure via interactions with 
residues from the other subunit and so perhaps this helix would be unlikely to move to 
accommodate a ligand.  
 
Figure 6.2  Putative ligand binding pocket of Sco5413tr and Sco4122, based on superimposition with HucR. 
Sco5413tr is in green; Sco4122 is in dark blue and HucR is in slate blue. 
 
Figure 6.3  View of the putative conserved binding site for a ligand. Salicylate (magenta) from the MTH313-
salicylate complex (PDB code 3GF2) is superimposed onto Sco5413tr (green). Sco4122 is in blue; Sco3914 is 
in red and MTH313 is in grey.  
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The presence of Cys16 from Sco3914 in this putative binding site may also still bear some 
significance, despite the findings in this work that it has a relatively high pKa (9.13) and 
would likely be protonated at a physiological pH. However, its formation of an adduct 
with β-mercaptoethanol does suggest that this residue could be readily modified by low 
molecular weight thiols and so this raises questions for future research into the function 
of Sco3914. The wing cysteine, Cys95, may have a more physical role in protein-DNA 
interactions which remains to be determined. Clearly, the modification affects DNA-
binding in the wild type and both C16S and C95S mutants. These cysteines are probably 
too far apart (~25 Å) to be involved in an intramolecular disulfide bond and these values 
are closely similar for the structures of the C16S mutant and the reduced form of the 
protein. Thus, at this point, the functional importance of these residues remains 
uncertain.  
 
The DNA footprints of Sco3914 and Sco4122 have been determined in this work and are 
as follows:- 
GCTGAAGACTTAGAAGCTAAAGTTCG  Sco4122 26 bp 
CAATAATTGCACACGCGGGCTATAT  Sco3914 25 bp 
The lengths of these two footprints seem to correspond to the typical MFR footprints 
shown in Table 6.2. 
 
The apparent lack of palindromicity in the DNA footprints determined for Sco3914 and 
Sco4122 is also quite unique in terms of MFRs which have been characterized to date, 
most of which have been shown to bind (pseudo)palindromic repeats. If the suggestion by 
Dolan et al. (2011) holds true and that an equivalent of the R86 in SlyA could potentially 
participate in an indirect readout of the DNA and is therefore able to recognize several 
slightly different sequences, then perhaps this lack of palindromicity could feature more 
prevalently as other transcriptional regulators are characterized.  
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Table 6.2  DNA footprints of several MFRs. (* correspond to multiple binding sites). 
Protein Organism Footprint (base 
pairs) 
Reference 
MepR Staphylococcus aureus 43*, 27 (Kaatz et al., 2006, Kumaraswami 
et al., 2009) 
MarR Escherichia coli 21 (Martin & Rosner, 1995) 
OhrR Xanthomonas 
campestris 
44* (Mongkolsuk et al., 2002) 
SlyA Salmonella typhurium 25 (Stapleton et al., 2002) 
HucR Deinococcus 
radiodurans 
21 (Wilkinson & Grove, 2005) 
MexR Pseudomonas 
aeruginosa 
28 (Evans et al., 2001) 
Sco3914 Streptomyces 
coelicolor 
25 This work 
Sco4122 Streptomyces 
coelicolor 
26 This work 
 
The presence of MFR structures in the PDB is increasing rapidly and, with the addition of 
more protein-DNA or protein-ligand complexes, significant advances could be made 
towards using these data to develop therapeutics aimed at these repressors. This would 
be extremely useful in the manipulation of the biosynthetic gene clusters in 
actinomycetes to increase the production of secondary metabolites. The data presented 
in this work will hopefully contribute to the growing wealth of knowledge in this area and 
follow-up work could include determination of the specific ligand as well as crystallization 
of the proteins with their cognate DNA sequences. These would allow us to structurally 
define the repression-derepression cycles of these proteins. On a more general level, 
these structures will contribute to our understanding of protein-ligand and protein-DNA 
recognition. 
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